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Candles 
The days of our future stand in front of us 
like a row of little lit candles --
golden, warm, and lively little candles. 
The days past remain behind us, 
a mournful line of extinguished candles; 
the ones nearest are still smoking, 
cold candles, melted, and bent. 
II 
I do not want to look at them; their form saddens me, 
and it saddens me to recall their first light. 
I look ahead at my lit candles. 
I do not want to tum back, lest I see and shudder 
at how fast the dark line lengthens, 
at how fast the extinguished candles multiply. 
Constantine P. Cavafy (1899) 
III 
Abstract 
There is little doubt today that ageing is a partially inherited characteristic with the 
environment playing an equally important role. In this project our aim was to 
elucidate the gene-gene and gene-environment interactions relevant to ageing through 
the use of theoretical models and the evolutionary theories of ageing. With our first 
model we establish for the first time the plausibility of an immunogenetic trade-off 
between reproduction and survival under infection pressure from the environment 
while making detailed predictions for the expected point of balance in two different 
countries, one developing and the other developed, together with predictions about the 
surprising speed with which an evolutionary transition between the two states can 
occur. In our second model we develop a detailed simulation program based on 
epidemiological studies to account for the action of the apolipoprotein gene in western 
populations, its association with lifestyle parameters, and its evolution over the last 2 
million years. We suggest a two-stage history for evolution of Apo E where the 
establishment of the E3 allele took place during the shift of humanoids to a meat-
based diet and the £2 allele started to appear slowly as a rare mutation. Later, with the 
spread of agriculture and the increasing longevity of humans, the alleles began to be 
selected more and more towards their current frequencies. Finally, we show how a 
combination of socioeconomic factors and the stochasticity of mortality can be the 
driving forces behind the heterogeneity seen in human populations today and reveal 
the key factors generating this heterogeneity. 
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1. Introduction 
1.1 Prologue 
Ageing and the finite nature of life have always been among the greater 
anxieties that people have to face. But the cruel face of ageing it is not death itself but 
the physiological decline that it brings to a once active and strong youth. In ancient 
Greek mythology ageing was known as one of the gods called Geras who was the 
ugly son ofNyx (Night) and Erebus (Darkness of the Underworld). 
Actually to define ageing is more difficult than expected since different 
organisms exhibit different age-related changes in a variety of basic processes. Even 
in a single species there is no one measurable quantity that characterizes the stage and 
rate of ageing. Instead we are forced to use general descriptions, which have value 
only when applied to populations, although they relate to properties of individuals. 
Ageing is often defined as the progressive loss of function accompanied by decreasing 
fertility and increasing mortality with advancing age (Kirkwood and Austad, 2000). 
This definition, although useful in general circumstances, refers to "progressive loss 
of function" which could mean anything from poor eyesight to poor thennoregulation. 
"Decreasing fertility and survival" are measurements best detennined for large 
populations, since they exhibit a great variability in individuals and small populations. 
Dcspite the fact that an adequate definition for ageing at the organism level 
remains problematic, the existing definitions are widely accepted and provide a sound 
basis for gerontological science. 
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1.1.1 Demography of ageing 
Human progress has produced a profound demographic change in favour of 
the old I. As biomedical science manages to fight more and more diseases, the 
probability that someone will reach old age keeps increasing. In the UK, life 
expectancy at birth at the start of the 20th century was 50.4 and 53.9 years for males 
and females respectively, while at the end of the century the corresponding numbers 
had risen to 74.6 and 79.6 years. Mean life span in 2021 is expected to reach 78.6 
years for men and 82.7 years for women (Table 1.1). Although declining child 
mortality played a significant role in the increase of life expectancy at birth, a 
corresponding increase has also affected life expectancy at older ages. For example, 
in the last 100 years expectation of life for men aged 80 rose by 2 years and for those 
aged 60 by 5 years, while it is expected to increase another 1.5 and 3 years 
respectively by the year 2021. These differences may not be big in absolute terms but 
an 80 year old man today has gained a 40% increase in life expectancy relative to 
1911, whereas the corresponding increase in life expectancy at birth has been 30%. 
Moreover the fraction of the population reaching age 100 in 1911 was just 1 in 10,000 
people, of whom 75% were woman. In 1950 the fraction increased to 2.5 in 10,000, 
while in 1996 it was 55 in 10,000 with 49 of them being women and 6 being men, i.e. 
55 times more than in 1911 (Table 1.2, and Figure 1.1) (Source: National Statistics, 
Social Trends 30 2000). 
I The tenn old can be used to describe both a centenarian and a 70 year old person, but in most 
countries the term old is used for the ages of 65+ years as the age at which one can begin to receive 
pension benefits (World Health Organisation). 
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Year 1911 1931 1951 1971 1991 1997 2011 2021 
At birth 50.4 58.0 66.1 68.8 73.2 74.6 77.4 78.6 
At age 20 44.0 46.5 49.4 50.9 54.2 55.5 58.0 59.1 
Males At age 40 27.5 29.5 30.8 31.8 35.2 36.4 39.0 40.( 
At age 60 13.7 14.5 14.8 15.3 17.7 18.8 21.0 22.0 
At age 80 4.9 4.8 5.0 5.5 6.4 6.7 7.7 8.3 
At birth 53.9 62.0 70.9 75.0 78.8 79.6 81.6 82.7 
At age 20 46.4 49.4 53.6 56.7 59.6 60.3 62.0 63.1 
Females At age 40 29.8 32.2 34.9 37.3 40.0 40.8 42.5 43.5 
At age 60 15.3 16.4 17.8 19.8 21.9 22.6 24.1 25.1 
At age 80 5.6 5.6 5.9 6.9 8.4 8.5 9.1 9.9 
Table 1.1. Expectation of life (years) at selected ages by gender, 1911 to 2021, 
within the United Kingdom (Amaranayake et aI., 2000). Data are three-year averages 
centred on the year shown. For 2001 the data are from the 1998-based national 
population projections. The expectation of life, shown in this table, is the average 
number of years which a person of that age could be expected to live, if the rates of 
mortality at each age were those experienced in that year. The mortality rates that 
underlie the expectation of life figures are based, up to 1996, on total deaths occurring 
in each year. 
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Males Females All 
1911 0.026 0.076 0.102 
1915 0.034 0.088 0.122 
1920 0.032 0.086 0.118 
1925 0.038 0.113 0.151 
1930 0.027 0.115 0.142 
1935 0.037 0.127 0.164 
1940 0.029 0.147 0.176 
1945 0.035 0.143 0.178 
1950 0.038 0.227 0.265 
1955 0.046 0.308 0.354 
1960 0.072 0.459 0.531 
1965 0.095 0.654 0.749 
1970 0.134 0.935 1.069 
1975 0.193 1.361 1.554 
1980 0.257 1.884 2.141 
1985 0.351 2.647 2.998 
1990 0.449 3.417 3.866 
1995 0.549 4.610 5.159 
1996 0.580 4.943 5.523 
Table 1.2. Number of centenarians per thousand of population in England and Wales, 
1911 to 1996 (Amaranayake et aI., 2000). 
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Figure 1.1. Increasing numbers (thousands) of centenarians in England and Wales 
between 1911 and 1995. Note the marked difference between males and females, due 
mainly to the greater longevity of women than men but partly also to the effect of 
wars (Amaranayake ct aI., 2000). 
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1.1.2 Gompertz-Makeham equation 
Despite the difficulties in defining ageing, a useful quantitative measure is 
based upon what is known as the Gompertz Law of Mortality, named after the British 
actuary Benjamin Gompertz. Gompertz (1825) observed that the mortality rate in 
adult humans increases in a geometric progression described by the equation: 
Jlx=a.ePx (1.1) 
where P is the "actuarial ageing rate" expressing how fast the force of mortality 
increases with age. The coefficient a is a measure of the "basal vulnerability". Basal 
vulnerability is the force of mortality extrapolated to age 0, although actual infant 
mortality is higher. What is missing from the basic Gompcrtz equation (1.1) is the 
distinction between intrinsic and extrinsic mortality, the latter representing the 
hazards of the environment that are independent of adult age. This is overcome by 
adding a new tenn y for the extrinsic mortality to give: 
Jlx = ex eP x + y (1.2) 
known as the Gompertz-Makeham equation. Equation (1.2) is flexible enough to 
account both for populations living under secure conditions (humans and captive 
populations) where the death rate is based mainly on the effects of ageing and also for 
populations in the wild where individuals living long enough to experience 
senescence arc rare. 
Promislow et al. (1996) have described how the Gompertz-Makcham equation 
fails to fit changes in mortality rate in certain invertebrate species (Caenorhabditis 
elegans, Drosophila melanogaster, Ceratitis capitata). The truth is that the 
Gompertz-Makeham model is too simple to fully describe the extremely complex 
phenomenon of ageing. Despite this, it is still the best approximation, in many 
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species, for the observed results of senescence without the need for more detailed 
mathematical models with complex and limiting assumptions. 
In Figure 1.2 the restrictions of the Gompertz model and its fit to the human 
death rates are easily observed when compared with mortality data for Britain in 
1991. One of the characteristics of a geometric progression is that it can be plotted as 
a straight line when the values of J.l are plotted on a logarithmic scale. The gradient of 
the line is equal to the rate of ageing P in the population. Figure 1.3 compares the 
observed rate with that predicted by equation 1.1. As can be seen the Gompertz 
model is a good description of the actual age-related changes in adult mortality but it 
shows a poor fit during very early deaths. In the rest of our work we will use the 
Gompertz-Makeham equation to account only for effects later in life. In cases where 
extrapolation to younger ages is required the results cannot be considered reliable (for 
a detailed description of patterns in early mortality see Lee, 2003). 
1.2. The Evolutionary Theories of Ageing 
The evolutionary theories of ageing try to explain in evolutionary terms the 
diversity of survival patterns between species and especially the universality, origin 
and shaping of senescence in higher animals (Kirkwood, 1985), in contrast to the 
view that ageing is just an inevitable characteristic of complex metazoans and requires 
no evolutionary explanation. 
1.2.1 Adaptive and non-adaptive theories of ageing 
The first distinction among the various evolutionary theories of ageing is 
bctwcen "adaptive" and "non-adaptive" theories (Kirkwood and Cremer, 1982). 
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Figure 1.3. Observed and fitted log transformed mortality curves. The characteristic 
of all exponential curves is that when they are plotted on a logarithmic axis they are 
transformed into a straight line. The gradient of the line represents the "actuarial 
ageing rate" ofthe population. The fit of the curve should be considered with caution 
since the age groups are not uniform and may slightly disturb the slope of the 
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Statistics). 
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Adaptive theories suggest that ageing itself is advantageous to the organism and is 
directly selected for. Thus between two organisms equal in all respects except the 
presence or absence of ageing, the one that undergoes senescence would do better. 
The non-adaptive theories suggest the opposite, i.e. that ageing is disadvantageous for 
the organism or at the best case neutral and that the trait selected for is longevity 
(Kirkland, 1989). Thus, the evolution of ageing must be explained indirectly 
(Kirkwood, 1985). 
1.2.2 Wallace 
The first evolutionary explanation of ageing was attempted by Alfred Wallace 
in an unpublished note, written between 1865 and 1870, with the title "The Action of 
Natural Selection in Producing Old Age, Decay, and Death". This was eventually 
published as a footnote in the English translation of Weismann's 1881 essay "The 
Duration of Life" (1881). 
"The deficiency of nourishment would lead to parts of the organism not 
being renewed; they would become fixed, and liable to more or less slow 
decomposition as dead parts within a living body. The smaller organisms 
would have a better chance offindingfood, the larger ones less chance. 
That one that gave off several small portions to form each a new organism 
would have a better chance of leaving descendants like itself than one 
which divided equally or gave off a large part of itself. Hence it would 
happen that those which gave offvery small portions would probably soon 
after cease to maintain their own existence while they would leave 
numerous offspring. "and " .. .for it is evident that when one or more 
individuals have provided a sufficient number of successors they 
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themselves, as consumers of nourishment in a constantly increasing 
degree, are an injury to those successors. " 
Wallace's theory was not developed in sufficient detail to be clear and it 
seems to combine adaptive and non-adaptive elements in its logic (Rose, 1991). 
Despite that, the first step towards an evolutionary account for the origins of ageing 
had been made and new and more challenging theories followed soon after. 
1.2.3 Weismann 
The first significant attempt to understand ageing from an evolutionary 
perspective was by Weismann (1881) who proposed that senescence is the result of an 
evolved limitation to the division potential of somatic cells. Weismann reasoned that 
this limitation evolved because it is beneficial to eliminate old and decrepit 
individuals, not because they are harmful but because they are a luxury. This first 
version of Weismann's hypothesis, which is the one for which he is mostly known 
today, is a pure adaptive theory with a programmed death mechanism. In this, old 
members of the population are assumed to be decrepit even in the absence of ageing 
leading to an obvious circular argument. 
However in a later essay, Weismann went on to propose a second non-
adaptive theory that considered old individuals as neutral and the evolution of ageing 
as a case of what he called "panmixia", where neutral characters deteriorate during 
evolution in a process similar to the loss of eyesight of cave-dwelling animals (for a 
full review of Weismann's ideas see Kirkwood and Cremer, 1982). 
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1.2.4 Mutation accumulation theory 
For many years after Weismann, evolution of ageing was neglected until 
Medawar (1952) put forward the basic principle for all evolutionary theories to 
follow. Medawar pointed out that in an age-structured population (Le. a population in 
which individuals can be segregated by age) the genetic contribution of the older 
members of the population to the production of new individuals is reduced with time 
independently of the presence of senescence. To follow Medawar's argument we 
have only to imagine a set of 1000 test tubes. If 10% of them are broken accidentally 
and in a random manner every month, we will have to buy 100 more each month to 
replace the breakages. If we do the same each month, the number of tubes from the 
original set will decrease irrespective of the existence of ageing or not. So the older 
the test tubes are, the smaller their number will be in the total just because they are 
exposed for longer to the hazard of being broken, consequently limiting their 
contribution to the future sets. In living organisms a similar process occurs through 
the random loss (by accidents, predation and disease) of individuals which affects 
more the old than the young members of the population even if there is no intrinsic 
biological ageing process, simply due to the fact that the old are exposed to danger for 
longer. Thus natural selection that maintains survival and fertility becomes weaker 
through the life history. Medawar (1952) proposed that this decline of the force of 
natural selection means that mutant alleles with deletcrious effects will reach a higher 
frequency in a mutation-selection balance the later the age at which they reduce 
fitness (Medawar, 1952; Partridge and Barton, 1993). This concept is now known as 
the "mutation accumulation theory" (Kirkwood and Austad, 2000). 
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1.2.5 Antagonistic pleiotropy theory 
Williams (1957) proposed an alternative to the mutation accumulation theory 
based on the same decline of the force of natural selection with age. The initial 
assumption is that senescence is an unfavourable character and its development is 
opposed by selection. To explain its presence, Williams suggest that senescence 
arises as the indirect outcome of selection acting on genes with different effects of 
fitness in different ages. This theory, now called the "pleiotropy" or "antagonistic 
pleiotropy theory" (Kirkwood and Austad, 2000) assumes that pleiotropic genes exist 
with opposite fitness effects at different ages or different somatic environments, being 
beneficial in earlier life but detrimental later. It must be noted that although William 
considers senescence as a result of adaptation his theory is a non-adaptive one since 
no selective advantage is recognised in ageing itself (Kirkwood, 1985). 
1.2.6 Disposable soma theory 
The newest and more unitary theory for the evolution of ageing is the 
disposable soma theory (Kirkwood, 1985; Kirkwood and Rose, 1991). In this, the 
organism is considered as a physical unit, transforming energy from its environment 
into progeny. In order to reach the point of progeny production though, it must use 
energy for growth, foraging, defence and repair. The theory then predicts that the 
energy invested in somatic survival and maintenance under the optimum allocation of 
energy is less than required to achieve intrinsic immortality. That optimum strategy 
for energy expenditure is based on the expected survival of the organism in the wild. 
Too high an investment in survival would be wasted when the organism dies, while 
too Iowan investment would result in premature death. So the disposable soma 
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theory is based on the underlying processes of somatic repair and maintenance closing 
the gap between mechanistic and evolutionary theories of ageing (Zwaan, 1999). 
1.2.7 Evolution of ageing and longevity 
Before we present the evidence for the different theories for the evolution of 
ageing we should briefly discuss the differences between longevity and ageing in 
terms of natural selection. As we saw earlier, evolutionary theory recognises that 
ageing originated and is maintained in life history as the result of a decrease in the 
force of selcction with age. According to this, ageing itself, or rather the rate of 
ageing, cannot be selectcd for since it is considcred as the result of ''un-selection'' or 
the by-product of selcction for anothcr character. In both mutation accumulation and 
optimality theories the parameter that is actually selected for is longevity. In the case 
of mutation accumulation, natural selcction postpones the action of deleterious genes 
towards older ages where the representatives of the age class can have little impact in 
the population, thus the proportion of survivors, i.e. the longevity of the individual, is 
the rclevant quantity and not the rate of deterioration which is the product of the 
changing selection force. When the optimality theories are considered, external 
mortality and its balance with reproduction are the two major contributing factors 
affecting the equilibrium of the trade-offs and the level of damage that can be 
tolerated at each age class, thus a shift in onc of thc two basic attributes will be 
selected through its effects on expected longevity and fecundity and not due to the 
amount of damage accumulated. Thus, although the term 'evolution of ageing' is 
often employed, it is 'evolution of longevity' that is often more appropriate except 
when one is specifically considering the origin of the processes of senescence. Within 
this thesis we shall follow customary practice and sometimes use the term 'evolution 
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of ageing' as a shorthand to refer to the evolution of the ageing process including 
longevity, although where greater precision is appropriate the term will be specified 
more precisely. This usage should not be taken to indicate any support for the idea 
that ageing, as a trait, has evolved for adaptive reasons. 
1.2.8 Evidence for the evolutionary theories of ageing 
Theoretical biology, as all other theoretical sciences, is based on the use of 
mathematics to provide explanations of empirical phenomena (for further discussion 
see Sober, 1993). Mathematical theories are based on assumptions of processes and 
they have requirements and predictions based on real processes or simple 
approximations of them. In order to verify a theory we need first to test its 
requirements and predictions logically-mathematically and then experimentally. In 
this section the attempts to investigate the modem evolutionary theories of ageing 
using model organisms will be described. The theories that are more or less widely 
accepted today are the mutation accumulation, the antagonistic pleiotropy and the 
disposable soma theory of ageing, the last two commonly being referred to as the 
optimality theories, since they are concerned with the optimal evolutionary strategy of 
the organism necessary to optimize its fitness, and they both require the existence of 
trade-offs. 
1.2.S. J Optimality theories 
The optimality theories have in common the idea of trade-offs, in the case of 
antagonistic pleiotropy, between early and late-life fitness traits, while for the 
disposable soma theory between maintenance and reproduction. We will now review 
the evidence for the existence of trade-offs in the life history of organisms. 
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One of the first methods used to test evolutionary theories experimentally was 
the separation of an initial laboratory Drosophila population into two groups, upon 
which different selection forces were exerted. One group was selected for early 
reproduction, termed the "young" line, while the other was selected for late 
reproduction, the "old" line. In one of the first experiments of this type Rose and 
Charlesworth (1981) found a negative correlation between early and late fertility and 
a significant negative correlation between longevity and early fecundity in the old 
line. Further experimental work using the same methodology of artificial selection 
(Luckinbill et aI., 1984) gave additional support to the trade-off between early 
fecundity and lifespan. Using similar principles Service et ai. (1988) exerted what 
they described as "reverse selection" for early-life fecundity in a population of 
Drosophila melanogaster that had previously been selected for late fecundity. They 
used the original population as a measure of comparison for the ability of the selected 
flies to return to their pre-selection state. Service et al. (1988) reported that during the 
course of reverse selection the early fecundity of the population increased 
significantly while their longevity decreased to the control levels as expected by the 
optimality theories of ageing. Partridge et al. (1999) also used the method of 'young' 
and 'old' lines to study trade-offs taking care to minimize gene-environment 
interaction and reported an increase in survival at the same time as a decrease in early 
life fertility, but contrary to most previous studies there was no increase in late-life 
fertility for old lines. It is possible that the increase of fecundity later in life, seen by 
others, was either an artefact of inadvertent selection for early breeding in the young 
lines or due to uncontrolled larval densities (Zwaan, 1993) 
Although the use of selection for late-life survival has provided valuable 
insight into the evolution of ageing and its mechanisms, these kinds of experiments 
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suffer from various problems (see Promislow et aI., 1996). Zwaan (1993) used an 
experimental design in which selection was applied directly for longevity. His results 
clearly showed that the long-lived females had lower fecundity than the short-lived 
ones at all ages. The disagreement with previous studies which reported higher late-
life fecundity for the old lines was attributed to the inability of experiments selecting 
on age at reproduction to distinguish between late-life fecundity selection and 
selection for longer lifespan. This raises the possibility of independent genetic 
variance between early- and late-life fecundity, or of interference from other 
correlated responses to selection, such as body size or developmental time. These 
considerations led Zwaan (1993) to propose that the observed increase in life span 
was due to the pleiotropic allocation of resources between maintenance and 
reproduction, as explained in the disposable soma theory, with lipid metabolism and 
starvation resistance playing an important role. 
Another approach to test the evolutionary theories of ageing and the existence 
of trade-offs is by the use of genetic correlation between fitness components of early 
and late life. If trade-offs exist between fecundity and age-dependent survivorship, a 
negative correlation is expected between the two traits, or a positive correlation 
between fecundity and Gompertz parameters (rates of ageing). On this basis, Hughes 
(1995) tried to test the validity of the mutation accumulation and pleiotropy theories 
using males of many different genotypes, but constructed to be identically 
heterozygous for the third chromosome which represents about 40% of the entire 
Drosophila genome. No correlations between fitness characters of early and late life 
were seen, except a weak relationship between male mating ability and Gompertz 
parameters of a not significant level. This does not necessarily mean that trade-offs 
were not prescnt in the life history of the male Drosophila. Hughes (1995) recognised 
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that the lack of significant negative correlations could be attributed to the lack of 
reproductive activity in the flies used for the survivorship assay and to the fact that 
only genes present on the third chromosome could be accounted for. Thus if the 
genes with the pleiotropic effects were on the other 60% of the genome, the method 
used would fail to detect their effects. In a similar experiment Tatar et al. (1996) used 
a very large population of flies, heterozygotic for the second chromosome, and 
reported a negative correlation between early fecundity (at age 3 days) and late-age 
mortality, while for older ages the correlation was positive. The first was explained as 
the result of the contribution of pleiotropy between early- and late-life fitness traits in 
ageing, while the second was suggested to be the result of accumulated mutations. 
Partridge and co-workers produced a series of experiments concentrating on 
the trade-offs between survival and fertility and their underlying mechanisms. Prowse 
and Partridge (1997) examined the effect of reproduction on future survival and 
fecundity of male Drosophila melanogaster by creating three groups of males: never, 
partly and always exposed to females. By reversing their mating status during the 
lifespan, they showed that the reproductive costs to fecundity far outweighed the cost 
to survival leading to the sterility of always-exposed males by an age when 70-90% of 
them were still alive. It was concluded that sterility made a much more important 
contribution to the evolution of ageing, defined as the decrease in reproductive value, 
than did death. On the same theme Sgro and Partridge (1999) went on to study the 
increase in death rates of female Drosophila after mating, and demonstrated the 
existence of a delayed wave of death following reproduction. They used females 
from young and old lines which they made sterile, either by irradiation or by the use 
of the dominant allele ovoDt which halts oogenesis in stage 4. In their conclusions, 
Sgro and Partridge (1999) suggested that this delayed wave of death might reflect 
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resource allocation between fecundity and survival as suggested by the disposable 
soma theory. Finally Sgro et al. (2000) studied the effect of selection for age at 
reproduction on female behaviour to test for correlation to selection. Their result 
suggested that the response of the flies with respect to age at reproduction is in part 
due to changes in the scheduling of female reproductive behaviour, with the young 
lines mating at higher frequencies early in life and old lines mating later, thus giving 
an underlying cause for the differences in reproduction that have been observed for 
the trade-off between fecundity and lifespan. 
The fitness traits of Drosophila and the trade-offs between them have recently 
been studied using new methods that are much more sensitive to detect changes in 
variance and correlations between the traits, or even target the specific genes 
involved. Steams ct al. (2000) used a new method that could solve many of the 
problems seen in experiments of selection for specific traits. They started by 
introducing an environmental challenge to the population leaving the system to find 
the right adaptation to solve it. They did this by manipulating the external mortality, 
artificially imposing high adult death rates on one line and low death rates on another. 
The results of the experiment confirmed the prediction of the optimality theories of 
ageing by exhibiting that there is no trade-off between early- and late-life fecundity 
but rather the trade-ofT is between early fecundity and late survivorship. To identify 
the specific genes responsible for this negative correlation between fecundity and 
survival, a promising study has been that of Silbermann and Tatar (2000) involving 
the molecular chaperone Hsp70, a heat shock protein whose main role is to provide 
protection of cells from denaturing stress. Using transgenic female flies engineered to 
overexpress Hsp70, they concluded that induced expression of Hsp70 improves 
thennotolerance and age-specific survival in the long tenn by inhibiting 
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differentiation and growth. Although the number of eggs produced by the female 
does not decrease, the adult progeny are affected by the protein's interference with the 
proportion of eggs that successfully hatch. Silbermann and Tatar (2000) proposed 
that Hsp70 imposed reproductive costs either by direct cost upon fertility, disrupting 
specific cellular processes during development, or by drawing resources for its own 
production from the pool of substrates available to the eggs. 
Although Drosophila has been the main organism for these studies, other 
organisms have also been used in selection experiments including the flour beetle, 
Tribolium castaneum, the bean weevil, Acanthoscedelis obtectus and the melon fly, 
Bactro cucurbitae where similar trends were found as in Drosophila melanogaster 
(for review see Zwaan, 1999). 
Another extremely important organism for research into ageing is the small 
nematode worm Caenorhabditis elegans, the organism in which specific genes 
significantly extending lifespan were first identified (Friedman and Johnson, 1988). 
These long-lived mutants have proved to be equally important in the elucidation of 
the mechanisms and evolution of ageing as the Drosophila selection studies seen 
earlier. In this case the focus is to find if the longer lived worms have a lower 
reproductive rate, and what are the genes responsible for the balance between them. 
Tissenbaum and Ruvkun (1998) studying the way that an insulin-like signal affects 
survival and reproduction in C elegans, found that weak daf-2 alleles and maternally 
rescued age-l alleles extending lifespan without arresting in dauer stage, also have the 
ability to reduce the fertility of the organism (see also part 1.3 for more on long lived 
C elegans mutants and dauer formation). The authors though, dismissed the idea that 
this reduced fertility was responsible for the extension of the lifespan (Tissenbaum 
and Ruvkun, 1998). Furthennore, evidence pointed to life shortening effects of some 
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modes of mating2 in C elegans, similar to those observed in Drosophila, providing 
further evidence for the existence of trade-offs (Gems and Riddle, 1996). In a study 
of 15 temperature-sensitive and 1 non-conditional daf-2 mutants, Gems et al (1998) 
found no decrease of brood size for the long living fonns. Intriguingly most 
organisms carrying da/-2 variants showed a significant reduction of unfertilized 
oocytes after the depletion of self spenn, thus pointing towards a possible trade-off 
between lifespan and number of oocytes produced. However puzzling results started 
to emerge for the causative nature of the trade-off. When the entire gonad of the 
nematode was removed there was no change in its lifespan, but if the gennline 
precursor cells were removed, with a laser microbeam, while the somatic gonad was 
left intact, a 60% increase was observed in the nematode lifespan (Hsin and Kenyon, 
1999; Riddle, 1999). This has led to the shift of our view for life-history trade-offs 
from a limited resource allocation mechanism to one of signalling, where a genn line 
originated signal represses the longevity of the organism, something that as we will 
explain later is not incompatible with the idea of a negative relationship between early 
and late life fitness (Leroi, 2001; Barnes and Partridge, 2003). 
In the case of vertebrates, selection experiments are much more difficult, 
while mutations that significantly extend lifespan are rarer. Nevertheless, natural 
populations of guppies (Poecilia reticulata) have been used to elucidate the ecological 
and evolutionary aspects of senescence. By manipulating exposure to predators, 
different populations of guppies were established, either with high or low predation. 
It was found that higher mortality rates led to earlier maturity and higher investment 
in early reproduction (Reznick ct aI., 200 I; Bryant and Reznick, 2004). In the case of 
birds the trade-off seems to operate between clutch size and adult survival 
2 C elegans can reproduce either as a hermaphrodite or by crossing with males 
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(Ghalambor and Martin, 2001; Nager et aI., 2001) where adult mortality can explain a 
significant amount of clutch size variation even when nest predation is controlled 
(Martin, 2002). Mice, the most common mammalian model, have also been used 
extensively in biogerontological research. Usually, experiments with mice are 
focused on the effect of dietary restriction on longevity, however in the last few years 
a number of mutations that extend lifespan have been found. Although these 
mutations are still not fully characterized, and the precise ways in which lifespan is 
affected are largely unknown, it has been found that at lcast for one of them, the dwarf 
mouse mutation, reproduction is greatly affected too, with most of the mice carrying 
the mutation being infertile (Liang et aI., 2003). Again, in the case of mice, as in C 
elegans, we should be cautious not to be misled into believing that the link between 
reproduction and longevity necessary signifies a causative relationship between the 
two. 
Lately there has been interest in the existence of similar trade-offs in humans, 
a highly controversial issue. These studies are mainly based on historical populations 
for which rccords for dates of birth, death and number of offspring exist. In the 
forefront ofthc debatc is the work ofWestendorp and Kirkwood (1998) which 
examined the relationship between longevity and reproduction using a historical data 
set from the British aristocracy. From the data it could be seen that when the study 
was restricted to women that reached menopause, female longevity was negatively 
correlated with number of children and positively correlated with age at first 
childbirth, confirming thc existcnce oftradc-offs. Westcndorp and Kirkwood's 
conclusion was criticised by Gavrilov and Gavrilova (1999) for failing to adjust the 
data for age at marriage, for overlooking confounding factors, such as the husband's 
fertility, and for using incomplete data. However in a reply to Gavrilov and 
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Gavrilova, Westendorp and Kirkwood (1999a) showed that neither of the first two 
concerns invalidated the finding, while they argued that although the data were 
inevitably incomplete, there was no reason why the missing data should have biased 
the comparison bctween women who dies at different ages in such a way as to 
produce an artifactual association. In a subsequent study on the genealogy of the 
British pcerage which went some way towards resolving the problem of 
incompletencss in the dataset, Doblhammer and Oeppen (2003) confirmed a strong 
correlation bctween parity and late-life mortality, even after correction for differences 
in hcalth and mortality before the age of 50. Lycett et al. (2000) examined the same 
relationship using records for a historical population that inhabited the Krummhorn 
region of north-west Gcrmany betwecn 1720 and 1870. The general data obtained 
from this analysis sccmed not to support the existence of trade-offs, but when social 
status was taken into account it was seen that for the poorest social group there was a 
negativc correlation bctwccn fecundity and survival. Similarly, Korpclainen (2000) 
found that an incrcase in longevity, at lcast in women, was linked with a decrease in 
the number of childrcn, but also, with a small increase in the number of surviving 
children. Finally, Thomas et al (2000), using data from 153 countries, also reported a 
ncgativc trcnd bctwccn fcmalc life span and fecundity, even after statistical correction 
for confounding factors. On thc other hand, there are historical population data that 
do not support the existcnce of such a trade-offs. Thcse are both older (Henry 1956, 
Gautier and Henry 1958, reviewcd in Doblhammer and Ocppen, 2003) and more 
recent studies (Le Bourg et aI., 1993; Wrigley et aI., 1997), but more interestingly 
direct long term observation of young women (20-30 years old) with bilateral 
salpingo-oophorectomy and no post operative hormonal replacement showed no 
influence in longevity (Nilsson et al., 2003b). The later can be attributed to an earlier 
24 
set of the trade-off in such a way that the actual investment in reproduction has 
already taken place in the level of precursor cells during early development, as seen 
earlier in the case of C. elegans, and the completion or not of reproduction during 
adulthood will have only a small effect under the specific environmental parameters. 
Despite the importance of studies on historical populations for our 
understanding of human ageing, they must be approached with great caution as their 
validity is based on many different factors, such as the detail of the kept records, 
duration of marriage, specific causes of death etc. Furthermore, the nature of the 
trade-off in humans, and in other animals, can have very complex dynamics. where 
the decrease in reproduction with increasing life span can be attributed to behavioural, 
economic or social reasons instead of physiological mechanisms (Mulder, 2000; 
Gavrilov and Gavrilova, 2002). 
1.2.8.2 Mutation accumulation 
Specific evolutionary predictions, that can be tested experimentally, can be 
made by mathematical models based on the mutation accumulation theory. Common 
simplifying assumptions are that mutations have an additive effect on age-specific 
survival and that they have the same probability to act at any age. These predictions 
are: a) the variance of fitness traits should increase with age; b) reverse selection 
experiments for early fitness, on lines produced from selection for late-life fitness, 
should only return to initial state slowly; c) the controlled introduction of spontaneous 
or directed mutations should accelerate the rate of senescence; d) inbreeding 
depression should increase with age (Promislow and Tatar, 1998). 
The change in fitness variance with age has been the most tested prediction of 
the mutation accumulation theory and has provided the most contradictory results. 
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According to the theory, the equilibrium frequencies of mutant alleles will increase 
with age due to the inability of natural selection to remove them from the population. 
Thus a decline in mean performance and an increase in the genetic variance of the 
population are expected with age. The requirement for an increase of genetic variance 
is fundamental, although it is not exclusive to the mutation accumulation theory. To 
test for an increase of genetic variance with increasing age, genetic variation for 
fecundity, mortality and male mating ability have been used, mainly in populations of 
Drosophila melanogaster. The first among many experiments to test the prediction 
for increased variance was that of Rose and Charlesworth (1981) which found no 
change in additive genetic variance with age. Engstrom et al. (1989) found an 
increased variance for fecundity, although questions have been raised about the 
mathematical manipulation of the results (Promislow and Tatar, 1998). Tatar et al. 
(1996) estimated the genetic variance for age-specific fecundity and reported a 
bimodal pattern, with peaks of the variance at 3 and 17-31 days, which they explained 
as the effect of mutation accumulation for the latter and the probable effect of 
selection maintaining variation in larval developmental rate for the former. Their 
analysis was therefore equivocal suggesting mutation accumulation as a major source 
of standing genetic variance for senescence without excluding the role of antagonistic 
pleiotropy. The genetic variance for male life history has been tested by Hughes 
(1995) who assayed male flies for age-specific competitive mating ability, age-
specific survivorship, body mass and fertility and obtained results in accordance with 
the mutation accumulation theory. 
Mortality is probably the most important feature of the life cycle in ageing 
research, and its genetic variation was first investigated by Hughes and Charlesworth 
(1994), who reasoned that if genes with deleterious effects are confined to older ages, 
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as the mutation accumulation theory states, then their frequency will increase with age 
and their mean value of fitness will decrease, increasing the genetic variability in the 
population. The results showed that genetic variability of mortality in the male D. 
melanogaster increased in later ages exhibiting substantial genetic and environmental 
variability. Promislow and Tatar (1996), using much larger sample sizes, observed an 
increase in the variance components for mortality but only during the first half of life, 
after which there was a marked decline. This unexpected decline in variance may 
have been due to a variety of reasons, such as temporal changes in laboratory 
conditions, variation in reproduction, demographic heterogeneity, insufficient sample 
size in very old age classes and finally, equally poor gene regulation in all genotypes. 
Promislow and Tatar (1996) rejected neither mutation accumulation nor antagonistic 
pleiotropy, but proposed that the assumptions made for the effects of the age 
specificity of rates and effects of polygenic mutations should be updated to account 
for the deceleration of mortality rates in older ages and heterogeneity. Pletcher et al. 
(1998) also found evidence for the increase of variance in early ages and its decline 
afterwards, suggesting that the absence of significant effects on mutation at older ages 
might have been responsible for this decline. 
The slow return to pre-selection phenotypes, in Drosophila experiments 
designed to test the optimality theory, can distinguish between mutation accumulation 
and antagonistic pleiotropy. In the first case the return is expected to be slow, since it 
relics on mutation-selection balance and drift, while for the second it will be rapid, 
since there is a positive selection force acting upon the trade-off between longevity 
and early-life fitness. Service et al. (1988) applied reverse selection for early-life 
fitness to a laboratory popUlation of Drosophila melanogaster that had been 
previously selectcd for postponcd senescence. The characteristics tested were early 
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fecundity resistance to stress of starvation, desiccation and ethanol. The results 
showed that early fecundity increased to control population levels while starvation 
resistance declined in accordance with a negative genetic correlation as predicted by 
the antagonistic pleiotropy theory. However desiccation and ethanol resistance did 
not decline, suggesting a lack oftrade-offs with early-life fitness components, 
providing possible evidence for the operation of mutation accumulation. Promislow 
and Tatar (1998) considered these results of Service et al. (1988) and found both 
methodological and theoretical problems. They concluded that the reverse selection 
response might be due to epistasis, combined with the different genetic background of 
the long-lived lines. 
Instead of testing the role of mutation accumulation in the evolution of 
senescence, the effect of controlled mutations on age-specific mortality can be 
directly assessed. In order to estimate the effect of mutations in ageing, Houle et al. 
(1994) created a set of mutation accumulation lines3 of Drosophila with the use of the 
SM I balancer chromosome and analysed 48 lines for the following traits: early and 
late fecundity, male and female longevity, male mating ability, early and late, 
productivity and body weight. The results showed that mutational effects were 
positively correlated among the young and old classes, although one of the 
requirements of the mutation accumulation theory is that mutations must have 
independent effects on early and late-life performance, otherwise changing the age 
where selection acts more strongly will have no effect on early-life fitness traits. 
Houle et al. (1994) concluded that the mutation accumulation theory is not enough to 
3 A mutation accumulation line is a Drosophila line that can accumulate mutations in the absence of 
selection against them. This has the effect that new mutations are fixed in the populations at almost the 
same rate as they appear. 
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explain the evolution of senescence, at least in D. melanogaster; and that mutation-
selection balance is sufficient to explain the additive genetic variance for fecundity 
and longevity. 
Finally, testing inbreeding depression can distinguish between mutation 
accumulation and antagonistic pleiotropy effects. Under mutation accumulation, if 
deleterious mutations have a higher frequency in older than in younger ages and if 
these mutations are recessive, as most mutations are, then inbreeding depression 
would be less in early than in later life. Charlesworth and Hughes (1996) developed a 
model to predict the age-related patterns of inbreeding depression and genetic 
variance. The theoretical predictions were later compared to experimental data of 
virgin male D. melanogaster and they found that in accordance with the mutation 
accumulation theory, the inbreeding load increased with age. Further work by 
Hughes and her team (Hughcs ct aI., 2002) using 10 isogenic lines and all the possible 
crossings bctwecn them, increasing the ability to detect dominance variance, found a 
dramatic increase of inbreeding effects with age, confirming their previous results. 
1.2.8.4 Conclusions 
As can be seen, the results obtained in different studies have not yet reached a 
definite and safe conclusion about the role of mutation accumulation theory and its 
complex rclation to the optimality theories. The contradictory results obtained, even 
from very similar cxpcrimcnts, cast doubts over the validity of some of the 
approaches used. The truth is that selection experiments using laboratory-adaptcd 
stocks may give rise to false conclusions, both for mutation accumulation and 
antagonistic pleiotropy thcories (Promislow and Tatar, 1998). Moreover the 
theoretical predictions of the model for the mutation accumulation theory assume that 
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fitness traits are normally distributed, that mutations affect only one age class, have an 
additive effect on survival and they all have equal effects, but none of the above is 
biologically realistic as can be seen from various studies (for more details see 
Promislow and Tatar, 1998). 
As for the optimality theories, from the experiments discussed, it is obvious 
that trade-offs between fecundity, especially early in life. and lifespan do exist. 
Despite that, the controversy continues about what kind of trade-offs there are, what 
are the mechanisms or the genes responsible, whether they are intrinsic or extrinsic, in 
which organisms they exist, and how important they are in the evolution of ageing. 
These are questions that are very difficult to answer based on our current knowledge 
and further investigation is needed both in model organisms and in humans with new 
methodologies that will overcome the limitations of the approaches used up to now. 
We can summarize our current ideas by saying that a number of different mechanisms 
of trade-offs in different levels of organization seem to exist. As we saw in part 
1.2.7.1, the classical view of life history theory for a direct resource allocation trade-
off has been enriched with behavioural, developmental, signalling, and 
immunogenetic mechanisms affecting the negative relationship between reproduction 
and survival. The trade-off of reproduction and survival is most likely controlled both 
by genetic mechanisms that carry the evolutionary history of the genus and through 
the plasticity of behaviour and early development responding to current experience in 
such a way that maximum fitness under the given conditions can be achieved. 
Probably. as many studies have shown (Snoke and Promislow. 2003), neither 
of the two theories can account for all the complex changes taking place during 
ageing. A more holistic view for the evolution of senescence is required that will be 
able also to account for recent findings such as deceleration of the mortality rate in the 
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very old, the decrease of genetic variance in the later part of life and the convergence 
and cross-over of mortality curves among cohorts in older ages. 
1.3 Genetics of Ageing 
So far we have considered general aspects of ageing and the theories put 
forward to explain its presence and evolutionary maintenance. Now we are going to 
consider the role of genes involved in ageing and longevity. As we saw earlier, 
senescence is detrimental to the organism, so we do not expect to see genes promoting 
ageing but rather genes evolved to confer longevity. 
The most straightforward way to search for longevity genes is generally held 
to involve the use ofmodcl organisms. Since the complexity of the interactions of 
genes within the genome and with the external environment increases with increasing 
level of organisation, the existence of lower organisms with a smaller number of 
genes and a clearer set of gene-environment interaction has proved a valuable tool in 
our efforts to elucidate the genetic mechanisms involved in ageing and longevity. 
However it is also apparent that a clear theoretical framework is essential to generate 
predictions that can make such studies much more efficient. We now consider the 
major model organisms used for studies in the genetics of ageing 
1.3.1 Saccharomyces cerevisiae 
The first organism to be considered will be Saccharomyces cerevisiae, better 
known as baker's yeast. S. cerevisiae is a unicellular organism with its lifespan 
measured usually by the number of times it divides, i.e. by the number of daughter 
cells produced (Jazwinski, 1999a). Various genes have been implicated in the ageing 
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process in yeast; the first to be studied were the RAS genes involved in metabolic 
control and stress resistance. In particular RAS2, which encodes a homologue of the 
mammalian signal transduction protein c-H-ras, operates as a part of a nutrient sensor 
having a central role in cell growth and division through several signal transduction 
pathways. These lifespan extending effects of the gene are exerted through at least 
two different pathways of metabolic and proliferation control; in one by the 
stimulation of adenyl ate cyclase, while in the other through the Mitogen Activated 
Protein (MAP) kinase pathway, both of them also being involved in cell growth and 
differentiation of multicellular organisms (Jazwinski, 1998). In addition, RAS2 plays 
an important role in stress responses through the Hogl kinase, which is a member of 
the MAP pathway. Hogl is a homologue ofp38 kinase (also belonging to the MAP 
pathway) responsible for stress response in mammals (Jazwinski, 1999a). RAS2 may 
operate in different ways to affect the ageing process, either as an adaptation gene 
compensating for a decline in homeostasis with age, or as a regulator of maintenance 
processes preserving homeostasis (J azwinski, 1999c). 
Other important genes for postponed senescence in yeast are the CDC7, 
CDC25, SIR4 and SIR2, SGSl, PHBl12 and the retrograde regulation genes (RTGl, 
RTG2, RTG3). CDC7 is a protein kinase, regulating cell cycle control and 
transcriptional silencing. CDC25 is involved in the glucose response signalling 
pathway, its mutants (cdc25-l0) mimicing caloric restriction and having an increased 
lifespan. The SIR complex is a transcription silencer of telomeric genes and of genes 
required for sexual mating (HML and HMR) (Finch and Tanzi, 1997). The SGSJ gene 
is a DNA helicase with a role in DNA recombination. An interesting feature of SGSl 
is its homology to the human gene for Werner's syndrome, showing a 24% identity 
and a 34% similarity (Saccharomyces Genome Database). The retrograde regulation 
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genes were first identified in studies with "petite" yeast (cells lacking fully 
functioning mitochondria) and they are responsible for an intracellular signalling 
pathway between nucleus and mitochondria, the retrograde pathway, which leads to 
the induction of expression of nuclear genes (Jazwinski, 1999b). Other genes found 
in "petite" yeast cells are the PHBJ and PHB2 coding for mitochondrial proteins, 
homologous to the human prohibitin gene, whose function is to interact with RAS2 
and adjust the mitochondrial activity (Jazwinski, 1999b). 
Lately, even more genes affecting yeast lifespan have been identified, like 
Rpd3, a histone deacetylase required for proper timing of replication origin firing and 
repression of transcription of other genes; and the HXT and HXK genes and the SnfJ 
kinase complex involved in glucose sensing and calorie restriction (for a recent 
review of the genetics of yeast ageing sec Bitterman et aI., 2003). An emerging key 
factor in yeast ageing is the SIR2 gene, which suppresses rDNA recombination. The 
rDNA locus, comprising 10% of the yeast genome, consists of 100-200 tandemly 
arrayed 9kb repeats coding for the rRNA. Only about half of rDNA repeats are 
transcriptionally active at any time. Homologous recombination between adjacent 
repeats leads to the formation of extra-chromosomal circular forms ofrDNA known 
as ERCs, which probably titrate the replication and transcription machinery of cells 
and result in its death (Sinclair and Guarente, 1997). Since the SIR2 gene is 
responsible for suppressing this recombination, its importance in the longevity of the 
yeast is evident. 
1.3.2 Caenorhabditis elegans 
The nematode worm Caenorhabditis e1egans, a member of the Rhabditidae, is 
the first organism in which "ageing" genes were identified. This roundworm, of 
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around Imm in length, is a mainly self-fertilizing hermaphrodite and its life cycle 
takes about 15-20 days at 20° C, making it ideal for ageing research. The first gene to 
be identified was age-I, also known as daf-23, a member of the daJfamily of genes 
(Morris et al., 1996). These are involved in entry into the dauer larval stage, a long-
lived stress-resistant dispersal form that the organism uses under adverse conditions. 
Known dafgenes with effects on longevity are the daf-2, age-i and daf-i6, the first 
two being dauer-constitutive (enter dauer stage even without the otherwise essential 
pheromone signal) while the third is dauer-defective (not able to enter dauer stage). 
Cloning of daf-2 and age-i suggested that they participate in a signal transduction 
cascade similar to what is found in vertebrates (Hekimi et al., 1998). age-i encodes a 
PI3-kinase while daf-2 encodes an insulin receptor transmembrane tyrosine kinase. 
All three of the genes discussed are involved in the insulin/insulin-like growth factor 
1 (IGF-I) endocrine system, which seems to be evolutionarily conserved from the 
nematode to humans. Two tissues, the sensory system and the reproductive system 
are believed to regulate lifespan by influencing the components of the DAF-2 
insulin/IGF-I pathway (Guarente and Kenyon, 2000). The DAF-2 pathway, in 
addition to ageing, affects reproduction, lipid metabolism and dauer formation 
independently of one another. Its main effect in ageing is exerted through daf-i6, a 
transcription factor that regulates a variety of genes including those involved in stress 
response, antimicrobial defence and metabolism, while at the same time repressing 
specific life-shortening ones (Murphy et al., 2003). 
Other genetic mechanisms extending the lifespan of C elegans are also 
considered. Mutants of the clock gene (elk) also show extended life span and exhibit 
slow development, lengthened cell cycle, and changes in behaviour such as slower 
oesophageal pumping and swimming rates. clk-l encodes a protein which is highly 
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conserved in all eukaryotes, its yeast homolog COQ7 being a nuclear-encoded 
regulator of mitochondrial function, which indirectly regulates the transcription of 
genes responsible for growth on non-fermentable carbon sources (Finch and Tanzi, 
1997; Hekimi et aI., 1998; Jazwinski, 1999b). It is believed that the longevity effect 
of clk-l is, at least partially, achieved by the redaction of extramitochondrially 
produced ROS (reactive oxygen species). Yeast, worms and mice seem to accumulate 
dcmethoxyubiquinone instcad of ubiquinone in the transport chain in the absence of 
elk-I, thus reducing the generation ofROS during respiration (Hekimi and Guarente, 
2003). 
1.3.3 Drosophila melanogaster 
A more complcx model organism than those considered up to now, commonly 
used for genetic studies, is the fruit fly Drosophila melanogaster. The fruit fly has 
proved to be a very useful and powerful model in ageing research, its role spanning 
from the development of early ageing hypotheses, such as the rate of living 
hypothesis, to recent evolutionary experiments and from demographic studies of 
patterns of mortality to the plasticity of life span (reviewed in Helfand and Rogina, 
2003). In addition to its significance in demographic studies, Drosophila has also 
been used to elucidate the genetic and physiological mechanisms of longevity. These 
studies have shown an inverse relationship between enhanced stress resistance and 
life span. Different lines exhibit resistance to different stresses but the most common 
are starvation, desiccation, heat, ethanol and most importantly oxidative stress 
associated with increased levels of antioxidant enzymes (Jazwinski, 1998). The 
oxidative stress hypothesis states that oxygen radicals generated during metabolism 
can damage proteins, lipids and DNA in the cells of the organism; mutations in genes 
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that reduce the activity of anti-oxidant enzymes such as superoxide dismutase (SOD), 
Mn superoxide dismutase (SOD2), catalase and thioredoxin reductase (TxrR) also 
reduce the lifespan of the fruit fly. On the other hand, experiments trying to increase 
the activity of the genes responsible for these enzymes throughout life (Orr and Sohal, 
1994) were unable to give consistent results, probably due to the significance of early 
development and maternal effects in Drosophila (Helfand and Rogina, 2003). Studies 
focused only in adults have managed to see a consistent life span increase of 10-20% 
(Sun and Tower, 1999). Recently it was shown that the effects of SOD on longevity 
are genotype- and sex-specific, with gene x genotype epistasis interactions playing an 
important role (Spencer et aI., 2003). In the case of starvation resistance, another 
important determinant for Drosophila longevity under stress, phosphoglucomutase, an 
enzyme controlling the utilization of glucose, may play an important role, since it is 
part of an elaborate mechanism affecting the total stored calories in the fly (Rose, 
1999; Montooth et aI., 2003). 
A promising case of a longevity mutation is the P-element insertion mutation 
of the methuselah gene conferring approximately 35% increase in average life-span 
and enhanced resistance to stresses such as starvation, high temperature, and free-
radicals. The methuselah gene codes for a protein of the G-protein receptor family, a 
group of receptors involved in a wide range of biological activities including 
neurotransmission, hormone physiology, drug response and transduction of external 
stimuli (Lin et aI., 1998). Specifically the mth gene may playa role in maintaining 
homeostasis and metabolism modulating cellular functions in response to stress. 
Recently, a second longevity gene was found in Drosophila named Indy (for I'm not 
dead yet) resulting in a doubling of average life-span and a 50% increase in maximal 
life-span (Rogina et aI., 2000). Although specific details for the function of Indy are 
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not known, it is closely related to a mammalian sodium diearboxylate co-transporter, 
a membrane protein that transports Krebs cycle intermediates, and it is expressed in 
the fat body, gut and oenocytes suggesting that Indy probably has a role in the 
absorption of metabolites and in intermediary metabolism. 
Finally, of great interest and importance is the effect of insulinlIGF signalling 
in Drosophila ageing. Earlier we saw how daf-2 and daf-16 can more than double the 
life span of C elegans. Screening of a number of mutations in each of the known 
components of the InsulinlIGF signalling pathway in the fruit fly, led to the discovery 
of three genes extending the Drosophila lifespan, the InR and DpllO, equivalents of 
the nematodes daf-2 and age-l respectively, and chico, an insulin receptor substrate 
with no nematode equivalent (Gems and Partridge, 2001). InR affects neurosecrotory 
tissue responsible for juvenile hormone. Homozygous InR mutants are lethal while 
heteroallelic flies are usually viable, dwarf and infertile adults, with females having 
ovaries similar to the diapaused wild-type. From all the different InR mutants, 
females of InRP5545/InREI9 have a reduced age-specific mortality and an 85% 
extension in longevity. The fact that not all InR alleles have the ability to increase 
lifespan has been attributed to complications in early development that continue later 
in life (Tatar et aI., 2001). In contrast to InR, chico homozygous female mutants were 
viable, and exhibited an increase of 48% median and 41 % maximum life span, while 
homozygous males were slightly short lived. The null allele chico l heterozygotes, 
showed a 36% and a 13% increase in median life span for females and males 
respectively. Additionally, heterozygote females are sub fertile while the 
homozygotes are almost sterile. In this case, as in InR, the gene leads to a reduced 
body size but in a recessive fashion, in contrast to its life extending effects that are 
semidominant and independently regulated from size (Clancy et al., 2001). The 
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existence of similar, evolutionarily conserved mechanisms between Drosophila and C 
elegans for the extension of life is of great importance in the biology of ageing and 
our understanding of its mechanisms. 
1.3.4 Mammals 
Among mammals, the organism most frequently used in laboratories for 
genetic research is the mouse. Genetic studies in mice concentrated mainly on the 
association of the immune system, and especially the Major Histocompatibility 
Complex (MIlC) to ageing. The results show a positive correlation between immune 
responsiveness and longevity (Jazwinski, 1996). Certainly, by far the most studied 
aspect of mice longevity is the effect of caloric restriction. Caloric restriction usually 
refers to diets providing an energy intake 30%-40% less than that obtained by animals 
fed ad libitum, or to the maintenance of the animals at a reduced stable weight. A 
40% reduction of calories, or a 50% weight compared to freely fed mice shows a 20-
40% increase in longevity4. Caloric restricted mice are smaller, with smaller major 
organs and less fat, while their fertility decreases or stops completely, with puberty 
and menopause occurring later. The effects of restricted energy intake are dependent 
on sex, stage of development, duration of the treatment and level of restriction 
(reviewed in Shanley and Kirkwood, 2000). The precise changes caused by caloric 
restriction in the organism, or their specific mechanisms, are still debated but 
generally there is an up-regulation of somatic maintenance and repair. One 
hypothesis for the underlying mechanisms is that by decreasing the energy intake, the 
oxidative damage is also decreased, due to lower energy flux and metabolism, thus 
slowing ageing. Unfortunately despite the great number of experiments conducted, 
4 Similar extension oflifcspan due to caloric restriction has been reported in rodents, yeast, worms and 
lately in primates. 
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the results obtained are largely unreliable, especially for the in vivo confirmation of 
the idea (Merry, 2004). If indeed caloric restriction can affect the production ofROS, 
then similar genetic pathways to those discussed for the other model organisms and 
their resistance to stress should be considered in mammals. The only mutant known 
to have increased resistance to oxidative stress and prolonged lifespan is the p66shc-l -
mouse. The p66shc is a splice variant ofp52shc/p46sch situated on the mammalian She 
locus and it is a cytoplasmic signal transducer, transmitting mitogenic signals from 
activated receptors to Ras (a homologue of RAS2, seen earlier in yeast). Mutation of 
the p66shC increases oxidative stress resistance in the intracellular and organism level, 
while its normal function is to be activated by ROS, and through p53, to induce 
apoptosis (Migliaccio et aI., 1999; Napoli et aI., 2003). 
In contrast with the organisms considered up to now, where a single 
insulinlIGF receptor exists, mammals have several homologous receptors including 
the insulin receptor and the IGF-I receptor (Gems and Partridge, 2001). Most of the 
long lived mutant mice show disruptions in the regulation oftheir hormone balance. 
Hereditary dwarfism in mice has led to a number of different models for extended life 
span. The Ames dwarf mice arc small and deficient in growth hormone (GH), 
prolactin and thyroid hormone. Although they are born with a normal size, their 
postnatal growth is retarded, reaching only one third of the size of their wild type 
siblings. It has been found that they can outlive the wild type mouse by around 350 
days for the males and more than 470 days for the females. (Brown-Borg et aI., 1996). 
A point mutation in the Prop-J gene which sits upstream of the pituitary specific 
transcription factor-l (Pit-I) gene and is required for its activation, is responsible for 
the effect (Liang et aI., 2003). Very similar are the Snell dwarf mice, with the point 
mutation directly in the Pit-l gene preventing the DNA binding of its product, thus 
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leading again to pituitary honnone deficiency and a 50% reduced adult size. The 
effects of the homozygous mutation on longevity are highly controversial but recent 
studies showed a 40-50% extension for females, while in the case of males husbandry 
conditions could lead to either a reduction (when housed with nonnal males) or 
increase (when housed with nonnal females) oflife span (Flurkey et aI., 2002). Since 
both Ames and Snell dwarf mice have a defect in exactly the same pathway, they 
share a lot of their characteristics, including reduced metabolism, body core 
temperature, infertility and most importantly very low levels of plasma insulin, IGF-I 
and glucose. Growth honnone stimulates IGF-l production, leading us to believe that 
the life extending effect of the mutations are due to a reduction of the insulinlIGF-1 
signalling pathway in a similar way to that seen in C elegans and Drosophila (Gems 
and Partridge, 2001). Further evidence for that can be found in the "little mouse" and 
GHRlBP knockout mice model. Having a missense mutation in the Ghrhr locus the 
"little mouse" is defective in the response to the hypothalamic peptide GH releasing 
honnone, having 1 % of the nonnal GH level and two thirds of the nonnal adult size. 
The homozygous genotype increases the life span of the mice by around 25% ,for 
both sexes, compared with the normal heterozygous for the Ghrhrlit gene (Flurkey et 
aI., 2001; Liang et aI., 2003). GHRlBP gene encodes two proteins, the growth 
honnone receptor (GHR), a membrane-bound receptor with a major role in the signal 
transaction process, and the growth honnone binding protein (GHBP) that probably 
modulates the level of circulating GH. The specific locus is also responsible for the 
Laron syndrome in humans, a fonn of hereditary dwarfism. GHRlBP knockout mice 
are also dwarfs with a weight of 40% relative to the wild type and increased fat 
accumulation, while they exhibit an increase in longevity of around 50%. The low 
IGF-llevcl confirms the idea that the lack ofGH signalling reduction is responsible 
40 
for alteration of the insulinlIGF-l pathways, thus decreasing the ageing rate of the 
organism (Coschigano et aI., 2000; Coschigano et al., 2003; Liang et al., 2003). 
Studies to examine the association between IGF-l and survival in mammals 
directly, found that mice null for the insulin-like growth factor-l receptor (IGF-IR) 
were dying in birth, probably due to respiration problems. On the other hand, the 
heterozygous knockout mice were viable, without developing dwarfism, and with 
normal metabolism, nutrient uptake, physical activity, fertility and reproduction. The 
level ofIGF-l was halved, as was the IGF-IR signalling response, while importantly 
there was a 26% increase in longevity (Holzenberger et al., 2003; Liang et aI., 2003). 
Finally, mice with a fat-specific insulin receptor knockout (FIRKO) also had an 
increase in mean life span of 18%. These animals had normal levels of the insulin 
receptor in all tissues except adipose tissue, where it was only 10-15% of the wild 
type. When food intake was measured as per gram body weight, the FIRCO mice 
seemed to consume more food despite the fact that they had a 50-70% decrease in 
body fat. Interestingly these knockout mice were able to maintain a normal glucose 
tolerance at 10 months of age in contrast to the wild type (Bluher et aI., 2003; Liang et 
aI., 2003). The latter leads to the interesting idea that caloric restriction and IGF-l 
signalling in mammals might work in similar or even linked ways to extend the life 
span of the organism. Work to validate this idea has proved that if a relationship 
exists it is certainly not a simple one and further work is needed (reviewed in Gems 
and Partridge, 2001). 
1.3.5 Other model organisms 
Other organisms are also used as models for research into ageing. One of the 
emerging models is the zebrafish Dania reria which combines vertebrate biology with 
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ease of large-scale mutational experiments. Although the zebrafish has been 
extensively used in other branches of biology, especially developmental biology, its 
potential significance for gerontology has only recently become evident (see Gerhard, 
2003). Another underrepresented class of animals in longevity studies is the Aves. 
Birds are long-lived homeotherms living up to three times more than mammals of 
equivalent size (Holmes and Ottinger, 2003). Their ability to live much more than 
mammals, while having a twofold metabolic rate compared to them, suggests that 
birds have specific adaptations against free-radical damage, a key parameter for 
cellular senescence. Moreover, various bird species have been used as models for a 
variety of ageing associated processes such as reproduction, neurodegeneration and 
respiration (reviewed in Holmes and Ottinger, 2003). Comparable to caloric 
restriction in other model organisms, many studies have tested the effects of dietary 
intake on breeding and overall health in birds (Walsh and Brake, 1999). The most 
popular avian laboratory models that can find further use into ageing research are the 
Japanese quail (Coturnixjaponica), the Budgerigar (Melopsittacus undulatus) and the 
canary (Serinus canaria) which are relatively short-lived species although wild 
species could also be used,as the white-crowned sparrow (Zonotrichia leucophrys), a 
model that has been extensively studied in the fields of neurobiology, nutrition and 
physiology (reviewed in Holmes and Ottinger, 2003). Nonhuman primate models 
have been used for a long time in biogerontological studies, especially to elucidate the 
physiological changes with ageing in various organs, as the brain and the heart, and to 
study age related diseases such as cardiovascular disease and diabetes. Caloric 
restriction studies suggest that similar mechanisms operate in primates as in other 
mammals with late maturity, increased insulin sensitivity and lower triglyceride levels 
and cholesterol (Lane, 2000). Genetic studies though, are very rare, or non-existent, 
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in nonhuman primates, mainly due to the extremely complex relationships in gene-
gene and gene-environment interactions and the lack of any known long-living 
mutations. 
1.3.6 Humans 
We have discussed the use of different model organisms to elucidate the 
genetic mechanisms behind ageing and longevity. Although these are very useful for 
the description of basie mechanisms of senescence in the molecular level their 
relevance to human ageing should be approached with great care. Despite the obvious 
common ancestry of humans and model organisms, the precise evolutionary pressure 
experienced by different phylogenetic groups and developmental schedules in the 
history of life might have significantly altered the importance and precise associations 
of pathways, even if initially they seem as evolutionary conserved in terms of basic 
function. Moreover, the main focus of our anthropocentric science is to improve 
human life expectancy and health. Ethical and practical problems make direct genetic 
studies and interventions in humans impossible. Nevertheless alternative ways have 
been found, mainly through the use of association studies and linkage analysis. 
Association studies, which are the most popular way to check for longevity genes, test 
for non-random associations of candidate genes with longevity in unrelated 
individuals (Dc Bcnedictis et aI., 200 I). Linkage analysis is designed to test for non-
random segregation at a marker locus in a pedigree and is much more difficult due to 
its requirements for two or more very old individuals in more than one generation 
(Lio et aI., 2003). Earlier, we saw the importance of the immune system in the 
longevity of mice, but immune responses have also been studied in humans, 
particularly the effccts ofthc HLA-DR (human lcukocyte antigen) locus on longevity. 
43 
HLA-DR is associated with autoimmune diseases, diabetes and probably apoptosis. In 
a case-control study of human centenarians three alleles, DR7, DR}} and DR}3, 
showed differences in frequency between centenarians and controls (Ivanova et al., 
1998). DR7 is considered a risk factor for CMV and HBV infections, celiac disease, 
and is also associated with Crohn's disease, a disease of the digestive track, and B-cell 
lympocytosis. A more recent study in a Sardinian population, though, has shown that 
the effect of HLA on longevity might be population specific (Lio et aI., 2003), 
something which might have been expected, considering that even in lower organisms 
genetic background plays a significant role in the genetics of longevity. Later we will 
return to the effect of the immune reaction on longevity with a model of trade-offs 
between reproduction and survival. 
The best known example of a longevity gene is Apo E one which codes for 
apolipoprotein E, a major part of lipid metabolism. ApoE and A CE (Angiotensin 
converting enzyme) loci were investigated due to their association with cardiovascular 
disease, atherosclerosis, LDL-cholesterol and Alzheimer's disease. Two alleles of 
apolipoprotein E and a variant of angiotensin converting enzyme showed a significant 
difference in frequency between centenarians and a younger control population 
(Schachter et al., 1994). The two ApoE alleles were the &4 which promotes premature 
atherosclerosis and is a risk factor for ischaemic heart and Alzheimer's disease (ApoE 
also plays a role in nerve development and repair), showing a decreased frequency in 
centenarians, and the &2 which is protective against high levels of cholesterol but also 
has an hypcrtriglyccridaemic effect and shows a higher frequency in the centenarian 
population. ACE, coding for a dipeptidy1carboxy-peptidase of the rennin-angiotensin 
system that regulates blood pressure and the production and degradation of 
angiotensin II and bradykinin respectively to affect cardiac growth, shows a deletion 
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(D) - insertion (I) polymorphism responsible for a significant effect of serum ACE 
activity (Schunkert et aI., 1994; Ramaraj et al., 1998). The increased frequency of 
ACEIDD found among centenarians during the Schachter et al (1994) study is 
surprising since the specific allele is linked with myocardial infarction, ventricular 
hypertrophy, and increased production of reactive oxygen species. Furthermore it is 
believed to have neuroendocrine and immunomodulation functions and has a strong 
linkage with the gene for human growth hormone (Schachter et al., 1994). It is also 
believed, that under some circumstances the A CE gene can be protective against 
serious cardiovascular diseases such as coronary artery disease (Pepine, 1997). 
Further studies in an enlarged cohort of French centenarians was able to confirm the 
association of longevity with Apo E but not with the A CE locus, which was 
considered as a false positive association (Blanche et al., 2001). In our second model 
we will examine the effect of Apo E on longevity in greater detail. We construct a 
virtual population to test the way it acts on the population to produce changes in 
mortality and we propose a new theory for its evolution. Other members of the 
apolipoproteins family, that have not been studied as extensively as Apo E but may 
playa role in human longevity are the Apolipoprotein B VNTR and Apolipoprotein J 
(Gonos, 2000). 
Recently, a genome-wide scan using 308 individuals belonging to 137 sibships 
of exceptional longevity, found a significant linkage near microsatellite D4S 1564 on 
chromosome 4 and longevity (Puca et aI., 2001). Further work identified that the 
microsomal transfer protein (MTP) gene was the gene responsible for the linkage. 
MTP is thought to be the limiting factor of lipoprotein assembly. People with two 
non-functional copies of the gene suffer from abetalipoproteinemia and have a near 
absence of ApoB particles in serum. }..f[P was also associated with lipoprotein 
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profiles, insulin resistance and fat distribution, though unfortunately no life extending 
effects have been found for the gene as yet (Geesaman et at, 2003). Generally a wide 
array of genes linked with age related disease has been considered as affecting 
longevity but with most of the time little experimental support (see De Benedictis et 
a1.,2001). 
Although, life extending mutations are not known in humans, the opposite, 
mutations that produce an ageing-like phenotype have been observed. The most 
famous of these is Werner's progeria, a rare autosomal recessive disorder with 
symptoms resembling ageing, such as greying hair, skin thinning, cataracts, 
atherosclerosis, osteoporosis and high risk for tumour development (Hegele, 2003). 
The first symptoms begin to appcar around the age of puberty, when the typical 
growth spurt is absent resulting in small stature, while most patients die before the age 
of 50. A mutation of a single gene (WRN), belonging to the RecQ family of DNA 
helicases, is responsible for the disease. The gene product of WRN is involved in a 
number of different enzymatic activitics including strand displacement as a DNA-
dependcnt ATPase, a 3'-5' DNA helicase for DNA unwinding and a 3'-5' 
exonuclease activity (Bohr et aI., 2002). Additionally, participation of human 
helicases WRN and BLM, responsible for the Bloom syndrome, in a protein complex 
functioning in DNA mctabolic proccsses at telomeric ends, has also been found 
(Opresko et aI., 2002). Recently, it was proposed that cases of an atypical form of 
Werner's syndrome are due to a mutation of a nuclear lamin AlC gene, a hotly 
debated subject (Chen et al., 2003). A known laminopathty which also causes a 
segmentcdS ageing phenotype, very close to that seen in Werner's syndrome, is the 
Hutchinson-Gilford progeria, a very rare autosomal dominant disease «1/1,000,000) 
S A phenotype that exhibits some ageing related characteristics but not others. 
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leading to death usually around age 14 (Hegele, 2003). In this case too, a single 
mutation in the LMNA gene encoding for the nuclear lamin AlC, comprising the 
nuclear lamina, is responsible. Other mutations in single genes are also known to 
cause progeria, such as the Cockayne syndrome, linked to mutations of the CSA gene 
in chromosome 5, showing profound postnatal growth failure and systemic signs of 
premature ageing, probably due to defects in DNA repair (Rapin et al., 2000); and the 
Trichothiodystrophy syndrome, due to mutation in either of two helicases 
ERCC21XPD or ERCC3IXPB, which encode the 2 helicase subunits of 
transcription/repair vector TFIIH, leading to a compromised transcription due to 
accumulation of DNA damage and inactivation of critical genes and enhanced 
apoptosis (de Boer et al., 2002; Hasty and Vijg, 2002). Finally, ataxia telangiectasia 
is caused by a mutation in the ATM gene, encoding a homologue of 
phosphatidylinositol kinases which plays a fundamental role in signal transaction, 
while the patients show cerebellar dysfunction, immunodeficiencies, graying of hair 
and cancer predisposition, among other effects (Jazwinski, 1996; Martin and Oshima, 
2000). These rare mutations, as we saw, are usually linked with the failure of the cell 
to maintain genomic integrity. It is surprising to see how single gene mutations 
associated with repair and maintenance of the DNA can have such large effects in the 
survival of the organism and the production of an ageing-like phenotype (Hasty et aI., 
2003). Nevertheless, evolutionary theories of ageing, and especially the disposable 
soma theory, long before the molecular genetics of these mutations were known, 
hypothesized the existence of such basic mechanisms that will regulate the rate of 
ageing. On the other hand, no examples are known for the ability of these pathways 
to increase longevity, limiting their potential to intervene in the process of senescence. 
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Despite the very promising genetic pathways influencing ageing discussed, 
such as oxidative stress resistance, insulin pathways and DNA repair and 
maintenance, we should not forget that only around 25-30% of longevity is actually in 
our genes (Ljungquist et aI., 1998; Cournil and Kirkwood, 200 I; Mitchell et aI., 
2001). As we shall see later, environmental conditions in adulthood, early 
developmental plasticity and maternal effects and probably most importantly, 
stochastic events, are of paramount importance for the quality and length of our lives. 
1.4 Aims and scope of this project 
The aim of this thesis is to elucidate the gene-gene and gene-environment 
interactions that affect ageing and longevity in humans. That is achieved through the 
construction of theoretical models of population and evolutionary genetics, based on 
epidemiological and demographical studies in contemporary populations. The models 
developed can help identify critical genes involved in ageing and account for some of 
the current data while our predictions can be further tested with the use of population 
studies. Furthermore, the project also aims to provide a theoretical approach to the 
intrinsic variability of the ageing process and account for the recently observed 
deceleration of the mortality in later ages. 
As a first step towards modelling life history theory and the effects of 
environmental or genetic parameters on longevity we re-address the original model of 
the disposable soma theory (Kirkwood and Rose, 1991). Using the Mathematica 
programming language we analyse the parameters of the model and see how the 
fundamental predictions of the theory are derived from the equation used to describe 
the trade-off between longevity and reproduction. 
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In our first model we describe a trade-off between reproductive success and 
survival based on the hypothesis that women with an increased resistance to 
potentially fatal infections are at greater risk of rejecting fetal implantation, and we 
examine its effects in populations with high and low rates of infection-induced 
mortality. We use the model to predict the rate of change of the responsible gene 
frequencies during rapid change of infection rate, such as has occurred in developed 
countries within the last century. The results resolve the paradox of genes that impair 
fertility in present-day populations by showing how they may be a legacy of a 
powerful trade-off that probably actcd until very recently in human evolution in 
developed countries and is likely still to be operating in developing ones. 
The second model addresses the action of longevity assurance genes and their 
interactions with a number of environmental parameters. Apolipoprotein E is used as 
an example of such a gene and its interaction with a number of lifestyle parameters 
affecting the onset of cardiovascular disease is examined. Furthermore, the variability 
of gene-environment interactions and the stochasticity of statistical distributions are 
considered as the possible key factors responsible for the heterogeneity of the ageing 
process. We also use the model to explore the force of natural selection on late acting 
genes, such as Apo E, and their future and past evolution. 
Finally we consider the effects of social class on longevity and ageing, 
showing how, physiological and psychological stress, attitude towards health, lifestyle 
choices, access to health services and early developmental effects can increase the 
intrinsic variability of ageing. Insights from our previous work are examined in the 
light of social variability and the possible effects of such variability are explored. Our 
analysis suggests that evolutionary differentiation due to social effects will have had 
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little impact on the genetics of human longevity, although social factors are very 
important in influencing gene-environment interactions. 
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2. Basic Aspects of Life History Theory and the Disposable 
Soma Theory of Ageing 
As we saw, the purpose of this project is to develop theoretical models of gene 
and gene-environment interactions affecting human ageing and longevity that can be 
tested through epidemiological and genomic studies directly in human populations. 
These aims are addressed with the use of mathematical models of the selection forces 
that act on a population in order to predict the extent of polymorphism expected with 
respect to factors influencing the ageing process. The first model that will be 
discussed is of the disposable soma theory as described by Kirkwood and Rose 
(1991), which we will subsequently develop further to account for other kinds of 
trade-off, especially those that work through the immune system during pregnancy. 
Before we describe the models some introduction to the basic terms, methods 
and programs used in this work will be given. 
2.1 The use of mathematical models 
Human conceptual abilities are limited when compared to the complexity that 
surrounds us and which we may wish to explain. The fundamental factor in how we 
choose to describe complexity is the way we use abstraction to group observations 
and focus only on the particular problem that we want to solve. So, during scientific 
inquiry we take the problem and reposition it in a conceptual universe, reflecting our 
theories about its behaviour, which are based on the different parts of reality we 
observe. This is the model used to test our predictions, which may sometimes be a 
simple conceptual model and at other times a formal mathematical model. Thus, the 
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use of models is common in all branches of science, whether this is based on physical 
observation, manipulation of a natural system or a series of differential equations. 
Even when we use a model organism, as seen earlier, to obtain information on the 
evolutionary processes and mechanisms relevant to ageing we treat the model as a 
realization of life in general, based on the assumption that its intrinsic properties are 
isometric with other living organisms. Since our basic assumption of isometry is only 
partially true, our model is only a metaphorical realization of the problem in an 
isolated conceptual reality (Lewontin, 1968). 
More specifically, mathematical models of biology provide us with an even 
wider capacity to abstract from the problem and test hypotheses that are either 
complex or non-testable by experimental methods. This provides us with a very 
powerful tool for the extension of our logic and the chance to reason based on the 
properties of numbers. According to Nietzsche, mathematics exists due to our ability 
to discount the facts that no two real objects are exactly the same to be counted, and 
that no exactly straight line, perfect circle, or absolute magnitude exists in nature 
(Nietzsche, 1996). This specific ability, to reduce the problem only to its relevant 
characteristics, is what makes the use of mathematics central in the study of complex 
systems in biology and science in general. It enables us to construct a frame of 
equations and mathematical principles that describe a testable logical argument. In 
contrast to physical models, mathematical models have no innate properties; instead 
they are based on a number of assumptions. The delicate balance between 
assumptions and reality has been a hotly debated issue, especially between 
theoreticians and experimentalists where the latter accuse the former for 
oversimplification. Undoubtedly, instances do occur where too simple or too complex 
assumptions have led to misrepresentation of actual processes leading to erroneous 
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conclusions (May, 2004). Thus, assumptions should be made carefully in order to be 
complex enough to represent reality but simple and general enough not to restrict the 
model by imposing a very limited set of parameter values and conditions. A second 
point that has commonly attracted criticism in mathematical modelling is how a 
disjunctivc statement can have any value in predicting patterns that were not included 
in the model (Sober, 2002). Not all models though need to be predictive. In some 
cases their main requirement is to fit and perhaps explain the available data. In this 
case we consult the existing information and find the parameter values that maximise 
the probability of the data (Akaike, 1973). In the very simple case ofthe comparison 
betwecn two data sets, an extremely common practice in biology, we use our 
expectation that the null hypothesis is true to infer a prediction for future observations 
by assessing the probability that the null hypothesis holds or not (in the case of a 
Bayesian analysis) or that the data could have arisen with reasonable probability (in 
the casc of a frcqucntist analysis). Even models that are historically provcn to be 
prcdictive, such as Einstein's general theory of relativity or Poisson's prediction of 
optical diffraction, are all based on the condition that they fit previous knowledge 
(Hitchcock and Sober, 2004). Theoretical models should contain enough information 
to bc able to make prcdictions but not so much as to overfit the data on an erroneous 
hypothcsis (Hitchcock and Sober, 2004). 
The different levels of balance between simplicity and realism in mathematical 
models make them challenging to use. Great care needs to be taken both in the 
assumptions and hypotheses used for their formulation. The different branches of 
science have long benefited from a theoretical approach to complex problems. In 
biology, mathematics were introduced in the area of quantitative genetics in the early 
20th century and thcy have very quickly became an intcgral part of the study of life. 
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Like all new techniques, though, theoretical models have been the subject of criticism 
and misuse. This does not mean that they are of limited or uncertain use but rather 
that they require time to develop as a methodology and they should, like all scientific 
research, be treated with a critical eye. We will continue section 2 with the 
description of well tested mathematical models that have been the standard tool for 
the evolution of life history. In this case a theoretical approach is the only possible 
way to account for changes through natural selection since the time required for those 
changes to take place make any direct experimentation, at least in the case of humans, 
forbidding. 
2.2 Measuring fitness 
The theoretical scope of the project requires the introduction of ways to 
measure the fitness of an organism, and since we are interested in its genetic 
properties, the fitness of its genotype or individual genes. Although a universally 
accepted definition for fitness does not exist we could say that in asexual organisms 
the fitness of the genotype is defined by its success, or not, in producing clones of 
itself, whereas in organisms with a sexual mode of reproduction, we can only refer to 
the fitness of genes in terms of their success in passing as many copies ofthemselves 
as possible into the next generation. 
In the models to follow, fitness is measured as the instantaneous rate of natural 
increase T, as this is given by the Euler-Lotka equation. 
r e-rx/(x)m(x)dx=1 
This is the basic equation for life history evolution and it was first postulated by the 
mathematician Leonhard Euler in 1760, and it was independently re-discovered by 
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Alfred Lotka, a mathematical demographer, in 1907. The model links the probability 
of survival to a certain age class l(x), to the number of offspring expected in that age 
class m(x), and the rate of growth of the population r. The requirements for the Euler-
Lotka equation to hold are that the population is in stable age distribution6, and that 
the mortality and fecundity remain constant in time. Although the above do not 
usually hold in natural populations, minor deviations have a very small impact on the 
quantitative predictions of the model (Hamilton, 1966; Steams, 1992; Charlesworth, 
1994). 
It is easy to imagine how r can also be applied to measure the fitness of a 
single genotype, as when reproduction is through clonal expansion, since we can 
consider each genotype as a separate population increasing in a different rate 
(Charlesworth, 2000). In the case of diploid organisms with sexual reproduction 
though, , is only an approximation of the rate of change of an allele frequency when 
selection is weak. Sex differences in survival, non-random mating, density-dependent 
changes in mortality and fecundity, and finally, spatially and temporally fluctuations 
in environmental conditions can have important effects on the level of approximation 
obtained by T, although these parameters can usually be ignored in large populations. 
Other, more direct methods of change in allele frequencies can also be used as a 
measure of genetic fitness, as we will see in our Apo E model. 
Next we will see how the Euler-Lotka equation can be used to predict the 
optimal strategy that an organism has to follow, in relation to ageing, to reach an 
evolutionary stable strategy under the disposable soma theory. 
~he proportion of organisms in each age class remains constant in time 
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2.3 Programming with Mathematica version 4.0 
Before we explain and test the model of the disposable soma theory of ageing, 
we should also consider the programming aspect of it. Due to the large amount of 
complex calculations required, computers have proved to be essential tools for 
theoretical biology. In our analysis of the disposable soma theory model a 
mathematical programming language, called Mathematica was used. In more detail, 
Mathematica is a fully integrated mathematical computing system combining 
interactive calculations, visualization tools and a complete programming environment 
(Wolfram, 1999). Its relative simplicity and its capacity to be programmed give it a 
flexibility that makes Mathematica a very successful tool for biological modelling. 
The model that follows is written in Mathematica and it is presented in its original 
output form of a Mathematica notebook. A notebook is an interactive document 
format that can combine spccific commands in the syntax of Mathematica-encoded 
mathematical expressions, free text which can include standard mathematical 
expressions, and display items of output such as graphs. 
2.4 Analysis of the disposable soma theory model. 
Although the first appearance of the ideas behind disposable soma theory was 
in a Nature paper of 1977 (Kirkwood, 1977), the first description of the underlying 
mathematical principles were presented much later (Kirkwood and Holliday, 1986; 
Kirkwood and Rose, 1991). Here we will replicate the model using Mathematica and 
we will discuss and analyse the conclusions and implications of the theory as those 
arc derived from the model. 
56 
As we saw earlier, the disposable soma theory is based on the framework of 
physiological ecology and its main target is to describe the optimal balance between 
reproduction and maintenance in a given organism under given conditions. As the 
problem of the evolution of senescence is considered under the light of life history 
theory the Eulcr-Lotka equation is used to measure fitness 
fe- rXl{x,s)m{x,s)dx=1 (2.1) 
whcre survivall(x,s) and fecundity m(x,s) are expressed as functions depending on 
age x and investment in maintenance s. From equation 2.1 we can see that a complex 
relationship exists between the Malthusian parameter r and investment in maintenance 
s. 
The equations for the schedules of mortality and reproduction can be derived 
from the Gompertz-Makeham model seen in section 1.1.2 (equation 1.2). The change 
of survivorship &(x) during a infinitely small change of age t5x can be calculated by 
multiplying the rate of mortality p(x) from the Gompertz-Makeham equation at age x 
with the number of survivors l(x) at age x 
t51(x) = -p(x)I(x)t5x (2.2) 
Solving equation 2.2 for l(x) gives us the analytical formula linking survival with age 
x, and the parameters basal vulnerability a, actuarial ageing rate p and age 
independent mortality yofthe Gompertz-Makeham model. Assuming that the age of 
maturation is a and the ratio of the population reaching this age is (J-V) where V is 
the total juvenile mortality we can express survival to age x as: 
( px PO) I(x) = (l-V)exp(a e -e rex-a)] (2.3) p 
The decline of reproduction can be obtained if we consider that a similar 
underlying deteriorating mechanism operates as in the case of survival. Considering 
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that at age of maturation a reproduction m(a) starts with a maximum value h and that 
no age independent decline exists, we can express reproduction at age x ~ a as: 
_a(e fix -efiQ ) 
m(x) = h exp[ ] (2.4) 
P 
We should note that by using the same value of P in both cases of age dependent 
survival and fecundity we assume that the mechanisms underlying the two processes 
have the same magnitude. One consequence of using a single p is that the model can 
not account for menopause and post reproductive lifespan. This has little effect on the 
original analysis since the life history of mice was used to fit the model but when data 
from human populations are used the discrepancy is important. In this instant we will 
use a fixed upper limit of reproductive lifespan of 50 years of age after which we will 
consider that the value of m(x) is zero. 
The central concept of the disposable soma theory is the existence of an 
energy budget that is invested in maintenance and reproduction dependent on the 
ecological expectations of the organism. Kirkwood and Rose (1991) included 
investment in maintenance s (on a scale from 0 to 1) in three parameters of the model, 
the actuarial ageing rate p, age of maturation ao, and maximum reproduction ho. 
Supposing that a value So exists for the investment of maintenance for which the 
organisms does not undergo senescence we can express the rate of ageing for s < So 
as: 
p = Po (SO -1) (2.5) 
S 
where Po is the actuarial rate of ageing when only 50% of So is invested in 
maintenance. For values of s= So and above P is assumed to be zero and the organism 
does not suffer from age dependent mortality. It was also assumed that the age of 
maturity decreases as more and more energy is invested in reproduction to the point of 
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aD, the age of maturity when all of the available energy is directed towards 
reproduction. 
a 
a=_o (2.6) 
l-s 
Again, in the case of reproductive rate at the age of maturity h it was assumed that 
there is a maximum reproductive rate ho which is achieved when all the energy is 
invested in the reproduction of the organism so that: 
h = ho(l-s) (2.7) 
Giving values to all the parameters of the model, mirroring what is seen in primitive 
human populations, we can plot the change in survivall(x) and fecundity m(x) with 
age x and investment on maintenance s. We can see in fig 2.1 that increasing 
investment in maintenance significantly increases the lifespan of the organism (a) 
while at the same time age at maturity increases, maximum rate of reproduction 
decreases and the decline of reproduction later in life is less steep (b). As we saw 
earlier in section 1.1.2 the Gompertz model cannot account for very early life 
mortality, and since the model is based on the Gompertz equation it inherits the same 
limitations which can be seen in figure 2.1.a as the straight line in the left part of the 
graph representing juvenile mortality. To be able to fit human data into the model we 
included an upper limit for reproduction, which can be seen as the point where the 
right most curve is cut off in fig 2.l.b. The effect ofa sudden end to reproduction 
becomes more apparent as the investment in maintenance increases. With the model 
to be described in chapter 3 we will address again the problem of menopause in the 
disposable soma theory model and we will adopt a more realistic strategy to account 
for the end of reproduction. 
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a) Survival vs age 
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Figure 2.1. a) Graph representing the change of survival with age for three values of 
investment in maintenance, 004, 0.5, and 0.6 from left to right b) Graph representing 
the change of fecundity with age for the same changes of investment in maintenance 
as in (a). 
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The opposite effects that increasing or decreasing investment in maintenance 
have on reproduction and survival are among the main predictions of the disposable 
soma theory, where high early development is expected to be followed with an 
increased rate of mortality, while a long lifespan is linked with a lower reproductive 
potential. Earlier, in section 1.2.7.1, we saw a number of experiments in Drosophila 
and other model organisms that seem to support this idea of trade-offs between 
longevity and reproduction (Luckinbill et aI., 1984; Partridge et aI., 1999). 
Having calculated the survival and fecundity curves we can now proceed to 
find the optimal level of investment in maintenance for the organism under the given 
conditions. Using equation 2.1 we can construct a curve between the instantaneous 
rate of natural increase r and the investment in maintenance s as can be secn in figure 
2.2. The value of s, in this case 0.5, corresponding to the highest value of r, 0.05 in 
fig 2.2, is the optimum stratcgy for a human population living under the conditions 
described by thc paramcters used. Thc relatively flat area around the maximum 
permits stratcgies with small differences to coexist in the population. 
We will continue our analysis of the disposable soma theory by testing the 
effects of changing thc parameters of the model and describing the resulting changes 
of the optimal balance betwecn investment in reproduction and survival and their 
evolutionary conscquenccs. The first paramcter to be considered is total juvenile 
mortality. It is easy to understand that by lowering the ratio of the population 
reaching maturity we also decrease the rate of population increase as can be seen in 
figure 2.3.a. Furthermorc, by incrcasingjuvenile mortality we observe that the point 
of the optimal balance betwecn survival and fccundity is shifted towards higher values 
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Figure 2.2. Curve describing the association between the malthusian parameter rand 
investment in maintenance s. The maximum point of r is 5% for a 0.5 value of s. The 
parameters used are: a = 0.001, Po = 0.2175, V = 0.4, y= 0.01, ao = 8 years, So = 0.8, 
ho = 1 child/year. 
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of investment in maintenance. Thus the model predicts that when a small ratio of 
offspring reaches maturity, adult organisms invest less in reproduction and more 
towards survival, prolonging both their longevity and reproductive lifespan. 
Similarly, when the basal vulnerability a or the actuarial rate of ageing f3 increase, the 
ability of the population to grow is lowered, while the optimal investment in 
maintenance required increases (figure 2.3.b and c). So according to the disposable 
soma theory model, under conditions of high intrinsic mortality the organism should 
invest more towards maintenance of its body in order to maximise its fitness since the 
accumulated damage lowers the lifespan of the organism to a level far lower than that 
expected under the specific environmental parameters. In contrast, when external 
mortality is increased, we see in figure 2.3.d that the level of investment in 
maintenance is decreased and the energy is diverted towards higher reproductive 
output and a shorter lifespan, as was experimentally verified in natural population of 
guppies (Reznick et aI., 2001; Bryant and Reznick, 2004). The above changes are 
based on the principle that the disposable soma theory predicts that the organism 
invests enough in maintenance to extend its lifespan, without wasting resources by 
extending life longer than what is normally likely to be experienced in wild 
populations subject to external mortality. 
After the analysis of the effects that the mortality parameters have on the 
optimal strategy of the organism, we will now consider what happens when the 
schedule of reproduction is altered. Increasing ages of maturity push the optimal level 
of investment to the left of the graph, as can be seen in figure 2.3.e, towards higher 
values of s while the maximum rate of increase is lowered. Longer periods of pre-
reproductive life require more energy to be invested towards the soma to ensure that 
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Figure 2.3. Graphs representing the changes of the optimum strategy when the 
parameters of the disposable soma are changed a) changing juvenile mortality V 
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(values: 0.2, 0.4, 0.6) b) changing the basal vulnerability a of the population (values: 
0.00 I, 0.0055, 0.01) c) changing the actuarial rate of ageing p (values: 0.15, 0.20, 
0.25) d) changing the age independent mortality r(values: 0.0025,0.02125,0.04) e) 
changing the minimum age of maturity ao (values: 6,8,10) f) changing the maximum 
rate of reproduction ho (values: 0.5, I, 1.5). 
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the organism will remain in good condition at least till the onset of reproduction. On 
the other hand, when the maximum level of reproduction is increased the investment 
in maintenance required to keep the population at its maximum rate of increase is 
lower (figure 2.3.f). Since the ratio of offspring reaching adulthood remains the same 
while in the same time the ability to reproduce increases, the organism can achieve a 
higher level of fitness by investing towards reproduction. This has also been verified 
by studies of human historical population where a higher number of children was 
associated with a shorter lifespan (Westendorp and Kirkwood, 1998; Korpelainen, 
2000). Moreover, as we saw in figure 2.1.b, lower investment in maintenance leads to 
an increase of early reproduction compared with that later in life. Again, experiments 
with Drosophila lines selected for early fecundity saw a pronounced decrease both in 
later reproduction and lifespan (Rose and Charlesworth, 1981; Luckinbill et aI., 
1984). The complete notebook for the computer program of the disposable soma 
theory model can be seen in Appendix 1. 
2.5 Conclusions drawn from the disposable soma theory of ageing. 
We have already discussed the general predictions of the disposable soma 
theory and the evidence supporting them. Our analysis has elucidated the detailed 
effects of changes in the investment in maintenance on survival and reproduction, as 
well as their combined effect on the optimal strategy that the organism has to follow 
to achieve maximum fitness under a specific set of conditions. Testing the disposable 
soma theory has also provided us with a number of interesting observations. While 
intrinsic rates of increased mortality increase the required level of maintenance for the 
optimal strategy, higher external mortality increases the investment towards 
reproduction. Selection for higher early or total reproduction will decrease lifespan, 
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while selection for late reproduction will increase longevity. Some weaknesses or 
shortcomings of the models were also made clear. For example, the model, in its 
present simple form, can not account for menopause in humans, something that we 
will try to improve in the immunogenetic trade-off model in the next chapter. 
Additionally, we saw that there is no distinction between the reproductive investment 
in offspring production and the investment in parental care. The later is an important 
parameter of the life history of the organism and especially humans, where the 
transfer of energy between generations constitutes a great proportion of the total 
energy available to an individual and can affect future reproduction and the fitness of 
the offspring. 
Despite its simplicity and a small number of problems, the disposable soma 
theory model is a very useful descriptive and predictive tool for research into ageing. 
It can account for a number of different experimental observations in a concise and 
clear way and point towards basic systems involved in ageing. Furthermore, its 
simplicity is making the model a very good platform where additional parameters can 
be added to describe more detailed trade-offs with specific gene mechanisms, as we 
will show in the next chapter. 
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3 Immunogenetic Basis For Trade-Offs Between Human 
Fertility And Lifespan 
3.1 Introduction 
As we saw earlier, the genetic basis of human longevity is an intriguing puzzle 
(Coumil and Kirkwood, 2001). The emergence of the modem evolutionary theory of 
ageing (Kirkwood and Cremer, 1982; Rose, 1991) follows many centuries of 
theoretical speculation about the factors influencing length of life, which began 
around 350 BC with the writings of Aristotle (Barnes, 1984). The modem 
evolutionary theory recognises that ageing is a non-adaptive character that arises 
through the decline in the power of natural selection at later ages. A key aspect of the 
evolutionary theory is the prediction that trade-offs which favour fitness in early life 
will be favoured by selection, even if the later deleterious consequences of such trade-
offs result in senescence and death (Partridge and Barton, 1993; Kirkwood and 
Austad, 2000). 
We have already discussed that among the ideas that make up the current 
evolutionary understanding of ageing, the one that most explicitly addresses the 
nature of potential trade-offs in an organism's physiology is the disposable soma 
theory (Kirkwood and Rose, 1991; Kirkwood, 1992; 1993; 1997; 2002). The 
disposable soma theory recognises that organisms must allocate resources among a 
number of metabolic demands, including somatic maintenance, growth, storage, 
reproduction, immune function, and so on. Under pressure of natural selection, the 
investment in survival must be balanced against investments in traits such as fertility, 
and the optimal balance will be influenced by ecological factors such as the level of 
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extrinsic mortality (Kirkwood, 2002). Thus, the disposable soma theory generally 
predicts a negative relationship between fecundity and age-dependent survivorship 
(although in some instances there might be trade-offs between, for example, somatic 
maintenance and fat storage that involve fecundity only indirectly). We also show 
that in addition to these specific trade-offs involving investments in somatic 
maintenance, Williams (1957) suggested that there might exist a broad class of 
pleiotropic gene actions such that genes favouring an organism's fitness early in life 
might have deleterious consequences for its fitness at later ages, which are also 
generally predicted to produce a trade-off between fecundity and age-dependent 
survival. 
As we have already discussed at length, numerous studies have examined the 
existence of inverse relationships between longevity and fecundity. The species most 
commonly used for this purpose have been members of the Drosophila fruitfly 
family. Trade-offs between fecundity and survivorship have been observed using a 
variety of methods ranging from artificial selection to genetic manipulation (Rose and 
Charlesworth, 1981; Luckinbill et aI., 1984; Zwaan, 1993; Tatar et aI., 1996; Sgro and 
Partridge, 1999; Zwaan, 1999; Steams et aI., 2000). Work on nematodes, mice and 
guppies has provided further evidence for the existence of trade-offs in other species. 
In recent years, studies have begun to investigate trade-offs between longevity 
and fecundity in humans. Despite the difficulty of obtaining the necessary records for 
historical populations Westendorp and Kirkwood (1998; 1999b) found that among 
British aristocrats, there was a significant inverse association between fertility and 
lifespan. Further studies by Thomas et al (2000), Korpclainen (2000) and 
Doblhammcr (2000) have confirmed this negative association between human 
longevity and reproduction, although Helle (2002) did not find it, while Lycett ct al 
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(2000) have shown that the trade-off appears to be affected by socioeconomic 
conditions. 
Our main focus in this chapter is a recently formulated immunogenetic 
mechanism which might explain a trade-off between human survival and fertility 
(Westendorp et aI., 2001). This is based on evidence that innate immune factors 
influence both the ability to withstand fatal infections and the capacity to initiate and 
complete a successful pregnancy (Piccinni, 2002), but in opposite directions. A major 
difference is characterised in terms of the T-helper type-l (Thl), associated with low 
interleukin (IL)-l0 and high tumour necrosis factor (TNF-a) levels, and T-helper 
type-2 (Th2) phenotypes, associated with the inverse cytokine profile. In the 
Westendorp et al (2001) data set only lout of 9 women with the Th 1 phenotype 
exhibited normal fecundity, while 3 out of 9 with the Th2 phenotype had any 
reproductive impairment, defined as having at least 3 consecutive spontaneous 
abortions before the 16th week of gestation. Although the importance of 
immunological factors in human reproductive failure remains controversial, there is 
clear evidence of the need for a special immunological relationship between mother 
and foetus which permits tolerance of the foetus as a foreign graft (Medawar, 1960; 
Choudhury and Knapp, 2001). Women with an innate Thl phenotype have a greater 
probability of spontaneous abortion than women with an innate Th2 phenotype. 
Conversely, individuals with an innate Thl phenotype show lower susceptibility to 
fatal infection, indicative of a greater likelihood of survival in an environment where 
infectious diseases exert a significant mortality pressure. The hypothesis that we 
examine in our model is that the selection push of the population towards Thl, based 
on increased survival, will have been countered by selection towards Th2, based on 
increased fertility (Westendorp et aI., 200 I). 
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3.2 Methods 
Modelling life history trade-offs 
Our model begins from the formalism described by Kirkwood & Rose (1991) 
to examine the predictions of the disposable soma theory. This required that 
fecundity and survival should both be dependant on the allocation of resources to 
somatic maintenance, so that by combining the schedules of fecundity and survival to 
compute fitness (as measured by intrinsic rate of natural increase), the optimal 
investment in maintenance could be determined. We have already discussed the 
underlying theory in section 1.2.6 while in the second chapter we described and 
analysed the model proposed by Kirkwood and Rose (1991) in some detail. 
Survivorship 
For the purposes of modelling the immunogenetic trade-off, we assume a 
variable 17, equal to Th2/Thi ratio expressing the phenotypic response of the immune 
system. The effects of varying 17 on survivorship are complex and must take account 
of effects on susceptibility to infectious disease across a range of ages within the 
population. Four parameters can, in principle, affect the survivorship schedule: child 
mortality V, and a, p, and r of the Gompertz equation (eq. 1.1). We focus our 
attention on modifying a and y, assuming pto be a characteristic of the species (see 
also Finch, 1990). We do not modify V, which corresponds to juvenile mortality, 
since our specific concern here is to model life-history trade-offs that affect the 
balance between fertility and immunity to life-threatening infectious disease during 
the reproductive years (our calculation of fitness - see below - uses the standard 
Euler-Lotka measure, which integrates the product of the fecundity and survivorship 
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tenns; this product is zero during the juvenile phase of the life-history (eq. 2.1». 
However, by changing ywe do account for significant effects on the early mortality in 
the young mature population. 
We express yas a function of lJ in the fonn: 
y(lJ)=KlJ+Y' 
where Kis a scaling constant and y' is the basic extrinsic mortality of the population. 
This causes a large effect on mortality rates at younger adult ages when the age-
depcndent increase in the intrinsic death rate is only small, but it has only a small 
effect at older ages (Figure 3.1a). Such an effect might describe diseases such as 
malaria, cholera and measles. 
The effect of increasing lJ on a will also be to increase mortality but this will 
have relatively little effect until later ages when the age-dependant increase in the 
intrinsic death rate will be greatly increased (Figure 3.lb). We represent this in the 
model as: 
a(lJ) = AlJ + a' 
where A is a scaling constant and d is the original basal vulnerability of the 
population. This might describe diseases like pneumonia and tuberculosis. 
We can insert these expressions for a(lJ) and J{lJ) into the Gompertz mode] 
and, following the methodology of Kirkwood and Rose (1991), obtain an expression 
for survivorship l(x. lJ) as: 
a(lJ)( eP x eP Q ) 
l(x,lJ) = (1- V) exp[ ] P - Y(lJ)(x-a) 
The impact of varying the investment in maintenance, as we saw in section 2.3, is 
incorporated by making the variables a (age at maturity) and p(actuarial ageing rate) 
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Figure 3.1. Effects on age-specific mortality of varying 11 assuming that: a). " affects 
the parameter y. (extrinsic mortality) of the Gompertz-Makeham equation; b). " 
affects the parameter q (basal vulnerability). 
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depend on a parameter s, which takes values in the range 0 to 1. The rationale for 
these assumptions is that the age of maturation should increase as more resources are 
directed towards maintenance, whereas the ageing rate should fall and can reach zero 
if sufficient resources are invested in maintenance. 
Fecundity 
We suppose that a reduced value of TJ, i.e. a shift towards Th2, is associated 
with improved reproduction so that 
or 
m(x n) = m'(x)_T._'h2_ 
,., Thl+Th2 
m(x,1]) = m'(x)-.!L 
TJ+ 1 
where m'(x) is the basic fecundity predicted by the Gompertz law under the disposable 
soma theory. So fecundity, m'(x), is assumed to be: 
where h denotes the maximum reproduction rate, which is assumed to occur at the age 
of maturation a, and the mUltiplier represents a Gompertz-like decline in intrinsic 
fertility, due to senescence. As we have already discussed, the original model was 
postulated for the life history of the mouse where decline in fertility plays a much less 
important role than in the case of humans where the reproductive lifespan, especially 
in women, is much shorter than total lifespan. To account for menopause we assume 
that the reproductive system is ageing with a different rate than the rest of the soma. 
We can incorporate that in the model by considering a new actuarial ageing rate PR for 
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the equation of fecundity. The relationship between PR and pcan be mathematically 
expressed as: 
where B stands for a constant describing the factor of change between the decline of 
the reproductive system relatively to the soma of the organism. The use of Blinks the 
age of menopause to the investment in maintenance s through its dependence to 13, 
thus permitting the postponement of the age of menopause with increasing energy 
used for repair and maintenance increasing the realism of the model. Although 
menopause is almost an exclusively human characteristic, a number of other 
organisms also show a faster decline of fecundity with age compared to survival 
(Finch and Sapolsky, 1999). Even though the biological mechanisms for such a 
difference are not known we propose that it might be the result of intense selection 
among the precursors of gametes in order to ensure the soundness of the information 
passed to the next generation. In the case of humans, fitting the equation describing 
the reproductive decline to data from females in a contemporary western population 
(Office of National Statistics, UK) reveals that Bis equal to 4, thus the rate of 
reproductive ageing in a women is four times higher than that of the rest of her body. 
Calculation of fitness 
To assess the trade-offs associated with Th21Th1 ratio we use as a measure of 
fitness the intrinsic rate of natural increase r given by the Euler-Lotka equation, 
fe- rx I(x,q)m(x,q)dx = 1 
which supposes that the population has a stable age distribution with the mortality and 
fecundity schedules remaining static in time. Although these assumptions do not 
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usually hold exactly for natural populations, minor deviations have a very small 
impact on the quantitative predictions of the model (Stearns, 1992). 
Software and parameter values 
Our models were programmed and run using Mathematica Version 4.0. 
Default parameter values were chosen so that around the fitness optimum the age-
specific mortality schedule was similar to that observed for contemporary human 
populations (see Figure 3.2). Contour plots were obtained under various assumptions 
for fitness r as a function of ,,(assumed to range from 0.1 to 10) and s (assumed to 
range from 0 to 1). The entire Mathematica Notebook can be seen in Appendix 2. 
3.3 Analysis of model 
To analyse the model for the immunogenetic trade-off between fecundity and 
survival we will use two populations, from Denmark and The Gambia, as generic 
examples of exposure to high and low infectious load. Using the life tables statistics 
of Denmark (Lopez, 2001) we can calculate the parameters a and ~ of the Gompertz 
model, with the use ofleast-squares fitting to a non-linear parametric model, 
considering that no external mortality is affecting the population (Figure 3.2). In the 
case of the Gambian life tables, we used the Danish ~ parameter and fit a new a and y 
for increased basal vulnerability and external mortality due to infections (Figure 3.2). 
Given the new values of a and y though we can also calculate lC and A. of the model 
for the Gambian population. The next step was to assume a genetic structure such 
that investment in maintenance, s, and the immunogenetic phenotype, 1], were 
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Figure 3.2. a) Comparison between WHO data values (points) and their fitted 
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models (lines), for Denmark (dashed line and grey points) and the Gambia (solid line 
and black points) for the increase of the force of mortality with age b) Percent 
survival for Denmark and Gambia as a function of age, as predicted by our models in 
each case. All population values were either calculated by the fitted Gompertz curve 
or selected to mirror the expected realistic values in each case. 
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continuous characters ranging from 0 to 1 and from 0.1 to 10, respectively. Our 
assumption that 17 can vary from 0.1 to lOis based on earlier estimations of an inter-
individual ten-fold variation in production of both the Th2-type cytokine IL-lO and 
the Thl-type cytokine TNF-a(Westendorp, personal communication). 
Based on the above we can now solve numerically the Euler-Lotka equation for both 
populations and get the fitness profiles expected from our equations for the evolution 
of life history (Figure 3.3). It is clear from Figures 3.3a and b that there is an 
optimum Th2ITh 1 ratio, just as there is an optimum investment in somatic 
maintenance. The optimum is the point that best balances the advantage of better 
immune protection from fatal infectious diseases against the risk of increased 
spontaneous abortion, just as the optimum level of somatic maintenance balances the 
advantage of increased resistance to damage accumulation against the disadvantage of 
drawing too many resources from growth, reproduction, etc. Figure 3.3 shows how 
the fitness of the population is affected by assuming different exposure to mortality 
pressure such as might be exerted by differential exposure to fatal infectious diseases. 
As described earlier, to generate Figure 3.3a, the population was assigned life table 
data based on a contemporary West African population (The Gambia) where exposure 
to infectious diseases, like malaria, still causes significant mortality pressure at all 
ages while Figure 3.3b used life table data for a contemporary European population 
(Denmark) where the risk of fatal infectious disease is very much smaller. It can be 
seen by comparing Figures 3.3a and 3.3b that there is a marked rightward shift in the 
optimum value of 17, signalling that the optimum strategy has moved in the direction 
of favouring a higher Th2ITh I ratio in a contemporary European context. 
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Figure 3.3. Contour plots of fitness r as a function of s (investment in maintenance) 
and II (ratio ofTh! to Th2), using mortality parameters for a). The Gambia, and b). 
Denmark, chosen to represent high and low infection load, respectively. Only 
positive values of r are shown with a maximum value of 0.03 for both cases and 30 
contours. Darker areas indicate lower values of r. The values for the parameters used 
can be seen in Appendix 2 
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Given that Figure 3.3 suggests a strong selection pressure to alter the cytokine 
profile in response to the kind of demographic change that will result from reduced 
exposure to fatal infectious disease, we asked how fast the genetic determinants of 
innate immunity might alter in a population that underwent rapid change from 
Gambian to Danish mortality pressures. For simplicity we assumed here that 17 is 
determined by a single gene with two alleles, such that the heterozygote would have 
the value 17 = 1 and that the two homozygotes would have 17 = 0.1 and 17 = 10, 
respectively. Denoting the two alleles of the gene responsible for determining 17 as G 
and g, so that GG homozygotes have 17 = 10 while gg homozygotes have 1] = 0.1, we 
used the calculated fitness (r) values to predict the changes in genotype and allele 
frequencies in future generations of a popUlation which started with the genotype 
distribution that was optimal under Gambian conditions but which now existed with 
the selection pressures imposed by Danish conditions (Table 3.1). It can be seen that 
the frequency ofthe g allele within the population declined to very low levels within 
about 6 generations, consistent with the fact that in the contour plot in Figure 3.3b the 
optimum zone includes the right-hand margin of the parameter space. 
3.4 Discussion 
Our immunogenetic model establishes the evolutionary plausibility of 
a trade-off between human survival and fertility mediated by selection on genes that 
determinate innate immunity. Furthermore, the model shows how within the context 
of the disposable theory, and given the ecological factors that affect mankind, this 
immunogenetic trade-off, which represents a clear example of the kind of pleiotropic 
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Freq. of genotypes Freq. of alleles 
Generation GG Gg gg G g 
1 0.315333 0.492424 0.192243 0.561545 0.438455 
2 0.083951 0.411584 0.504465 0.289743 0.710257 
3 0.023263 0.258516 0.718222 0.152520 0.847480 
4 0.006579 0.149069 0.844351 0.081114 0.918886 
5 0.001881 0.082980 0.915139 0.043371 0.956629 
6 0.000541 0.045431 0.954028 0.023256 0.976744 
7 0.000156 0.024667 0.975177 0.012490 0.987510 
8 0.000045 0.013336 0.986619 0.006713 0.993287 
9 0.000013 0.007193 0.992794 0.003610 0.996390 
Table 3.1. Predicted changes in genotype and allele frequencies when a population 
that has evolved to optimise the immunogenetic trade-off under Gambian mortality 
conditions is transferred to Danish mortality conditions. 
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gene action envisaged by Williams (1957), seems critical for human longevity. The 
model shows how the advantage of increased resistance to fatal infectious disease can 
be offset by the increased risk of spontaneous abortion to produce an optimal zone of 
gene frequencies where these effects are balanced. Although in the model we have 
assumed that the genetic basis of innate immunity is simple, it is sufficient to describe 
the evolutionary implications of the Th2ITh 1 balance and illustrate the effect of trade-
offs on longevity and reproduction. A more realistic model might allow for a larger 
number of genes, with possible epistasis among them. However, in order to develop 
such a model, the methodological and mathematical difficulties would be enormously 
increased. In a model with a larger number of responsible genes it is likely that 
individual gene effects would be smaller than has been assumed here, which might 
predict a somewhat slower genetic change than is shown in Table 3.1. It is also worth 
noting, that when Figures 3.3a and 3.3b are compared with regard to the optimal 
values of s, the optimum in the case of Denmark is slightly higher (0.542) than that in 
Gambia (0.526). Such a difference is consistent with the predictions of the disposable 
soma theory since increased survival requires a higher investment in maintenance and 
repair. 
The immunogenetic model described in this work confirms the plausibility of 
the hypothesis that the relatively high prevalence of genetic factors that impair 
fertility in present-day popUlations may be the legacy of a trade-off that was of great 
importance until quite recently. If this is true, it implies that the rapid reduction in 
exposure to the risk of fatal infectious disease that has occurred over the last century 
might be responsible for altering the selection forces on major detenninants of the 
human life history and that a process of adaptation in developed countries is likely to 
be still ongoing. 
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4 Apolipoprotein E as an Example of the Use of 
Epidemiological Data in an Evolutionary Model 
4.1 Introduction 
According to the British Heart Foundation diseases of the heart and circulatory 
system (cardiovascular diseases (CVD» accounted for more than 235,000 deaths in 
the UK during 2000, with half of them due to coronary heart disease (CHD) and a 
quarter from stroke. At the same time CVD is the second most common (after 
musculoskeletal conditions) cause oflongstanding illness encountered in the 
population. CHD is the main form of heart disease and the single most common 
cause of death in the UK, killing one in four men and one in six women (Petersen, 
2002). 
From the above, it is clear that genes affecting CHD and CVD are extremely 
important to human longevity and successful ageing. The first such gene to be 
discovered was the apolipoprotein E (apo E) gene situated on human chromosome 19 
at locus 19q 13.2, a 3.7 kb long gene containing four exons and coding for a 317 
amino-acid polypeptide that after cleavage gives rise to a 299 amino-acid long mature 
protein (Hagberg et aI., 2000). Apolipoprotein E (APO E) is a member of a diverse 
family of proteins collectively known as apolipoproteins, carrier proteins specializing 
in lipoprotein particle formation, secretion, transport, binding and metabolism (van 
Bockxmeer, 1994). Another member of the apolipoprotein family closely linked with 
Apo E on chromosome 19 is APO C2, a necessary cofactor for the activation of 
lipoprotein lipase, and the cell surface receptor for LDL that plays a significant role in 
cholesterol homeostasis LDLR (Online Mendelian Inheritance in Man). APO E is 
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synthesized in many different areas of the body such as the liver, brain (primarily 
astrocytes), skin, macrophages and steroidogenic organs. The plasma pool is derived 
mainly from the liver while the central nervous system pool is produced locally 
(Smith,2002). In plasma, APO E is a component of triglyceride-rich chylomicrons, 
very-Iow-density lipoprotein (VLDL) particles and their remnants, and high density 
lipoproteins (HDL), while it also serves as a ligand for the low density lipoprotein 
(LDL) receptor family and binds heparan sulphate proteoglycans during lipid 
metabolism (Hagberg et aI., 2000; Shih et aI., 2000). 
Apolipoprotcin E has three major and more than thirty minor isoforms usually 
linked with diseases. The three common alleles are epsilon (E) 2, E3 and E4 producing 
thrcc homozygous (E2/E2, did and E4/E4) and three heterozygous (E2/E3, E3/E4 and 
£2/(4) genotypes (RaIl et aI., 1982). The difference between them lies at two amino 
acid residues 112 and 158; with the most common allele E3 having cysteine and 
arginine respectively while E2 has cysteine and E4 arginine at both of them (Hagberg 
et aI., 2000). 
What makes apo E such an interesting topic for longevity studies is the fact 
that the carriers of different alleles show differences in the incidence of coronary 
artery diseasc (CAD), peripheral atherosclerosis, Alzheimer disease, possibly stroke 
and evcn ability to recover from trauma (Smith, 2002). The underlying mechanism 
for the action of the gcne involves an interdomain interaction betwecn the amino- and 
carboxyl- terminals of the protcin producing isoform-specific lipoprotein preferences 
such that E2 and E3 protein isoforms bind preferably to HDL (the "good" 
cholesterol), while the E4 isoform shows a preference for VLOL (Dong et aI., 1994). 
The APO E2 isoform is defective in binding the LOL receptor although it retains its 
ability to interact with LOL-receptor-related protein and other related receptors 
84 
(Smith, 2002). A small number of &2 homozygotes suffer from a condition known as 
type III hyperlipoproteinemia, characterized by accumulation of cholesterol-rich 
remnant lipoproteins due to incomplete catabolism of chylomicrons and VLDL 
leading to premature atherosclerosis. The fact that although 90% ofthe patients are 
&2 homozygotes, but only 5% of the &2 homozygotes suffer from the condition, 
suggests that further factors are required for the phenotypic expression of the 
condition (Marz et aI., 1998). 
4.2 Apolipoprotein and global distribution 
The global frequencies of the three common alleles vary significantly between 
populations with different ethnic backgrounds, with &2 almost absent from the Inuit of 
Ammassalik, Mayans of Mexico, Yanomame of Brazil and Amerindians in general 
and Australian aborigines, while on the other hand &2 is relatively common in 
Chinese, Malaysians and Papua New Guinea aborigines (Gerdes et aI., 1996b). In 
general &3 is globally the most common allele ranging from a frequency of 0.536 in 
African Pigmies to 0.911 in Mayans. The rarest of the three alleles is &2 with a 
fluctuating frequency between 0.145 to just 0.02. The frequency of &4 varies from 
0.052 in Sardinians to 0.407 in Pigmies and shows a negative correlation to &3 allele 
(Fullerton et aI., 2000). In Europe, and between populations of Caucasian descent, 
there is a north-to-south gradient of decreasing &4 frequency opposite to the spread of 
agriculture (Gerdes ct aI., I 996b; Corbo and Scacchi, 1999). 
Generally in Caucasian populations it is believed that the carriers of the &2 
allele are more likely, and the &4 carriers less likely, to reach old age than the &3 
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homozygotes. The common study strategy has been to compare gene frequencies 
between a young and an old group from the same population and check for any 
significant differences of the candidate gene between the two. Although this kind of 
study has provided significant insight into the way that genes affect longevity, it must 
be treated with caution. Small groups, especially those for the old, and low 
representation of the uncommon genotype, in this case E2, can lead to a poor 
statistical calculation of the true allelic effects. Also we should be careful when we 
suppose that the same selective pressures have acted on both groups, since the quality 
of life, technology and mcdical science have changed significantly during the last 100 
years. The assumption that the penalizing effect of the candidate gene is not apparent 
in the young group can be misleading since the precise age of gene action and the 
presence of any pleiotropic effects are not fully studied yet. Finally the effects of 
linked genes and the composition of the groups should be carefully considered and 
checked, especially when healthy individuals are used, which are not always 
representative of the general population or the gene action, even more so when they 
include individuals from different ethnic backgrounds. 
4.3 The role of apolipoprotein E in CVD 
Using a group of300 French centenarians and a group of 160 adults with 
between the ages of20 and 70, Schachter et al (1994) found a significant decrease in 
the frequency of the E4 allele among centenarians while the E2 allele was significantly 
increased. Although the use of an adult control population of up to 70 years of age is 
expected to decrease the overall significance of the gene effect, since it would have 
already started producing apo E rclatcd mortality, the differences observed were large 
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(from 11.2% in control to 5.2% in centenarians for £4, and from 6.8% to 12.8% for 
£2). In an enlarged study (600 centenarians) of the same cohort six years later, 
Blanche et al managed to confirm the original findings (Blanche et aI., 2001). 
Participants of the Framingham offspring study were used for a cross-sectional 
prevalence and cohort study to describe the association betwccn apo E alleles and 
CHD (Wilson et aI., 1994; Lahoz et aI., 2001). It was observed that an elevated risk 
of CHD was associated with a gender specific effect of apo E £4 allele. 
But not all studies showed a relationship between the apo E genotypes and 
risk of death. Galinsky et al (1997) did not found a significant difference in the 
frequency of the apo E gene between the young and old groups concluding that it may 
be too simplistic to associate apo E isoforms with increasing risks for early death. 
Kuusisto et al (1995) using a non-diabetic Finish cohort of 1067 subjects between 64 
and 74 years of age concluded that the apo £4 allele cannot be regarded as an 
important risk factor in the elderly. Instead they proposed that the &4 allele exerts its 
increascd risk during middle age. The exclusion of subjects "too ill to participate", 
and the small number of subjects homozygous for the £2 and £4 alleles, could have 
played a significant role in dampening the effect of the gene. In contrast, a study in 
Swedcn (Cordcr et aI., 1996) reported that selective survival involving the apo E 
polymorphism was important in the oldest old (>85 years) with good cognition, but 
had no effect in survival of younger individuals. 
In a meta-analysis of 10 studies Wilson et al (1996) reported an association 
between the presence ofthe £4 allele and CHD for both sexes, but they could not see a 
significant association between the £2 and E3 alleles and CHD. A longitudinal study 
of elderly Finish men in two cohorts, one in Eastern and the other in South-western 
Finland, reported greater odds of CHD for different genotypes at each site but this risk 
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was generally linked with the presence of E4. They concluded that apo E genotypes 
confer risk information dependent on the mortality history of the population, its 
environmental factors and its genetic background influencing the risk of CHD 
(Stengard et aI., 1996). Gerdes et al (2000) using a relative mortality risk and the 
dE3 group as a reference, found that there are very modest differences between the 
relative risks of the genotypes compared with what is seen when odds ratio is used. 
For the apo E alleles they estimated that E2 carriers have a lower and E4 carriers have 
a higher risk of mortality compared with the E3E3 group, concluding that apo E is a 
"frailty gene" and not a "longevity gene". In a study using a group of 179 Finnish 
centenarians and comparing them within the group Frisoni et al (2001) found that E2 
allele increases with increasing age above 100 years of age, concluding that the E2 
carriers might be predisposed to reach extremely old age. Finally in a study in Belfast 
using subjects of the MONICA study (MONItoring of CArdiovascular trends) the 
age-associated decrease of the E4 allele was further supported and evidence was also 
found for the link of the E2 allele with longevity (Rea et aI., 2001). 
Up to now the studies mentioned were done almost exclusively on Caucasian 
populations, and as we mentioned before there is a great amount of variation between 
the frequencies of the three common alleles in populations with different ethnic 
origins. In a study of Japanese ischemic heart disease (lHD) patients, it was found 
that E4 allele was an independent risk factor for silent myocardial ischemia without 
showing any association to the lipid profile, while the E2 allele was consistent with its 
role in lowering LDL (Nakata et aI., 1996). Gerdes et at (I 996b) found that in a 
Greenland Inuit population, which exhibits a high frequency of the E4 allele, carriers 
of this allele showed higher mean plasma lipoprotein-related variables. In a cohort 
study in Chinese Han apo E also proved to be an important factor for longevity of 
88 
individuals >85 years of age, with the E4 allele linked to higher mortality. To 
examine the effect of apo E polymorphism in different ethnic groups Lee et al (2001) 
studied the apo E associated mortality risk in Caucasians, Hispanics, and African-
Americans living in northern Manhattan, New York. They observed that the E2 allele 
seemed to reduce mortality risk for Caucasians and Hispanics but not for the African-
Americans. The E4 allele was not associated with higher risk in any of the groups. 
On the contrary, it seemed to lower the mortality risk for the African-American group. 
Finally Stengard et al (1998), using nine population-based samples of middle-aged 
males from the WHO Monica project, found that around 50% of interpopulation 
variation in average serum total cholesterol level and approximately 40% of the 
variation in CHD mortality rates could be explained by the relative frequency of the 
E4 allele. The fact there is so much difference between the apo E allele frequencies 
between different populations, despite the same effects of this alleles on lipoprotein 
profiles, suggests that either there is a strong component of genetic background that 
can deal with the extra lipids in serum, or that there are differences in the selection 
pressures applied in the past of each ethnic group. 
4.4 Role of apolipoprotein E in other disorders 
Apolipoprotein E has also been implicated in other age dependent conditions 
such as Alzheimer's disease (AD), which is the most common form of senile 
dementia (Smith, 2002). Genetics, lifestyle and environment are all involved in the 
disease. AD changes are similar in some degree to the "normal" changes during 
ageing in human brain (Finch and Sapolsky, 1999). The main pathologic traits by 
which AD is defined are: senile plaques containing the amyloid p-peptide (AP) in the 
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form of highly aggregated and extracellular amyloid; neurons containing 
neurofibrillary tangles; and regional neuron loss in the hippocampus and entorhinal 
cortex (Finch and Sapolsky, 1999). The 1::4 allele of apo E has been shown in a 
number of studies to be associated with both familial and sporadic forms of the 
disease, causing higher incidence and earlier age of onset, and affecting its pathology 
and rate of progression (reviewed in Roses, 1997). Although there are still no 
established mechanisms to account for the link between AD and apo E the majority of 
hypothesis can be summarized in three main categories. The first proposed 
mechanism is through the effect of APO E on AP production, aggregation and 
catabolism, with APO E being co-localized with AP in senile plaques with 1::4 having 
an impact on the amyloid cellular uptake. Secondly APO E may have a direct effect 
on neurons or glial cells, including tau phosphorylation, neuronal survival, neurite 
extension, and on the allele-specific protective effects on neurotoxicity and oxidative 
cytotoxicity, with 1::2 being the most protective. Finally, the third proposed 
mechanism is that the link between apo E and AD is due to changes in cerebral blood 
flow related to atherosclerosis, something that has evidence both for and against from 
various studies (reviewed in Smith, 2002). 
Taking into account the effects that APO E has within brain tissue, it is easy to 
understand that it may affect a lot more of brain function and pathology than just AD. 
Normal age-associated cognitive decline, and mild cognitive impairment (MCI) in 
particular, have been repeatedly associated with the presence of the 1::4 allele. MCI is 
defined as isolated memory impairment in an otherwise healthy individual. DeCarli 
ct al (2001) found that the presence of the 1::4 allele increased the risk ofMCI and the 
risk ofMCI conversion to AD. To test if apo E is a factor modifying general 
cognitive ability the genotype of202 children was screened and compared with their 
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IQ scores; no association was found between the apo E isofonns or the level of its 
expression and cognitive ability (Turic et aI., 2001), while in a second study with 134 
young females (19-21 years old), £4 was associated with only a modest increase in IQ 
(Yu et aI., 2000) suggesting that the cognitive effect of the alleles is either irrelevant 
in a healthy population or that the alleles produce their effects during middle age. 
Furthennore apo E has also been linked with response to head injury, where 
patients with the £4 allele have a worse outcome after traumatic head injury. In a 
study of93 patients with head injury it was found that 57% of the £4 carriers resulted 
in death, vegetative stage or severe disability, compared with 27% of non carriers 
(Teasdale et aI., 1997). To assess the association between chronic traumatic brain 
injury and apo E genotype Jordan et al (1997) studied 30 professional boxers and 
concluded that possession of the £4 allele may be linked with increased severity of 
chronic neurological deficits. 
In addition to the association of apo E with AD, cognitive decline and head 
injury, various other studies have found associations with a number of different brain 
pathologies. Both £4 and £2 were linked to cerebral amyloid angiopathy-related 
hemorrhage, irrespective of AD pathology, with individuals carrying the £2£4 
genotype being at risk at a particularly young age. As with brain injury, £4 was 
associated with adverse outcome from intracerebral hemorrhage. Less certain is the 
relationship of apo E with stroke where it is generally believed that £4 may have a 
small effect of increasing the risk for an ischemic stroke but has no effect on the 
outcome after the event (reviewed in Horsburgh et aI., 2000). 
It is easy to sce the importance of the apo E gene in longevity and health of 
the elderly. Its well documented association with CHD and AD and its emerging 
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importance in other age related pathologies makes it a very good candidate for the 
title of first human "ageing" gene, if something like that exists at all. 
4.5 apo E evolution 
Up to now we have seen the function of apo E and its importance in longevity 
and health, but we have avoided the important questions of how and why apo E 
polymorphism has evolved. One of the major ideas of the evolution of senescence is 
the mutation accumulation theory, which states that alleles with deleterious effects 
restricted to older ages can achieve higher mutation selection balance than those with 
such effects early in life (Medawar, 1952). It is widely believed that the apo E gene 
belongs to the category of genes acting at a sufficiently late age that it is immune to 
direct natural selection. 
To consider the evolution of apo E we should start from its origin. Although 
the 1:3 allele is the most common allele worldwide and both £4 and £2 alleles can be 
derived from it by a single base change, E3 is not widely considered to be the 
ancestral human apo E allele (Mahley and Rall, 1999). In contrast to the human three 
allele system, non-human primates carry a single variant that resembles the human £4 
allele (Hanlon and Rubinsztein, 1995). This fA-like isoform of the non-human 
primates (and other mammals in general) does not have the same lipoprotein 
preference as the human counterpart. Another residue of APO E that needs to be 
considered is residue 61. By changing the arginine at residue 61 to threonine (as in 
the rhesus and squirrel monkey) the lipoprotein specificity of the allele will change 
from VLDL to HDL, giving E4 an E3-like preference (Mahley and Rall, 1999). Finch 
and Sapolsky (1999) suggested that the evolution of apo E in primates went through 
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two stages, first the 61 residue was changed from a threonine to an arginine in early 
hominids, and then the substitution of cysteine 112 to arginine gave rise to the 
human E3 allele. A final change of the 158 arginine to a cysteine is responsible for 
the production of the E2 allele, which probably arose multiple times since the base 
pair transition responsible is common, due to the high frequency of methylation of 
cytosines within CpG dinucleotides such as those present in the codons involved 
(Hanlon and Rubinsztein, 1995; Finch and Sapolsky, 1999; Mahley and RaIl, 1999). 
The worldwide frequency of E3 relative to the ancestral allele E4 suggests that 
either there is a strong negative selection against the latter or a positive selection for 
the former, or even both at the same time. Since the diseases associated with apo E 
are evident usually after the end of the reproductive lifespan it was thought unlikely 
that they could playa role in human evolution (Hanlon and Rubinsztein, 1995). To 
account for the evolution of the gene a number of different suggestions were made 
based on the dietary changes during human evolution, APO E's role in neurological 
development, head injury and immunoregulation, or simply that the allele frequencies 
observed today are just due to chance and genetic drift (Hanlon and Rubinsztein, 
1995). In a study of585 Danish men Gerdes et al (1996a) found a significant 
difference in the number of offspring between men with different apo E genotypes, 
with E3£3 genotype carriers showing the highest number of children while the E4 
carriers showed the lowest. The lack of any known mechanism to link APO E and 
lipids to fertility and the fact that many other factors, that can or cannot affect the 
number of children through the action of apo E, were not considered, suggest that the 
results of the study might be due to reasons other than the association of apo E with 
male fertility. 
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Sapolsky and Finch (2000) put forward an interesting idea for the evolution of 
E2 and selection against the E4 based on these alleles' role in AD, proposing that the 
apo E E2 isoform is the most recently evolved as a highly adaptive subtype increasing 
the probability of its female carriers to achieve higher fitness due to grandmothering. 
The "grandmother hypothesis", initially put forward to explain the long post-
reproductive lifespan in women based on the grandmother-grandchild food sharing in 
hunter-gatherers (Hawkes et aI., 1998), gives a possible insight into apo E evolution 
by the association of APO E, AD and oestrogen. Oestrogen treatment is considered to 
delay or even prevent AD in post-menopausal women (Tang et aI., 1996) and it may 
be a signal linking female fertility and the onset of the disease (Breitner and Miech, 
1999; Sapolsky and Finch, 2000). Thus post-reproductive women with the £2 and E3 
alleles will have been more likely to contribute to the gathering and sharing of food, 
thus increasing the chances of their genes spreading in the population. Finch and 
Sapolsky (1999) also mention that in autopsy studies on baboons and monkeys some 
degree of atherosclerotic heart change was observed, but they still use the 
"grandmothering" hypothesis as the most likely factor affecting the selection of the 
apo E isoforms, although they recognise the possibility that the three alleles might 
have been established before the evolution of this social function. 
A more interesting point in the story of the evolution of apo E is the presence 
of the E4 allele. Since it is clearly disadvantageous, how can it be retained in the 
population? Martin (1999) proposed that the E4 allele could be advantageous in cases 
of infections with pathogens requiring host lipids for survival. Parasites like 
Trypanosome brucei that cannot carry out de novo liposynthesis may depend upon 
host LDL for acquisition oflipids. So the high affinity of E4 for some lipids might 
actually hinder their uptake by the pathogen. 
94 
Although CHD is a disease that is evident mainly after the end of reproductive 
age in humans the British Heart Foundation statistics show that there are on average 
40 deaths per 100,000 individuals under the age of 65 every year (Petersen, 2002). 
But death is not the only result ofCHD and atherosclerosis, morbidity is also 
important in an evolutionary context since it will lower the overall fitness of the 
individual and its offspring. Furthermore vascular disease and atherosclerosis may 
hinder reproduction directly by changing the sexual ability of the individual. A strong 
association is believed to exist between male impotence and vascular diseases 
(Bortolotti et aI., 1997) with arteriosclerosis being an important factor (Jensen et aI., 
1999). Erectile dysfunction (ED) is a problem common mostly in middle age men 
and can be considered as analogous to CHD, arising from progressive blockage of 
small vessels and reduced arterial compliance. Importantly ED and CHD share the 
same risk factors leading to atherosclerosis (Feldman et aI., 2000), and although there 
is no documented association between ED and apo E we suggest that it is very likely 
to exist. 
Our hypothesis is that the increased energetic requirements of humans during 
pregnancy, lactation and early development, imposed by our large brain size, drove us 
towards the consumption of a higher energy diet and especially meat-eating. Since 
the effects of the three alleles are more pronounced while on a fatty diet, we propose 
that the acquisition of energy from meat provided the selective advantage towards the 
£2 and £3 genotypes that carry the lower penalties for high lipid consumption. We 
test our hypothesis with the help of a simulated human population characterised by a 
number of risk factors for CVD. 
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4.6 Methodology 
Based on our previous discussion on apo E we will simulate its effects on a 
human population and use our model to investigate the selection and evolution of the 
three apo E alleles. The model will simulate the population directly instead of relying 
on use of the Euler-Lotka equation as in Chapters 2 and 3. Direct simulation avoids 
the assumptions of stable population structure needed for the Euler-Lotka equation to 
be valid. Moreover, having a model that made use of equations that statistically 
summarize the population would lead us to lose the contribution of the uncommon 
events, unless we make assumptions about how uncommon they are and how they 
affect the entire population. With the use of a direct simulation we can avoid these 
problems as long as the forces exerted on the population are known and the number of 
repetitions is large enough to give a statistical validity to our population. 
Additionally, direct simulation can provide valuable insight into epidemiological 
studies, which by definition use a relatively small number of individuals, by providing 
information on the frequency of the observations. Thus although we are unable to test 
1,000,000 individuals we can test 1,000 and simulate the rest. We can then test how 
often our observations can arise in multiple sets of studies each with 1,000 
individuals. 
Before we describe the program used for the simulation we will explain the 
framework of the model as well as the difficulties encountered during its construction. 
The first step is to decide which are the relevant factors affecting the action of apo E 
on longevity. There arc two kinds of risk factors associated with cardiovascular 
diseases. The first kind is the non-modifiable risk factors, of which the more 
important arc heredity, in this case apo E genotype, and gender. The second kind is 
the modifiable risk factors. According to the British Heart Foundation the main 
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modifiable risk factors for CHD are: smoking, unhealthy diet, lack of physical 
activity, high alcohol consumption, poor psychosocial well-being, raised blood 
pressure, raised blood cholesterol, obesity and diabetes (Petersen, 2002). In section 
4.6.1 we will review the evidence for the association of each risk factor with CVD 
and the action of apo E. 
After identifying the relevant factors affecting the action of apo E we needed a 
measure of risk to describe their effect on longevity. The most straightforward and 
convenient measure of risk when the basic Gompertz model is used to account for the 
mortality of the population, is the relative risk as will be defined in section 4.6.2. 
However, as we shall see later, epidemiological studies usually express the increase or 
decrease of risk in terms of the odds ratio. Although both measures of risk describe 
an elevated or lowered probability of an event taking place within a group relative to 
another group, the change of an odds ratio to a relative risk is not a simple problem 
and we will address this in section 4.6.2. 
Another complication during the construction of the model arose due to the 
lack of quantitative data for the gene x environment interaction between apo E and the 
risk factors used. This has led us towards the use of a novel approach of estimating 
these interactions based on independent measurements of risk for each factor and the 
qualitative form of the relationship between the gene and the environment. A number 
of assumptions are needed for such a view of the gene x environment interaction to 
work which will be presented in detail in section 4.6.3. 
A basic aspect of our simulation program is the use of a Gumbel distribution 
to represent the mortality schedule of the individual. In section 4.6.3 we will explain 
what a Gumbel distribution is and its biological significance. For now it will suffice 
to say that we used the specific statistical distribution due to its close fit to a modified 
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version of the Gompertz model describing the change of mortality with age and, in 
this case, also the probability of death per year of age. The modified Gompertz curve 
and the Gumbel distribution were used throughout our model to account for the effect 
of risk factors on the mean lifespan of the simulated population and to randomly 
choose an age of death for the individual as we shall see later. 
Another important aspect of our model is that it has a large stochastic 
component. That means that every time the program was run a different result was 
obtained. Each single run is only one of the almost infinite possibilities of the model, 
but a group of runs statistically summarized provides an indication of how the 
population is expected to evolve. To achieve a level of stochasticity mirroring nature 
we made extcnsive use of random numbers. In section 4.6.5 the basic theory behind 
random number generators and information on the algorithm used are given in detail. 
Finally, in section 4.6.6 we present the procedure followed to construct the simulated 
population and we describe in detail the method of random walk uscd to make the 
distinction bctwecn stochastic change and change due to selection. 
Beforc we start to prcscnt in detail the differcnt parts of our model we should 
notc that in this part only the construction of a general form of the model, also callcd 
the default vcrs ion, is presented. To fully explore the significance of the diffcrent 
factors affecting the action of apo Eon longcvity we use a numbcr of differcnt 
vcrsions of the program with the same basic characteristics as the basic model but 
with quite different parameters values. These versions will be dcscribed and tested in 
the part 4.7. 
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4.6.1 Risk factors 
As we saw earlier the first step for the development of our simulation is to 
identify the relevant CVD risk factors affecting the action of apo E on longevity and 
disease. Here we will review the evidence supporting our choice of two non-
modifiable and four modifiable risk factors. For the first category of non-modifiable 
factors, genotype is the obvious choice since we are interested in apolipoprotein E, 
while gender is a significant modifier of mortality as we will see, especially in the 
case of cardiovascular disease. In the case of modifiable risk factors the choice was 
based on current knowledge of lifestyle parameters affecting CVD while keeping in 
mind the need for independence between the risk factors, simplicity and availability 
of data. Consequently, obesity and diabetes, although well known factors affecting 
the incidence of the disease, were not included as non-independent of the rest CVD 
risks factors, while psychological well being lacks the simplicity of association with 
the disease and quantitative data are extremely difficult to obtain. On the other hand, 
diet and physical activity are parameters that have played very important roles in our 
recent evolutionary history and have contributed both to our great success as species 
and to the contemporary prevalence ofCHD. Smoking and alcohol consumption have 
emerged as significant factors in the last two centuries and are likely to affect CVD 
risk in the future, especially in developing countries. Moreover, as we shall presently 
sec, a large number of studies have investigated the association of diet, alcohol, 
smoking and exercise with CVD and apo E. 
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4.6.1.1 Non-modifiable risks factors. 
Genotype 
The first risk parameter that we will consider is the apo E genotype. The 
importance of the apo E genotype and the possible mechanisms that can affect CRD 
and CVD were reviewed earlier. We should note here that we assume that the gene 
generates a risk factor only in conjunction with an environmental parameter. The 
gene function is to transport lipids through the bloodstream, when these are kept in 
their minimum amount we consider that all genotypes transport the essential 
quantities and no risk is generated. Thus, there are no risk factors for the different 
aIIeIes but for the interaction between a specific aIIele and each environmental 
parameter. That is a concept that we will further explain in section 4.6.3 where the 
method used to find the genotype x environment interaction will be described in 
detail. 
Gender 
The second risk factor that should be taken into account is gender. It is well 
documented that women suffer less from CliO-related mortality than men (Lloyd-
Jones ct al.. 2002; Panagiotakos ct al.. 2002; Petersen, 2002). Notably, women show 
a lag of 5 to IS years in coronary mortality and morbidity relative to men 
(Panagiotakos ct al.. 2002). Although the precise reasons for that difference are not 
yet known it has been thought to be due to the protective role of female hormones, 
with observational trials of women undergoing hormone replacement therapy 
supporting this notion (Humphries and Gill, 2003). Recently, randomized trials 
showed that there is no protective effect of hormone therapy for CVD, casting serious 
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doubts on theories of their role in generating the difference of cardiovascular risk 
between men and women (Humphries and Gill, 2003; Lokkegaard et al., 2003). We 
will discuss the relative risk between men and women later on in section 4.6.2 
together with the methodology to change odds ratios to relative risk. 
4.6.1.2 Modifiable risk factors 
Diet 
The first modifiable risk factor that we will address is diet. Diet is a well 
known modifier of cardiovascular risk and extensive infonnation has been 
accumulated on the different ways that CHD is affected by our nutrient and calorie 
intake. The currently accepted view is that long-chain saturated fatty acids, such as 
palmitic acid found in meat and dairy fat, increase LDL-cholesterol. When these are 
replaced by carbohydrates both HOL and LDL are decreased keeping their ratio 
constant. But the common form of carbohydrates in the Western diet contains refined 
polysaccharides with high glycemic index, increasing serum glucose, insulin and 
fasting triglyceride levels, another risk factor for CHD. Trans-unsaturated fats 
produced by hydrogenated vegetable oil, formed from their change to solid or semi-
solid form for frying or baking, increase LOL while decreasing HOL. The most 
favourable diet change though, is the replacement of saturated fat with monosaturated 
or polyunsaturated fats, lowering LOL significantly, while HOL is decreased only 
slightly, and without any parallel increase in triglyceride levels, especially when the 
very long chain n-3 polyunsaturated fat found in fish is used (Sacks and Katan, 2002). 
As we mentioned earlier, the model assumes that apo E is a risk factor when 
combined with a lifestyle parameter, in this case diet, and that the effects are no 
different betwecn men and womcn. Although there is evidence for higher sensitivity 
101 
of women to triglyceride levels and lower sensitivity to LDL, the assumption is a 
reasonable approximation for the purposes of the model (Sacks and Katan, 2002). In 
the case of diet, which is believed to be the fundamental risk in the evolutionary 
history ofCVD, the apo E genotype is considered in relation to nutrient intake to 
produce the diet relative risk. Evidence for the importance of diet and the change it 
can bring can be seen in a recent study of free-ranging baboons. Animals living close 
to tourist facilities, coming into contact with an easily accessible and energetically 
dense food source, showed two- to three-fold increases in serum insulin and very high 
HDL, VLDL and LDL cholesterol compared with wild foraging baboons (Kemnitz et 
aI., 2002). We consider that in the absence of any lipid intake or excess energy, there 
is no distinction between the six genotypes, but as the fats and energy intake increases 
there is a genotype-specific risk associated with the dietary change. According to 
this, we expect that the same amount oflipid change will have a bigger effect on LDL 
for the £4 carriers, both for the increase and decrease oflipid intake. There is a 
number of studies reporting that £4 carriers have a greater plasma lipid response 
during dietary intervention while others failed to find any significant change (for a 
complete summary see Ordovas, 1999) with Weggemans et al (2001) concluding that 
the effect was too small for a successful therapeutic approach. Ordovas et al (1995) 
summarised the available literature for the gene-environment interaction for lipid 
response to diet concluding that the apo E £4 allele carriers are more responsive to 
diet than the other two allele carriers and that the effect is likely be more intense when 
the total amount of fat is changed, a conclusion also shared by Hagberg ct al (2000). 
In order to quantify the effect of diet in terms of risk factors we first need to 
recognise the different possible categories of dietary patterns. Using cluster analysis, 
Millen et al (2001) described 5 distinct dietary patterns with unique food behaviours 
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and nutrient intake profiles. The dietary data collected among 1,828 women 
participating in the Framingham study revealed the presence of five clusters: Heart 
Healthy, Light Eating, Wine and Moderate Eating, High Fat, and Empty Calorie. 
Although the cluster names are self-explanatory we will describe them in a bit more 
detail. The Heart Healthy group was characterized by high consumption of foods 
typically recommended for healthy diets, as fruits and vegetables. The Light Eating 
group had an overall low food intake. The Wine and Moderate Eating group was 
similar with moderate intake of fats and sweets and high wine consumption. The last 
two groups of High Fat and Empty Calorie were characterized by fewer servings of 
healthy nutrient dense foods, micronutrients and fibre with the first group showing 
high fat consumption, while the later ate more sweets (Millen et al., 200 I; 2002). In a 
later paper using the same dietary clusters, Millen et al (2002) calculated the risk 
factors of carotid atherosclerosis disease corresponding to each cluster. As was the 
case for the gender risk factor described earlier, the diet-associated risk was expressed 
as odds ratio instead of relative risk, thus we will deal with their calculation in section 
4.6.2. 
Alcohol 
There is little doubt that alcohol consumption has an effect on the prevalence 
of CHD. A number of case control and cohort studies have demonstrated the 
presence of a U- or J- shaped curve relating alcohol intake and CHD risk, and alcohol 
and all-cause mortality (Corella et al., 2001). It is widely believed that moderate 
alcohol intake has a protective effect which diminishes with increasing dose after the 
point of heavy consumption. The levels of moderate and heavy alcohol intake are 
difficult to define, as well as the levels of desirable alcohol consumption in a 
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population. Usually the distinction is made at the level where alcohol stops having a 
protective effect. The UK Department of Health currently suggests that 3 to 4 units7 
(26 - 34g) per day for males and 2 to 3 units (17 - 26g) per day for women of all ages 
is "sensible", while higher doses carry progressive health risks (Department of Health 
and Inter-Departmental Working Group, 1995). Other studies found that consumption 
of up to 6 units per day is beneficial (Bovet and Paccaud, 2001) while most agree that 
more than 9 units of alcohol per day is heavy intake and should be avoided (Marmot, 
2001a). Alcohol is associated with a wide range of medical and social problems, and 
in some groups, especially those with low CHD risk, all-cause mortality increases 
with intake even below 9 units per day, mainly due to accidents and violence which 
increase with ethanol consumption (Bovet and Paccaud, 2001). The pattern of alcohol 
intake has proven to be of almost equal importance to quantity. Episodic drinking 
sessions that reach the weekly intake of a moderate drinker can have the same 
detrimental effects as heavy intake (Marmot, 2001 b). Binge drinking may be the 
reason for the absence of protective effects of alcohol in Northern European countries 
(Finland, Scotland) and may playa significant role in the current rise in mortality seen 
in Eastern Europe (Bovet and Paccaud, 2001). Another important aspect ofaIcohol 
intake is whether the lower risk is a result of the beverage or of the alcohol it contains. 
Studies have shown that although there are beverages containing bioactive 
compounds able to lower ClID risk, such as flavonoids and resveratrol in red wine 
(Kris-Etherton et al., 2002), the protective role of moderate alcohol consumption is 
independent of their action (Mannot, 200 I b). 
The biochemical mechanisms through which moderate alcohol consumption 
reduces the risk of ClID are not yet fully elucidated, but the main factors are believed 
7 One unit of alcohol in the UK is equal to IOml or 8.7 g of absolute alcohol (density O.87g1mL). 
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to be: the concentration ofLDL and HDL in blood, the ethanol involvement in 
endothelial function, the platelet function in blood clot formation and their enzymatic 
dissolution (Zakhari, 1997). In terms of the effect of alcohol on blood lipoproteins, it 
is well established that there is an increase ofHDL that seems to account for up to 
50% of the lowered CHD risk (Rimm, 2001). This may be attributed to the increased 
hepatic production of apolipoproteins and lipoproteins, the increased lipoprotein 
lipase concentration and the decreased removal ofHDL cholesterol as a result of 
alcohol (Rimm et aI., 1999). Platelets are a key factor in thrombosis which can 
contribute to myocardial infarction or stroke. Alcohol's antithrombotic effect is 
related to granule secretion and fusion and fibrinogen activity (Zakhari, 1997). 
Furthennore moderate drinking affects endothelial function by increasing nitric oxide 
release, alcohol dehydrogenase activity in the blood vessel wall antagonizing 
lipoprotein oxidation, and may also be involved in prevention of inflammation due to 
fatty streaks in the arteries (Zakhari, 1997; Puddey et aI., 200 I). 
While moderate alcohol consumption confers protection from atherosclerosis, 
heart attacks and stroke, heavy consumption not only increases other forms of 
mortality, but it also increases the risk of cardiomyopathy, cardiac arrhythmia, 
hypertension and hemorrhagic stroke (Zakhari, 1997). Alcoholic cardiomyopathy is a 
heart muscle disease seen most often in alcoholics in their late 40s. It is characterized 
by increased myocardial mass, dilation of the ventricles and wall thinning. It is the 
result of myocyte dysfunction due to high ethanol intake which causes changes in 
mitochondrial, endoplasmic reticulum and contractile protein function and disturbs 
calcium homeostasis (Piano, 2002). Alcohol-induced arrhythmias are considered as 
the basic factor of sudden alcohol-related coronary death especially in subjects with 
previous CAD history. These arrhythmias were first observed at weekends and 
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holidays ("holiday heart syndrome") and are related with high alcohol intake that 
causes atrial fibrillation (loss of synchrony between the atria and the ventricles) even 
in people with otherwise healthy hearts (puddey et aI., 1999a). Finally, the effect of 
alcohol in increasing blood pressure is well documented in both men and women. 
Consumption of more than 15 units/week in women increased the prevalence of 
hypertension (Nanchahal et at, 2000) while in studies where alcohol intake was 
lowered to moderate levels, blood pressure decreased significantly after just 4 days 
(Zakhari, 1997). Alcohol-related changes in the sympathetic nervous system, 
vasopressin release, the rennin-aldosterone system and atrial natriuretic peptide may 
play an important role in increasing the blood pressure of heavy drinkers (Kauma et 
at, 1998). 
The genotype-environment interaction between apo E and alcohol is still a 
point of debate. Kauma et al (1998) reported a significant increase of blood pressure 
associated with apo E in men with moderate and heavy alcohol consumption, while 
no effects of the genotype were observed in men "abstainers" and women. Although 
the £4 allele is linked with high LDL cholesterol, Kauma et al (1998) surprisingly 
found that subjects with the £2 allele were more susceptible to the blood pressure 
increasing effect of alcohol compared to the £4 carriers. In a reply to this article 
Puddey et al (J999b) questioned the validity of the observations and reviewed their 
own work, which showed that blood pressure changes due to alcohol were not 
affected by the apo E genotype. To examine whether apo E variation modulates the 
association between LDL cholesterol and alcohol, Corella et al (2001) used a healthy 
population sample from the Framingham Offspring Study. For the male participants, 
they were unable to find any difference of LDL with genotype for non-drinking men 
while a significant difference was observed for drinkers. LDL cholesterol in £2 
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carriers was lower in drinkers than non-drinkers, being the other way around for the 
E4 allele carriers. For women the effects of APO E on LDL cholesterol were obvious 
for both drinkers and non-drinkers alike (Corella et al., 2001). 
The last aspect of alcohol consumption that we will discuss is the idea that 
recommending moderate alcohol intake at a national level will lower the prevalence 
of CHD. There is no doubt that in the last two decades people have become more 
health conscious than in the past and are willing to follow public health advice. 
Discussion of the health benefits of red wine is believed to be have been a driving 
force in the increasing sales ofred wine in the US (Klatsky, 2001). Before advising 
moderate alcohol intake we should make clear that there is also going to be an 
increase of other forms of mortality associated with ethanol intake. Secondly, the 
population theory of alcohol consumption argues that increase of the mean alcohol 
consumption in the population will also increase the number of heavy drinkers, thus 
diminishing the benefits of moderate intake for the population in total (Marmot, 
2001b). 
Smoking 
Smoking is mainly associated with mortality through cancer, but it is also a 
significant risk factor for cardiovascular disease. It is believed that the products of 
tobacco combustion damage the vascular epithelium, increasing the secretion of 
adhesion molecules promoting thrombosis and atherosclerosis (Humphries et al., 
2001). Cigarette smoking has been linked to the insulin-resistance syndrome, causing 
elevated triglyceride levels, decreased HDL cholesterol, dysfibrinolysis and an 
increase in small dense LD L particles, all risks of CVD (Eliasson et al.. 1997). The 
association of smoking and apo E genotype has been studied by Humphries et al 
(200 I) using a sample of 3,052 middle-aged man with no history of CHD, concluding 
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that smoking is a risk factor for CHD especially in men having the £4 allele while £2 
carriers exhibited no increase at all. Further studies have supported the effect of apo 
E genotype on the cardiovascular disease risk of smoking in hypertensive male (van 
der Meer and Witteman, 2002), while others failed to find any evidence for this 
genotype-environment interaction (Keavney et aI., 2003; Liu et at, 2003). 
Exercise 
Physical activity is considered to be a significant factor in the prevention of 
both primary and secondary cardiovascular disease (Fletcher, 1997). It is estimated 
that some 37% ofCHD deaths can be attributed to physical inactivity (Press et aI., 
2003). Regular exercise can improve myocardial contraction and its electrical 
stability, increase heart-stroke volume and cardiac output, and decrease heart rate. At 
the same time, endothelial function is also improved, the dilatory capacity of the 
coronary arteries is increased, while inflammatory factors are decreased. Physical 
activity also reduces platelet aggregation and increases fibrinolytic activity affecting 
the tendency of blood to clot. Finally lipid oxidation is stimulated; lipase activity is 
increased, accelerating triglyceride clearance and the conversion ofVLDL to HDL, 
while a higher HOL to LOL ratio is observed together with a decrease in fasting 
insulin levels and its response to glucose (see review by Press et aI., 2003). 
Interestingly, a number of studies found that although occupational physical activity 
causes much higher total energy expenditure than leisure-related physical activity, it is 
not associated with changes in the CHO risk factor (Koenig et aI., 1997; Kaprio et aI., 
2000). Rothenbacher et al (2003) confirmed that moderate levels of leisure exercise 
were enough to decrease the risk of CHO, but they also found a positive association 
between work-related physical activity and risk of CHO. They attributed that 
discrepancy to the different duration and intensity associated with each mode of 
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physical activity, although they recognised that residual confounding of another 
associated risk is also possible. At the same time, a link between physical fitness and 
all-cause mortality and CVD has been shown to exist (Blair et al., 1995) which leads 
us to ask how closely linked is occupational physical activity with physical fitness or 
physical well being, what are the factors affecting that association and how they 
compare with those ofleisure exercise? To my knowledge, these questions have not 
been answered yet despite their importance for revealing which are the main factors 
of exercise affecting cardiovascular and general health. Recently, an investigation has 
been carried out to assess the amount, type and intensity of exercise needed to lower 
CHO in men (Tanasescu et al., 2002). The study involved 44,452 men, whose 
information was updated every two years from 1986 to 1998, and revealed that there 
is a significant inverse dose-response relationship between total physical activity and 
cardiovascular risk, while intensity was also related to reduced risk, with walking 
pace showing an inverse relationship to CHO incidence. 
Since, as we mcntioned earlicr, exercise has an effect on the lipid profile and 
APO E is a key factor involved in that process, we would have expected that the 
association bctwccn APO E phcnotype and lipids is affected by physical activity 
patterns. A numbcr of different studies using quite different populations and 
techniques have come up with conflicting results. Using young adults from the 
CARDIA study Schmitz et al (2001)concludcd that fitness did not influence the 
association betwccn APO E and HOL or LOL, a result in accordance with another 
study on Finnish males between the ages of 9 and 24 (Schmitz et aI., 2001; Bernstein 
et al., 2002). While a population study by Bcrnstein et al (2002) found that £4 carriers 
had a greater protective effect from intense exercise compared to &2 carriers or £3 
homozygotcs. To explain the contradictory rcsults, Bernstein et al (2002) addressed 
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two important points, exercise intensity and the detailed association between physical 
activity and HOL change. We have already seen that the intensity of physical activity 
is modulated through a dose-response mechanism, as for the change in serum lipids 
there is evidence suggesting that exercise increases HOL in those who need it more 
(Thompson and Rader, 200 I). Zmuda et al (1998) showed that the ability to increase 
the HOL cholesterol levels in blood through endurance exercise training is limited in 
subjects that initially had low HOL, probably due to the failure of exercise to change 
their triglyceride metabolism. Coillard et al (2001) using the HERITAGE family 
study concluded that endurance exercise is especially helpful in men with low HOL 
and high triglyceride levels, in contrast to those with isolated low HDL who seem to 
be much less responsive. Thus the discrepancy between the different studies can 
either be attributed to different intensities of the schedules which were followed or to 
the underlying heterogeneity of the population. 
4.6.2 Relative risk and odds ratio 
We have already presented the evidence for the risk factors chosen for our 
model and now we will describe the method used to quantify their effect on CVO. To 
achieve this we used a proportional hazard model describing the risk ratio between 
two different sets of conditions. According to this, if J.!l(X) is the hazard of death of 
genotype 1 at age x. and J.12(X) is the hazard of death of a genotype 2 at the same age 
x, then J.!l(X) = RX J.12(x). where R expresses the relative risk of genotype 1 compared 
to genotype 2 (Gerdes et aI., 2000). 
The first case that we will consider is the calculation of the relative risks for 
the six different genotypes produced by the combination of the three common alleles. 
For the calculation of the risk factors associated with each genotype we relied on the 
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work of Gerdes et al (2000). Using individuals with the dE3 and £2£4 genotypes as 
the reference group (a convention that we will keep throughout our model) Gerdes et 
al (2000) estimated the average relative mortality risk in £2 and E4 carriers in 3 
different studies. Out of the three we will use the values of 0.9 and 1.13 as the most 
representative for the relative risk of £2 and £4 carriers respectively. Due to the low 
frequency of £2 and E4 homozygotes in most populations, the great majority of studies 
combine the homozygotcs and heterozygotes with the £3 allele in a larger category of 
£2 and £4 carriers. Thus the relative risk measurements are done between the £3E3 
homozygote and the combined £3E2 and £2£2 genotypes for the £2 allele, and 
similarly for the £4 carriers. In order to construct our model though, we need to know 
the risk factor for each one ofthe genotypes instead of just the risk for the carriers of 
an allele. To calculate the risk ratio for all the six different genotypes we first have to 
find their allelic effect, the change of the mean lifespan observed if we could 
substitute one allele ofa population of homo zygotes with the allele we are interested 
in. Using the relatives risks described by Gerdes et al (2000) and a form of the 
Gompertz curve representing the change of mortality with age we found that carriers 
of the £2 allele were expected to live 1.12 years more than the homozygotes for &3, 
while the carriers of£4 showed a decrease of 1.3 years in average lifespan compared 
to the £3£3 genotype (Figure 4.1). Assuming that the alleles have an additive effect, 
as supported from experimental evidence (Bohnet et at., 1996; Zerba et aI., 1996). we 
ean use the frequencies of the two different genotypes within the carrier groups for 
each allele to calculate the allelic effects in each case. Thus we were able to calculate 
that the presence of one £2 allele extends mean life span by 1 year, while a single £4 
allele decreases life expectancy by 1.1 years. Again using the assumption of an 
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Figure 4.1. Change in the force of mortality with age for 8383 homozygotes and 82 
and 84 carriers. 
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additive allelic effect we can find the mean lifespan of each genotype and to finally 
turn those in the fonn of risk factors relative to the E3£3 genotype to be used in our 
model (sec Appendix 3). 
Many health studies though, use odds ratios to describe the data obtained, 
instead of the more accurate relative risk. The odds ratio is calculated by dividing the 
odds of an event in a treated or exposed group by the odds of the event occurring in 
the control population. Its popularity is mainly attributed to the widespread use of the 
logistic regression to analyse binary categorical data. The problem is that the logistic 
regression and the odds ratio are accurate only for rare events «10%) but are often 
used to study common outcomes (McNutt et aI., 2003). In these cases the odds ratio 
usually overestimates the true effect of the risk factor of interest (Robbins et aI., 
2002). To approximate the relative risk from the adjusted odds ratio we will use the 
very popular methodology of Zhang and Yu (1998) as the simplest one, and the one 
that requires less infonnation for the dataset used. According to this 
where RR is the relative risk, Po is the incidence of the outcome in the non exposed 
population and OR is the odds ratio. Despite the method's slight inaccuracy in 
calculating confidence intervals and inability to account for confounding factors, its 
balance between simplicity and precision makes it an especially useful tool (Robbins 
ct aI., 2002; McNutt et aI., 2003). 
We will use equation (1) to calculate the relative risk associated with gender 
using the odds ratio provided by Stevens et al (200 I) and the incidence described by 
Panagiotakos et al (2002). Substituting the incidence for women with 20% and the 
OR with 0.525 we can calculate the relative risk as 0.58. Using the Gompertz model 
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for the probability of death per year of age we can see that the difference produced 
between males and females is almost 6 years which is within the limits of the 
expected lag of cardiovascular disease between men and women (Figure 4.2). 
Using the same method we estimate the relative risk associated with each dietary 
pattern group of the Framingham study based on the odds ratio provided by Millen et 
al (2002). If the Heart Healthy group is used as the reference with risk ratio 1.0, using 
equation (1) the Light Eating risk is corrected to 1.17, the Wine and Moderate is 
changed to 1.32 which is very close to the original odds ratio mainly due to the small 
representation of the group in the population. The relative risk for a High Fat diet is 
1.36 and finally the Empty Calorie diet risk factor was estimated to 2.07. The 
Mathematica notebook with the detailed calculation can be seen in Appendix 4. 
For the remaining risk factors considered, relative risks were provided by 
Stampfer ct al. (2000). So in the case of alcohol consumption and for the purposes of 
the model we considered seven groups of alcohol intake: the non-drinkers group, 
three groups for various levels of moderate intake, and three groups for heavy intake 
including those with episodic binge drinking despite their mean alcohol consumption. 
For simplicity we assumed that there is no difference between men and women for the 
risk factors in each group. As a basis we used the risk factors as calculated by 
Stampfcr ct al (2000) using a sample of84,129 women in the Nurse's Health Study. 
Although, as we saw earlier, the association of smoking with apo E is still 
debatable, in the model we assumed that there is an interaction between them and 
again used the risk factors presented by Stampfer et at (2000) using the four groups 
provided. Ilere we should mention that in the case of former smokers there might be 
an increased representation of those already suffering from CHD which will disturb 
the calculated risk factor, and that the group with 1-14 cig/day can include very 
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Figure 4.2. Difference of average age at peak mortality between men and women. 
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different patterns of smoking ranging from irregular smokers to moderate but 
everyday ones. 
Finally, to incorporate the changes of CHD incidence in relation to physical 
activity we used five different groups of activity patterns depending on their duration 
of exercises in hours per week as described in Stampfer et al (2000). 
4.6.3 Genotype environment interaction 
As we have seen, there are studies that link apo E genotype with all the 
modifiable risk factors described, but their precise interaction in quantitative terms 
remains almost completely unknown. Although the description of the interaction 
between genotype and the modifying parameters ofthe CVD risk will require a series 
of epidemiological studies in a big population, we will try to compensate for the lack 
of data using the given risk factors and qualitative results of the existing studies to 
predict the expected associations between environment and apo E genotype. 
We will go through the method used using the risk factors for CVD associated with 
smoking. The first step is to assume that all the risk factors considered up to now are 
independent of each other, so that for example people that smoke more have the same 
chance of drinking more as those that never smoke. Although there is some evidence 
to support the opposite (Twisk et aI., 200 I) the simplicity that this assumption confers 
significantly outweighs the small changes that the clustering of risk factors would 
cause to our calculations. This assumption permits us to consider that if all other 
factors arc equally distributed among smoking groups, then the differences observed 
between the six genotypes can be considered as the result of smoking x genotype 
interaction. Moreover, since the £3£3 genotype is by the far the most common 
I Defined as "strenuous enough to build up sweat" 
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genotype in western populations, we can assume that the risk factors described by 
Stamp fer et al (2000) are those corresponding to the £3&3 genotype. The next step is 
to construct a graph of relative risk with category of smoking and fit a line through the 
data in accordance with our knowledge of the quantitative relationship between the 
two. This provides us with a continuous curve of changing risk with level of smoking 
(Figure 4.3.a). Using this curve we can find a series of curves relative to the one we 
already have that their risk ratio across all categories will correspond to the relative 
risk observed between the genotypes (Figure 4.3.b). Thus we have an approximation 
of the apo E genotype x smoking interaction for the risk of CVD. Similarly we can 
calculate the relative risk between apo E genotype and the rest ofthe modifiable risk 
factors. Thus in the end, the total risk of an individual can be simply calculated as the 
product of the gender relative risk and all four modifiable risk factors corresponding 
to the individual's genotype. Details of the method used can be seen in Appendix 5. 
A simulation of 500,000 individuals in the program revealed that our method 
overestimates the average risk of the population by 3.5. Calibrating the model 
according to this we achieved a simulated population with a similar mean and 
variance to a real population (real mean -75.9, while simulated mean -75.7 years of 
age). Further tests of our program proved that the calculated relative risks accurately 
reflect the situation of real life populations. 
4.6.4 Gompcrtz model and the Gumbel distribution 
As we mentioned earlier we can use a curve derived from the Gompertz model 
to link relative risk to changes of mean life span and to represent the probability of 
death at each age. To derive the equation for that curve from the equation of the 
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Figure 4.3. a) Graph represcnting the original (solid) and fitted (broken) lines for the 
change ofrclative risk with category of smoking. b) Calculated lines for the 
intcraction bctwccn smoking and apo E gcnotype. From top to bottom the lines are 
for &2&2, &2&3, &3&3 and &2&4, &3E4, &4E4 genotypes. 
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Gompertz model, seen in Chapter 1, we consider that the survivall(x) at an age x can 
be found as: 
where p(x) is the force of mortality at age x. Thus the change in survival or equally 
the change of mortality from age x-I to x can be written as: 
- j.u(Y-I)dy - j.u(y)dy 
MDiff =e I -e 0 
or 
_ (_I+;-I+"'ja (I-e"ja 
MDiff = e P -e P (2) 
This transformation of the Gompertz curve is equivalent to a probability density 
function (PDF), having a total probability of 1 and each of the points of the curve 
denotes the chance of death at the specific age for an individual with basal 
vulnerability ex and rate of ageing~. Comparing the modified Gompertz curve 
relative to the PDFs of other well known statistical distributions commonly used in 
mortality studies we found that the Extreme Value Distribution for minima is almost 
identical to it (Figure 4.4 and Appendix 6). To understand the biological significance 
of that, we first have to explain what the extreme value distribution is. Probabilistic 
extreme value theory is mainly concerned with the stochastic behaviour of the 
maximum or minimum of distributions. Although it has a long history in statistics, 
dating back to the beginning of the 18th century, its use has been limited in 
engineering and hydrology to predict the reliability of complex machines and the 
frequencies of extreme physical phenomena. There are two classes of extreme value 
distributions: the first class known as the generalized extreme value distribution, and 
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the second one as the generalised Pareto distribution (Bali, 2003). We will consider 
the first class which includes three different families of extreme value distributions: 
the Gumbel, the Frechet and the Weibull, each alternatively called type 1,2 and 3 
extreme value distributions respectively (Kotz, 2000). All three of them are mainly 
used in reliability theory in engineering; especially the Weibull model that can be 
used to predict the lifetime of complex mechanical objects and which has also found 
some use in demographic statistics. Here we will use a form of the Gumbel model for 
the minimum which gives the distribution of the smallest extreme from a set of 
normal or logistic curves. In terms of biological significance we can consider 
humans, and animals in general, as complex biological machines that will fail when a 
core part of the system fails. Each part will be expected to fail based on a normal or 
logistic distribution in accordance with the ideas of Fisher, stating that a quantitative 
genetic characteristic that is influcnced by the environment will show a normal 
distribution around a mean. The use of an extreme value distribution, in the writer's 
opinion, is an important alternative to consider age related mortality and changes. In 
this way we can account both for the heterogeneity in ageing rates of different organs 
within a single organism and for the deceleration of the force of mortality at later 
ages. 
To accurately construct the age-of-death probability density curves in our 
program, we made use of recent UK population data to calculate the a and P 
parameters of the Gompertz model. To do that we used the interim life tables from 
The Government Actuary's Department for males in England and Wales for the years 
1999-2001. In Appendix 7 thc dctails of the methods used to calculate the Gompertz 
parameters can be seen while the graph representing the number of deaths in each 
year of age can be seen in figure 4.5. 
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Figure 4.5. Number of deaths with age for England and Wales for the years 1999-
2001. The close fit of real data to what is expected form the Gumbel distribution and 
the modified Gompertz is evident. 
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4.6.5 Random number generators 
To simulate a real-life population as realistically as possible we will make extensive 
use of random number generators. Although very sophisticated true random numbers 
generators exist today that make use of radioactivity, radiowave noise or even lava 
lamps, they are mainly used for cryptographic applications and have high demands of 
processing powers, making them prohibitive for population models. Instead we shall 
use a pseudo-random number generator from the GNU Scientific Library (GSL 
version 1.4) for C and C++. These generators, commonly used for simulations, 
employ an algorithm to generate a deterministic set of numbers which behave and 
look similar to genuine random numbers (for more information on random numbers 
and random number generators see LEcuyer, 1998). The algorithm that we used was 
MT19937 by Makoto Matsumoto and Takuji Nishimura which is a variation of the 
"Mersenne Twister" generator and has a period of219937 - 1 (about 10"6000) and is 
equi-distributed in 623 dimensions (GSL Reference Manual). 
The model uses random numbers to allocate the genetic and non-genetic 
parameters of the model for each simulated individual based on the frequencies found 
in real populations. Then, an overall risk ratio was calculated and a probability curve 
constructed, describing the probability of death at each age for the given combination 
of factors. Again using random numbers, an age of death is chosen from the 
probability distribution of the individual to represent the stochastic component of 
longevity. 
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4.6.6 Simulating evolutionary change 
Since we have already described the basic aspects of the methods used to 
obtain the various elements of model, we are now ready to present the procedure 
followed by the program to simulate a human population and the process of 
evolutionary change for the frequencies of the three apo E alleles. To start, our 
population consists of an equal number of males and females. These are grouped into 
couples which reproduce either till they reach their 50th year of age or until one of 
them dies. The reproductive schedule is the same as found in contemporary western 
populations, so that the probability of giving birth decreases with increasing age. 
Each offspring is given a random genotype based on the genotypes of its parents and 
in the end all the produced genotypes are pooled into a matrix which constitutes the 
initial conditions for the next generation. The process is repeated as many times as 
the number of the generations required. If the apo E alleles have a selection 
differential between them, we expect to see that there will be a directional change of 
their frequencies in the population with each successive generation. In the model this 
can be observed in the case that the proportion of early deaths in the population is 
higher for one of the alleles compared to the other two, and this effect is within the 
normal rcproductive lifespan so as to limit the number or survival of the offspring. 
The results of the model, as expccted, have a very big stochastic element. 
This is expected in nature and seldom will selection be so intense so that the 
stochasticity of the system is negligible in relatively small groups. To overcome the 
problem and obtain reliable results we had to run the model many times so we could 
further analyse the data statistically. A simple version of the program can be seen in 
Appendix 8. 
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4.6.7 Statistical manipulation of the results 
Our model can be used to test if, in a western population, there is selection for a 
particular allele or genotype. To minimize the random variation of our results we 
used a set of at least 60 runs, each comprising 200,000 individuals followed for 50 
generations. These provided a number of different possibilities for the system to 
evolve. We summarized the data calculating the mean and standard deviation of all 
60 runs for each generation and each allele, using the results to plot the mean and 
twice the standard deviation around it to indicate the confidence intervals of the line 
(Figure 4.6). Since a regression analysis assumes that the variance of the sample 
remains the same, it is not appropriate to use it in this case where we can clearly see 
that the variance increases with each generation. To overcome the problem we used 
the method of random walk in one dimension to obtain the average change with each 
generation. First, we have to assume that the change of the allele frequencies is linear 
and can be described by a simple equation. As long as the alleles do not have a 
pleiotropic effcct, which will balance the selection for or against them, we will expect 
their frequencies to increase until they are fixed or extinct in the population. A simple 
equation to describe the change can be written as: 
a, = a,_1 + d + ~, 
where at is the frequency at time or generation t, at./ is the value of the frequency in 
the previous generation, d is the change bctween two consecutive points in the series 
and..!; is random noise with an underlying normal distribution. In order to calculate d 
we find a Yjt such that: 
with j = I, ..... ,60 
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Figure 4.6. Change of the three apo E alleles with each generation. The red line 
represents the E3 allele, the blue the E4 and the yellow the E2. The broken lines 
represent the 95% intervals of the tree lines. 
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and i = 1, ..... ,49 
giving us a sample of 49x60 elements. From this sample we can easily find the mean 
and its confidence interval (CI). If the CIs are positive then there is evidence for a 
significant increase of the allele frequency with each generation, while if negative the 
allele goes towards extinction. In the case that 0 is included within the confidence 
intervals, we cannot consider the change of frequency to be significant and selection 
is probably extremely weak, with the change attributed to the randomness of the 
system (Appendix 9). The 49x60 matrices obtained were also transferred into 
Minitab statistical software to test the significance between and within different 
variants of the program. Furthennore, the mean life span of the population can be 
easily calculated by running the simulation without reproduction for 500,000 
individuals giving us the expected changes in lifespan associated with each parameter 
of the model. 
4.7 Use and results of the model 
Having explained the methods used for the construction of our model and 
simulation program we are now ready to present the results obtained by our default 
version of the program and start testing the selection pressure on the apo E alleles 
under a number of different conditions. In section 4.7.1 we will explore the 
parameters used in our model by running the simulation and changing a single 
parameter every time. For part of 4. 7.2 we will use our model to elucidate the origin 
and early evolution of the three alleles by the use of data from contemporary hunter-
gatherers to parallel the conditions of human lifestyle during the spread of the two 
novel £2 and £3 alleles in a prehistoric population. 
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4.7.1 Analysing the parameters ofthe model 
A number of different variants of the program were considered. The default 
version of the model, with parameter values similar to those found in a typical 
western country, clearly shows that there is selection for the £2 and E3 alleles against 
the £4 one, with the £2 frequency increasing slightly more rapidly than that for £3, 
although there is no significant difference between them. 
The second variant of the model is concerned with the selection forces applied 
to the alleles when only a fraction of the population is affected by the action of the 
gene. If we consider that only about 30% of the total mortality in the population is 
apo E dependent and that apo E dependent and independent mortality have the same 
underlying shape (Health Trends - A Working Document, 
http://www.hcalth.gov.ab.calpublic/documentlHealth_Trends/index.html) then we can 
run the entire simulation again to see if there is any selection for the gene in a 
heterogeneous population with various causes of mortality. The program shows that 
even when apo E independent mortality is considered, selection for the alleles is still 
evident and approximately one third of the original. Thus ifno antagonistic 
pleiotropy for the apo E alleles exists, then in a contemporary western population a 
clear selection against the £4 allele and a positive one for the £2 and £3 alleles can be 
observed. Again, the rates of increase for the £2 and £3 alleles do not differ 
significantly. 
Changes in diet 
The model was also used to test how the selection forces on the Apo E alleles 
change when the lifestyle parameters in the model vary. The first parameter 
considered was diet. For the first change the Heart Healthy and Light Eating groups 
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were decreased by 20% while the High Fat and Empty Calorie groups increased to 
compensate for the change. Then we altered the model in the opposite way, with 
High Fat and Empty Calorie groups decreased by 20%. As can be understood the 
second change will be much smaller since the two groups have much lower 
frequencies, as can be seen in Millen et al (2002). In the first case the average 
lifespan of a population with only apo E related mortality decreased from 75.69 to 
74.93 years, while in the second case the average lifespan increased to 75.98 years. 
The selection forces for the alleles in both cases remained significantly different from 
zero, but when their frequencies for the two diets were compared with each other or 
with the original pattern, no significant differences were found. Additionally, there 
was no significant difference between £2 and £3 change with any of the diet variants 
considered; from now on this will be the case unless otherwise stated. 
Chan2es in alcohol consumption 
As we saw earlier, alcohol is a very important parameter for the cardiovascular 
health of the population, but it is also linked with risk of accidental mortality and 
many social problems. What makes alcohol a special case is that together with 
smoking it is closely monitored by governments and both are commonly subjects of 
high taxation, making them central in policy decisions. As with diet, we used two 
different variants of the simulation. In the first, light drinkers were decreased by 
25%, while in the second the decrease was in the groups of the heavy drinkers. The 
mean lifespan increased by 0.28 years in the first case, while in the second case a very 
slight decrease to 75.54 years of mean lifespan was observed. This does not mean 
that an increase of alcohol consumption will be beneficial for the population. Our 
model measures the longevity of a group dying from cardiovascular apo E related 
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aetiology; it is well known that heavy drinking will have a direct adverse effect on the 
heart muscle that will overcompensate for the slight increase we observed. Our 
results just point to the complex association of alcohol and longevity and our inability 
to follow simple strategies to successfully use the beneficial effects of ethanol while 
avoiding its abuse. In terms of the selection at the level of the entire population, there 
seems to be no significant difference between the two variants of the model, so that 
the 25% change in either way will not affect the selection pressure on the alleles, 
although in the case of £3 and £4 the effect is more intense than for the £2 allele. 
Chan2es in exercise level 
The next parameter to be addressed was the level of physical activity of the 
population. First we tested the changes in longevity and selection when the minimum 
level of the exercise in the population was 2.5 hours per week, or the equivalent of 
walking fast for half an hour every weekday. This resulted in an increase of mean 
lifespan to 76.19 years, half a year more than the present mean. The second variant of 
the program tcstcd the results of a decrease by 25% of the two most active groups. In 
this case the population lifespan dropped to 75.41 years, showing that the small 
frequency of very active individuals is too small to playa significant role in the 
longevity determination in the population. Selection for the gene remained significant 
but there was no difference for it between the default and the first exercise pattern and 
between the first and the second change in the level of exercise. 
Changes in smoking 
The final parameter investigated was the prevalence of smokers in the 
population. Although a significant decrease has been seen in smoking in western 
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countries over the last decade, the problem still remains and in many developing 
nations is increasing rapidly. Once more, two variants of the model were considered. 
In the first, the smokers increased by 25% while in the second the population 
consisted solely of non-smokers. The model predicts that a 25% decrease in non-
smokers would result in a mean life span of 75.57 years which is fairly close to the 
initial lifespan. On the other hand when we take out all the smokers from the 
population the mean longevity jumps to 82.95 years. For both variants there was no 
significant difference between the £2 and £3 alleles, but now there was more 
dissimilarity than usual. In the case of decreasing the non-smokers, the selection 
pressure was still significantly different from zero and non significant in relation to 
the default form of the model. In the second smoking variant of the simulation we see 
that £2 and £4 retain their CIs for the mean all positive and all negative respectively, 
while in the case of the £3 allele the value of the average random walk for the first 
time loses its significance, thus it can be attributed to the stochastic nature of the 
model. To demonstrate that this result was not due to some extreme case we ran the 
model 120 times instead of the standard 60 but the non-significance for the £3 allele 
remained stable. At the same time, the change in smoking caused a significant 
difference relative to the default situation, with the change of the £3 allele being 
significant at the 0.949% level while the other two aIIeles showed even higher levels 
of significance. Since the difference in the parameter tested was much larger than any 
other difference previously tested, it was expected that the random walk would now 
be different from what we saw earlier. As for the loss of significance in the case of 
the E3 allele, it docs not mean that the selection for it is solely based on the effects of 
smoking. Running another variant of the model with no smokers in the population for 
a group affected solely by apo E related mortality we see that the selection force on 
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the alleles is strong, but when only 30% of the population is affected, then the 
selective pressure is diluted enough to be indistinguishable from the randomness of 
the system. Furthermore even though the change for the E3 allele does not reach the 
95% significance level, most of the area of the CI for the mean remains above zero 
indicating that it is expected more often to have a small positive change rather than a 
negative or no change at all. All results are summarized in tables 4.1 and 4.2. 
4.7.2 Origin of the apo E alleles 
Further variants of the model addressing the problem of the past evolution of 
the apo E gene were also tested. For this purpose we used the program which 
included apo E un-related mortality and two different patterns of diet. In the first one 
the main source of energy was provided by a meat diet with a high fat content. There 
is evidence that around 2.5 million years ago our early ancestors started to consume 
food requiring more tearing than grinding, signifying the change towards meat eating 
(Boyd Eaton et at., 2002; Richards, 2002). This meat will have initially corne from 
small mammals and scavenged skulls, left over by bigger predators, with the use of 
tools to get access to the brain, a part of the body that carnivorous animals do not 
always consume (Cordain, 2002). Of course this would have been very opportunistic 
in the beginning but as the size and sophistication of hom in ids increased so did their 
ability to hunt larger prey, as can be seen in the case of Neanderthals (Hockett and 
Haws,2003). Although humans retained a diverse diet, modem hunter-gatherers 
show that they probably relied on meat for more than 50% ofthe daily calorie 
consumption (Kaplan et al., 2000). In the second variant of the model, the diet was 
changed from high fat to high carbohydrates. In this case the relative risk of an 
132 
Run Parameters Mean Lifespan 
Run 1 default Default 75.69 
Run 3 diet 1 Heart Healthy and Light Eating groups decreased by 20% 74.93 
Run 4 diet2 High Fat and Empty Calorie groups decreased by 20% 75.98 
Run 5 alcohol 1 Light and non-drinkers decreased by 25% 75.97 
Run 6 alcohol 2 Heavy drinkers decreased by 25% 75.54 
Run 7 exercise 1 Entire population moderately active (2.5h/week) 76.19 
Run 8 exercise 2 Most active groups decreased by 25% 75.41 
Run 9 smoking 1 Non-smokers decreased by 25% 75.57 
Run 10 smoking 2 No smokers in the population 82.95 
Table 4.1. The simulated average lifespan in years of each variant considered in the 
absence of non Apo E related mortality. All the changes, except the last one, are 
moderate changes in lifestyle parameters that can take place in the population within 
relatively short term (- 25 years). 
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Run Apo E allele Mean change of allele 95% confidence frequency per generation intervals for the mean 
£2 0.0003352 0.0002661 0.0004043 
Run 1 default £3 0.0002785 0.0001809 0.0003761 
£4 -0.0006137 -0.0006946 -0.0005327 
£2 0.0000846 0.0000497 0.0001195 
Run 2 deafult 2 £3 0.0000846 0.0000316 0.0001377 
£4 -0.0001692 -0.0002140 -0.0001244 
£2 0.0000900 0.0000547 0.0001252 
Run 3 diet 1 £3 0.0000899 0.0000360 0.0001438 
£4 -0.0001798 -0.0002257 -0.0001340 
£2 0.0000809 0.0000480 0.0001139 
Run 4 diet2 £3 0.0000643 0.0000130 0.0001157 
£4 -0.0001453 -0.0001905 -0.0001000 
&2 0.0000836 0.0000524 0.0001148 
Run 5 alcohol 1 &3 0.0000818 0.0000326 0.0001309 
&4 -0.0001654 -0.0002081 -0.0001226 
&2 0.0000847 0.0000500 0.0001195 
Run 6 alcohol 2 &3 0.0000588 0.0000074 0.0001103 
&4 -0.0001436 -0.0001880 -0.0000991 
&2 0.0000895 0.0000555 0.0001235 
Run 7 exercise 1 &3 0.0000629 0.0000108 0.0001149 
&4 -0.0001524 -0.0001959 -0.0001088 
&2 0.0001088 0.0000749 0.0001427 
Run 8 exercise 2 &3 0.0000637 0.0000115 0.0001158 
&4 -0.0001725 -0.0002171 -0.0001279 
&2 0.0001283 0.0000897 0.0001668 
Run 9 smoking 1 &3 0.0000974 0.0000383 0.0001564 
&4 -0.0002256 -0.0002766 -0.0001746 
&2 0.0000406 0.0000205 0.0000607 
Run 10 smoking 2 &3 0.0000259 -0.0000051 0.0000514 
&4 -0.0000665 -0.0000936 -0.0000393 
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Table 4.2. The mean change of the each allele frequency for the various variants of 
the model with the 95% CI of the standard error ofthe mean in each case. For all runs 
we had 60 repetitions each, except run 10 which had 120. 
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empty calorie diet was used to signify the overabundance of calories in the diet of a 
human adapted to long periods of near famine. Agriculture started around 10,000 BC 
somewhere in the Near East and later independently in other parts of the world. This 
led to an increasingly sedentary population with access to food high in carbohydrates 
and calories. At the same time a general decline in health and stature was observed, 
together with the appearance of some nutritional disorders (Richards, 2002). Farmers 
probably expanded due to their ability to sustain their bigger numbers, thereby 
spreading their new technology. This movement can still be seen in Europe today and 
displays a south-east north-west gradient similar to the frequencies of the apo E 
alleles (Cavalli-Sforza et aI., 1993). For both cases the other parameters considered 
will be changed to mirror what we expect to find in a population in the Palaeolithic 
and Neolithic ages. Thus, alcohol consumption and smoking will be set to zero, while 
we will assume that the entire population is moderately active. The final variant of 
the program to be tested takes into account that only 10% of the entire population will 
be affected by the action of the gene. This is based on the fact that only 20% of a 
Badza population, a modem equivalent of hunter gatherers, reach the age of 65 and 
that even from those, not everyone will die from apo E related diseases (Kaplan et aI., 
2000). The result for the last three variants can be seen in Table 4.3. Again for £2 it 
seems that there is no significant difference between the two diets although the high 
carbohydrate diet seems to have a more pronounced effect. In the case of the t3 allele 
the significance seen here is probably due to the randomness of the model used rather 
than a real effect. For the last run of the program it can be seen that the selection for 
£2 remains significant even in the case where a very sma)) proportion of the 
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Run ApoE Mean change of allele 95% confidence intervals allele frequency per generation for the mean 
£2 0.0003212 0.0002829 0.0003596 
Run High Fat £3 0.0001759 0.0001240 0.0002278 
£4 -0.0004971 -0.0005586 -0.0004357 
£2 0.0003603 0.0003102 0.0004105 
Run High Carbo £3 0.0003267 0.0002621 0.0003913 
£4 -0.0006871 -0.0007652 -0.0006089 
£2 0.0000252 0.0000044 0.0000461 
Run High Fat 
£3 0.0000215 -0.0000074 0.0000504 with 10% Apo-E mortality 
E4 -0.0000467 -0.0000814 -0.0000120 
Table 4.3. The mean change of the each allele frequency for the three variants 
concerned with changes in diet mirroring those found during human evolution. The 
first and third variants have the same parameters but for the last one the effect of Apo 
E is limited to only 10% of the entire population. 
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population is affected by the action of the gene, while for &3 although the difference 
can not easily be distinguished from the random events it seems that it is enough to 
playa role if the time interval is sufficiently long. 
4.8 Discussion 
Our aim was to find if the apo E gene is acted upon by natural selection in a 
contemporary population despite the fact that its main effect is beyond the end of 
reproduction. We have shown that given the environmental parameters often found in 
Western countries the level of selection can be calculated as the change of frequency 
of the alleles between generations. We found that the &2 and &3 alleles are selected at 
the expense of the &4 allele, with &2 showing a larger but not significantly different 
change per generation compared with the &3 allele. Furthermore the selection 
remained significant even when the parameters changed between 20-25%, showing 
that the model is not very sensitive to the frequencies considered, thus our results will 
stand even if there is a degree of error in the values used. In the case of smoking we 
saw that when the smokers are taken out of the population the change of &3 allele per 
generation loses its significance while that for &2 remains positive. We also checked 
for the expected changes in longevity when we vary the environmental parameters of 
the model which has provided us with a useful way to test the effect of these changes 
and get a quantitative view of the benefits or losses to the mean lifespan. 
Up to now the fact that APO E has an effect beyond the reproductive lifespan 
of humans has posed an interesting puzzle for the evolution of the gene. As we saw 
earlier, one of the prevailing views is the one described by Finch and Sapolsky (1999; 
2000) based on the grandmother hypothesis (Hawkes et aI., 1998). The grand-mother 
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hypothesis is based on the idea that the mother-child food sharing seen among hunter-
gatherers may allow post-reproductive grandmothers to enhance their daughters' 
fertility thus elevating their own fitness and increasing the selection for long 
postmenopausal lifespan. Finch and Sapolsky argued that this evolutionary advantage 
will have caused selection for an apo E allele that will have delaed neuropathology 
and mortality. Although this is a compelling hypothesis, despite some problems with 
the underlying theory (see Kennedy, 2003), which may work at a secondary level to 
increase selection for the apo E alleles, our model showed that it is not strictly 
necessary. According to our simulations the direct effect of apo E on the mortality or 
morbidity of the population is sufficient, at least in contemporary Western 
populations, to produce a differential of selection between the alleles in a wide 
number of different situations. 
Our results clearly indicate that although the main effect of apo E is beyond 
the end of the reproductive lifespan of humans, the relatively rare events of early 
mortality or morbidity are enough to produce selection against the £4 allele. 
Considering these findings in the light of mutation accumulation theory, we can see a 
new important aspect of this concept. Since most longevity associated genes, such as 
apo E, will cause a distribution around a mean for the corresponding mortality, 
evolution will very rarely, if ever, manage to push a gene action entirely out of the 
reach of selection. Most often the effect of the gene will be gradually moved to older 
and older ages. Furthermore this action will take place simultaneously in many genes 
since if a single mortality distribution is exposed significantly more often to the action 
of selection, it will be moved towards older ages faster, until it reaches a balance with 
the rest of the mortality genes. This process will continue to drive the evolution of the 
longevity of the organism until the age-related mortality becomes non-significant in 
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relation to the age-independent mortality. The above view of the evolution of 
longevity can account for the fact that in the wild very few animals die of natural 
causes as well as the difference between longevity in the wild and in captivity. In 
addition it can explain how the same genes in different but closely related species can 
produce big differences in longevity. In this respect the evolution of longevity, 
although based on selection of individual genes, is more of an evolutionarily 
coordinated transfiguration of the whole organism to achieve the maximum lifespan 
in the given conditions (for similar ideas see Hamilton, 1966). Based on the above we 
can see how common age related diseases today, with late age of action, could have 
played a role in our evolutionary history even if their action is currently much beyond 
the expected lifespan of our early ancestors. Cardiovascular disease can be 
considered as an example of just such an evolutionary process. All primates seem to 
follow the same basic rules for the evolution of late acting diseases, with differences 
in their sensitivity towards various environmental and physiological parameters 
(Rudel ct aI., 1998). If they live in a protected environment and are exposed to 
similar diets to those of contemporary humans, they will develop similar age-related 
diseases (Kemnitz et aI., 2002). So, can we apply our model to make predictions 
about the past evolution of the apo E gene? Ifwe assume that cardiovascular disease 
played a role even in early humans, which as we saw earlier is possible, and the 
relative risks are comparable with those seen today then we can cautiously use the 
model to get an indication about the presence or not of the selection in our early 
evolutionary history and its approximate intensity. 
Assuming that the ancestral allele was £4, since this is found in almost all 
other primates, and considering the prevalent view that £3 originated from a C-T 
transition at codon 112 while £2 arose from another C-T transition at codon 158 from 
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the £3, we can use the changes in frequency per generation predicted by the program 
to obtain an indication of the evolutionary history of each allele (Finch and Sapolsky, 
1999; Mahley and RaIl, 1999). As we saw earlier in a population showing high 
consumption of fat, according to our model, the expected change ofthe £2 allele per 
generation will be 0.0000252 while for £3 it will be 0.0000215. Given the current 
prevalence of the gene in Europe of 0.0845 for £2 and 0.7415 for £3 and assuming 
that the conditions remained comparable to the parameters used in the final run of the 
model, then we will expect to have an evolutionary history of around 60,000 years for 
£2 allele, with a minimum of34,000 and maximum 350,000 years, and 600,000 for E3 
with a minimum history of265,000 years. Of course conditions have changed 
significantly during our evolutionary history so that the linear process assumed in our 
calculation is a simplification of the problem. What is instead expected is a nearly 
exponential increase of the selection for the gene, increasing very slightly in our early 
ancestors. As cardiovascular disease becomes more important, the increase becomes 
bigger and bigger. Furthermore we do not know the exact fraction of the population 
affected by the action of the gene. We assumed a 10% ratio while we used a diet of 
meat. Thus we probably overestimated the very early levels of selection. According 
to these observations we can hypothesise a history for the human apo E gene in two 
stages. The first stage starts with the change of the £4 from its ape form to the one 
found in humans today, either due to an unknown advantage conferred by this isoform 
or more probably due to a bottleneck in our early history. Later as early hominoids 
started to add protein and fat to their diets, probably by scavenging subcutaneous fat, 
bone marrow and brains from discarded kills, the previous mutations of £4 to £3 
began to be selected. The intensity of selection would have increased with increasing 
brain size and reliance on meat and of course longevity (Finch and Stanford, 2004). 
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During this time, as the £:3 allele increased in frequency, a mutation of it arose that 
conferred even better protection from the adverse effects of meat eating, the £2 allele. 
This time can probably be characterised by a linear change in allele frequencies. The 
second stage probably started with the beginning of agriculture where humans were 
now able to live a much more secure life, increasing their lifespan and the selection on 
the alleles of apo E, most likely starting an exponential rate of change for the allele 
frequencies. Furthermore agriculture also brought a decrease of health, mainly due to 
overcrowding and high level of carbohydrate in the diet, with the first significant 
appearance of diseases common today, such as diabetes and, importantly, diseases of 
the vascular system (Richards, 2002). We are probably still in the second stage of the 
gene selection which will end either by the extinction of the £4 allele or with a 
balance bctween the three alleles due to some as yet unknown pleiotropic effect of 
them. A two-stage evolution of the gene may explain the global differences of the 
alleles. So with the first stage we can account for the high frequency of the £4 allele 
in Africa, where we expect the selection to be present but much attenuated by external 
mortality and the relatively recent use of agriculture, while the second stage can 
explain the north-south gradient of the £2 allele in Europe coinciding with the spread 
of agriculture. 
Of course all our work is based on our current knowledge and understanding 
about the operation of the apo E gene. Further work is needed to elucidate the precise 
quantitative relationship of the apo E gene with the parameters of the model so that 
our predictions can become more accurate. In that respect, the simulation described 
can work as a framework of a gene-environment interaction where new data can be 
added easily to see their effect on the longevity of the population and selection 
applied on different alleles. Nevertheless, from our discussion already we can see that 
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although the apo E gene is known to be a part ofthe lipid transport system in the body 
it may worthwhile to ask what is its role in cases of caloric restriction, a high 
carbohydrate diet and dietary related diseases. 
To summarize, our results show that apo E is selected in a normal western 
population even when different lifestyle parameters change. One ofthe most 
significant changes made in the model was smoking and how this affects the action of 
apo E. We were also able to elucidate some new aspects of the mutation 
accumulation theory and how it might operate, moving distributions of gene effects 
during the selection for longevity. Additionally we gave an example of how an 
extreme value distribution can describe an altered form of the Gompertz model. 
Finally we tried to answer how the apo E evolved and we proposed a two-stage 
process in relation to meat eating and the spread of agriculture. 
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5. The Effects of Social Class in Longevity 
There is little doubt that ageing is the product of a set of complex interactions 
between our genes and the environment with time. In this Chapter we will explore 
how social class in human societies might affect the ageing process of an individual 
and ultimately its longevity. Examples will be drawn from a wide variety of sources. 
Furthermore, our previously developed models will be considered in the context of 
living conditions within an unequal society while an analysis of global data will be 
used to illustrate our main conclusions. The genetic and non-genetic factors involved 
in the heterogeneity of ageing between castes or social groups will be addressed. 
Finally we will explore the effects of inequality of longevity on the evolution of 
human populations and ask whether we will expect to find evolutionary selection 
differences between social groups. 
5.1 Introduction 
Most commonly the definition of society refers to the patterns of relationships 
among individuals within a definitive territory (Scupin, 1992) and is free from any 
necessity for a social stratification. The emergence of social classes, as sub-groups of 
the population given a specific role in society, is the result of a social structure where 
the relationships among individuals are driven by transfers of resources between 
specialist groups. These groups share common attributes and dexterities and interact 
in particular ways with other groups in the society. The nature and balance of the 
interactions between the different classes are central in political theory and have been 
the subject of rigorous investigation through the disciplines of sociology, philosophy 
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and economics. In our current work we will concentrate only on the effects of social 
status and its measures in relation to public health and ageing. 
Inequality in health between different social groups is a fact long recognized. 
Frederick Engels (1845) described disturbing pictures of urban mid 19th century 
Britain, where inappropriate dwellings, poor hygiene conditions and malnutrition, 
were widespread among the working class. These resulted in 57% of children in the 
poorest classes dying before the age of five, compared to 20% in the most affluent 
families. Fatal cases of small-pox, measles, scarlet fever, and whooping cough, in 
children living in industrial cities were four times more frequent than the national 
mean. Children were reported working as young as eight or nine years old. Engels 
also cites a Dr Hey describing the deformities of the spine and limbs due to overwork 
and poor nutrition, while Dr Hawkins (the medical commissioner for Lancashire at 
the time) described the factory workers of Manchester as surprisingly short, lean and 
pale with a high percentage of alcoholism. Others reported that most men were unfit 
to work after 40 years of age and they were by then considered as too old. Women 
were forced to work up to delivery and to resume 3 to 4 days after giving birth for fear 
of being laid off, while young girls working in factories very commonly exhibited 
menstruation problems (Engels, 1845). 
5.2 Markers of inequality and their link to health and mortality 
Despite the fact that in developed countries today this kind of situation sounds 
alien and unacceptable, it is sadly a condition that still exists, to some extent, in some 
developing countries. Even in today's advanced economics there is significant 
inequality in health and longevity between social groups. Many recent studies have 
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found that there is a correlation between markers of social status and lifespan. 
Usually education, income and occupation are used as indicators of socioeconomic 
level and their association with morbidity and longevity is tested in a sample of the 
population. Each marker of social class though, captures only a part of what 
constitutes our status in society. Education refers to the early part of life, it is 
sometimes linked with the status of the parents and it is also predictive of later 
success. Occupation is a marker of the conditions of adult life and a link between 
education and income. On the other hand income relates directly to material 
conditions at the specific time and can be independent of occupation or education. 
Income can affect health directly in the short- or long-term since it is the key factor in 
determining access to better housing, food, health care, recreation etc (Avlund et aI., 
2003). Regardless of their differences, the markers discussed can give consistent and 
reliable associations between social class and inequalities in health and lifespan as 
long as their specific properties are kept in mind. Bopp and Minder (2003), using 
data from the Swiss National Cohort, found that mortality from age 25 to 85 is 
negatively correlated with the level of education for both men and women. Moreover 
for males the differences seem to decrease with ageing so that the mortality curves 
converge at around the 89th year, in accordance with the majority of literature; while 
in the case of women the difference is much more difficult to observe. 
Although health status is a much more subjective measure than lifespan, in 
most studies higher social status means not only a longer life but also a longer health 
expectancy, with the differences between social classes being greater than that 
observed for longevity (Bronnum-Hansen, 2000). People in lower classes, in addition 
to living a shorter life, are expected to also spent more years in ill health, both in 
absolute terms and as a percentage. For example, for a 25 year old Belgian with the 
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lowest level of relative education, out of the 43 years of further expected longevity it 
is predicted that 25 will be in good health and the remaining 18 in perceived poor 
health, in contrast to those at the highest level where out ofthe 46.5 years only 4.8 are 
expected to be in perceived poor health (Bossuyt et al., 2004). Of course the question 
remains whether individuals with a higher education consider their health good even 
when someone with a lower education will consider it poor. Generally, when the 
calculations are based on perceived health, the health expectancy is higher in all 
socioeconomic groups than it would have been if longstanding illness was used 
(Bronnum-Hansen, 2000), but no evidence exists that this overestimation is much 
higher in specific parts of the population. Further evidence for the differences 
between social classes are provided from the work of Huppert et al (2000) where 
event-based prospective memory, the ability to remember to carry out indented 
actions, at ages 65+ was negatively associated with less education and lower social 
status irrespective of the objective perception of health of the participants. 
Not all studies though are able to observe this inequality in health between 
social classes. Notably a study in an elderly population (mean age 80 years) in Hong 
Kong showed no association between income after retirement and lifespan, which led 
the authors to attribute the lack of correlation either to the survivor effect in the cohort 
used, or to the well developed and easily accessible health and social services in this 
Chinese province (Woo et al., 2000). What the writers overlooked in this case 
though, is the fact that the mean age of the population used in their study was very 
close to the crossover point of mortality between a high and low mortality group. As 
was shown by Bopp and Minder (2003) the differences in longevity in this area are 
much reduced compared to that seen earlier in life. Nevertheless, the characteristics 
of a society or of an economic program can alter, up to a point, the level of inequality 
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between privileged and disadvantaged members of a population, but sadly not to 
eliminate it. This can be seen in the work of the EU Working Group on 
Socioeconomic Inequalities in Health, where 11 western European countries were 
compared based on their inequalities with respect to morbidity and mortality 
(Mackenbach et al., 1997). Despite the methodological problems arising from 
historical differences in the timing of the epidemiological transition between 
European countries, and differences in the causes of mortality between countries, it 
was found that France has the highest inequality in mortality between social classes 
while the Nordic countries exhibit the highest degree of inequality relative to 
morbidity. Generally within Europe a north to south gradient of inequality has been 
reported, with Mediterranean countries showing much smaller differences between 
social classes (Mackenbach et al., 2000). The authors proposed that "open" societies, 
where social position exhibits a low "heritability" and is more affected by personal 
characteristics, wiIllead to a larger inequality in health (Mackenbach et al., 1997). 
A highcr social status is not always beneficial for health. In developing 
countries the trend bctwecn class and health is commonly reversed. Jamaica, a 
middle income developing country, shows a complex association between income, 
education and hypertension, with both the low- and high social classes having 
elevated blood pressure relative to the intermediate groups (Mendez et al., 2003). In 
China, higher social status was linked with an unfavourable serum lipids profile (Yu 
ct al., 2002). In these cases, a high socioeconomic status is linked with an early 
adoption of westernized lifcstyles characterized by smoking, sedentary lifestyle, and a 
high fat diet. Generally, distinct groups of the population progress through 
epidemiological transitions at different times, with a different starting point and a 
different rate, with the more affiuent classes starting earlier and progressing much 
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more rapidly (Gulliford, 2003). In some more recently industrialized countries the 
after-effects of a socioeconomic change can still be seen in the prevalence of diseases 
linked with lifestyle. A study in Barcelona, Spain, showed that although total deaths 
were negatively associated with employment status, cardiovascular mortality in men 
was more common in the higher-level professional group (Borrell et aI., 2003). These 
effects can be addressed with the "diffusion theory", where the higher socioeconomic 
groups in affluent countries were the first to afford the change to an unhealthy 
lifestyle which then spread to other populations, lower social groups or poorer 
countries, until the more well off started a second transition to a more health-
conscious lifestyle (Mackenbach et aI., 2000). A very good example of the above is 
the variation in tobacco consumption and physical activity among social classes in 
Spain, where it was found that smoking habits passed through a series of four 
diffusion states from their adoption in the highest classes to their spread in the 
disadvantaged ones (Borrell et aI., 2000). 
5.3 Non-communicable disease and social status 
As we have already mentioned, cardiovascular disease and cancer incidence 
contribute to the differences observed in mortality and morbidity between social 
classes. Generally, non-communicable diseases, largely heart disease, stroke, cancer, 
diabetes and obesity, are the major factors in the inequalities in health observed in 
both developed and developing countries. It has been shown that greater increases in 
systolic blood pressure and decreases in diastolic blood pressure are linked with lower 
socioeconomic categories after the age of 50, while low social class also increased the 
risk of hypertension (Roux et aI., 2002). Prevalence of diabetes was also found to 
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increase with decreasing income and education in Denmark (Tang et aI., 2003). 
Nilsson et al (2003a), investigating five biomarkers of biological ageing, concluded 
that men and women from a higher social class appeared to be biologically younger 
than individuals of the same age but lower class. The recent increase of people living 
into old age and the low mortality in infants and young adults have contributed to 
elevating the importance of non-communicable diseases which are mainly age-related. 
The overall risk for the group is dependent on the past and cumulative risk 
experienced by the specific group (Beaglehole and Yach, 2003). Since disadvantaged 
social classes seem to be less interested in their future health (Roos et aI., 2001) 
socioeconomic status is one of the main determinants for the risk factors of non-
communicable diseases. So, particularly in the north and west Europe, those with 
higher education consume more fruit and vegetables than people with lower education 
(Roos et aI., 200 I). At the same time, intake of saturated fats is increasing with 
occupation category further elevating the risk factors for cardiovascular disease 
(Lopez-Azpiazu et aI., 2003). Lower social status individuals gain weight more 
rapidly than those with a higher status, leading to overweight and obesity, one of the 
most important emerging dangers of public health (Martikainen and Marmot, 1999), 
while increased incidence of smoking and drinking leads to a pronounced further 
accumulation ofunhcalthy behaviour in lower educational groups (Prattala et aI., 
1994). 
5.4 Social status and psychological stress 
Here we will also briefly address the idea that inequality in health can be, at 
least partly, attributed to psychological factors. Under this hypothesis one of the key 
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factors of social position is social participation and control of one's life. The latter 
can be clearly seen in the example of occupation, where jobs with high psychological 
demands and low control put people at high risk for cardiovascular disease (Marmot, 
2003). Psychological distress is a well known factor is coronary heart disease, as was 
exhibited among others, by Stansfeld et al (2002) in a cohort study of London-based 
civil servants. Power of control thus, can be an important factor in translating social 
status to health (Marmot, 2003). Similar phenomena have been observed in non-
human primates, those with a low status in the group exhibiting signs of stress with 
enlarged adrenal glands, exaggerated cortisol response, changes in dopamine 
metabolites concentration and most importantly increased atherosclerosis (Kaplan et 
aI., 2002; Marmot, 2003). Insufficient participation in society can also lead to 
elevated psychological stress, and can be perceived as the comparison of an 
individual's ability to own articles that have a social status currency. Socially 
oriented items and items of lUXUry have been both related to health, independently of 
economic hardship (Marmot and Bobak, 2000). 
5.5 Environmental conditions and longevity 
Differences in health between social groups may extend much further than just 
differences in behavioural characteristics, lifestyle preferences and psychology. 
Exposure to even mild environmental stress may contribute to even further widening 
of the inequalitics in mortality bctween classes, especially for members of vulnerable 
groups such as the old. A characteristic example is the link between temperature and 
mortality. Increased temperatures increase demands on the cardiovascular system, 
elevating cholesterol levels and blood viscosity, whereas low temperatures are linked 
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with influenza epidemics, increased blood pressure and fibrinogen levels (Curriero et 
a1.,2002). It was estimated that a five day heat wave in England during 1995 (max 
temperature 35.2°C) was responsible for an 8.9% increase in mortality with an even 
larger effect in the Greater London area (Rooney et aI., 1998). Also in 1995, a heat 
wave hit Chicago from the 1 t h to the 16th of July causing at least 700 excess deaths, 
mainly associated with cardiovascular diseases (Semenza et aI., 1996). 
In most countries, though, the peak of the mortality rate is observed during the 
winter months. Cardiovascular disease and ischaemic heart disease account for half 
of the excess winter mortality mainly attributed to thrombosis due to 
haemoconcentration, increased plasma fibrinogen and endotoxin inhibition of 
fibrinolysis. Nearly half of the remaining surplus mortality is due to respiratory 
diseases, mainly because cold suppresses, through stress hormones, the resistance of 
the immune system to respiratory infection and assists the survival of bacteria in 
droplets (Keatinge et aI., 1997). Aylin et al (2001), over a period of9 years, found an 
average of 30,000 excess cold-related deaths per annum in Great Britain, making cold 
a significant public health problem. One might think that living in countries with 
milder winters might avoid the effects of excess winter mortality. Paradoxically this 
is not true and Mediterranean countries show larger seasonal changes than 
Scandinavia (reviewed in Mercer, 2003). For a given fall in temperature, mortality 
increased to a greater extent in countries with milder winters, probably due to the fact 
that in warmer regions people live in colder houses, wear less protective clothes and 
are less active outdoors (Keatinge et aI., 1997). Also the fact that these populations 
are acclimatized to a different set of conditions should not be overlooked. 
Populations in warmer regions seem to be more vulnerable to cold, while those living 
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in colder regions are much more sensitive to elevated temperatures (Curriero et at, 
2002). 
But is exposure to temperature linked with socioeconomic status? It is easy to 
imagine that disadvantaged groups will be more exposed to temperature stress than 
the affiuent classes. Studies in Brazil (Gouveia et at, 2003) and Britain (Lawlor et 
at, 2000) found no association between deprivation and temperature-related 
mortality. This can be attributed to some methodological problems of the first paper 
(see Keatinge, 2003) and the complex effects of council housing in Britain and the 
confounding factors of deprivation in the second case. Aylin et al (2001) were also 
unable to find the association between quality of dwelling and excess winter 
mortality, but at the same time they found that it was linked to the lack of central 
heating calling for further investigation of the relationships. Certainly the association 
between low temperature and excess winter mortality is a complex one and although 
lower indoor temperature increases the effect (Keatinge et aI., 1997), behavioural 
means of minimizing heat loss also play an important role both in- and outdoors 
(Mercer,2003). Furthermore the quality of insulation or status of the house may not 
necessarily be good indicators for the home-heating habits of the occupants. For 
extreme heat, the association of increased mortality with social class is much easier to 
see. The excess number of deaths in the Greater London area in the 1995 heat wave 
can be attributed to the "heat island" effect in urban densely populated areas, high air 
pollution and poor housing, all characteristics of a disadvantaged environment. 
Furthermore in the heat wave of the same year in Chicago, living conditions and 
especially the presence or absence of air-conditioning were very important for the 
differences in mortality with increasing temperature (Semenza et aI., 1996). 
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Generally, low education level and poverty have been associated with increased 
mortality during high temperature (Curriero et aI., 2002). 
5.6 Early development and phenotypic plasticity 
The effect of socioeconomic status on health and mortality is an example of 
the interaction between the genome and the environment. We have treated this 
interaction as a direct association, where the interplay between the two factors is 
based in the real-time conditions experienced by a fully matured organism with a 
given set of responses. But the balance of these responses between the genes and the 
environment can also be significantly affected by both the environmental challenges 
during development and the expectations of what these challenges will be. 
Devclopmental plasticity and maternal effects are two major factors influencing the 
phenotype of the individual and its ability to express the right responses in accord 
with the environmental cues it receives. 
Phenotypic plasticity, the variation of phenotype of a given genotype, due to 
early developmental or maternal effects has been extensively studied in insects. 
Social hymenoptera are an extreme example, where from a single genotype a queen or 
a worker can develop. These alternative morphologies are the product of different 
rearing conditions between individuals with otherwise identical potentials, causing 
large differences in lifespan and reproductive ability (Page and Peng, 200 I; Chapuisat 
and Keller, 2002). This kind of polyphenism is the result of differential gene 
expression due to hormonal regulation (Evans and Wheeler, 1999). Similar 
mechanisms can also be found in other insect species where division of labour exists, 
as in weaver and leaf-cutting ants (Keller and Genoud, 1997; Hughes et aI., 2003). 
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Less extreme examples of phenotypic plasticity due to pre- and post-fetal events have 
been observed in model organisms, such as the D. melanogaster and C. elegans and in 
mammals and birds (Lindstrom, 1999; Ackermann et aI., 200 I; Dillin et aI., 2002). 
When it comes to humans and specifically the effect of socioeconomic status 
on longevity, we will focus our attention on the effects of undernutrition during early 
pre- and post-fetal development on the health of the individual when adult. Different 
ageing markers have been associated with weight at I year old, leading Sayer et al 
(1998) to question if rates of ageing are determined in utero, concluding that the 
association between early growth and ageing are causal, with some systems being 
programmed in early life. A number of age-related diseases are also linked with early 
development and maternal effects. Cardiovascular disease is associated with small 
size at birth, which in tum is related to maternal bodyweight (Stein et aI., 1996). 
Coronary heart disease also seems to be associated with low weight gain in infancy, 
and moreover with rapid childhood weight gain in boys that were thin at birth 
(Eriksson ct ai., 2001; see also for commentary Osmond et aI., 2001). Studies in 
Britain have revealed that low growth rates increase the prevalence of cardiovascular 
risk factors including blood pressure, and plasma concentrations of glucose, insulin, 
fibrinogen, factor VII and apolipoprotein B (reviewed in Barker et ai., 1993). 
Diabetes and glucose intolerance as well as insulin resistance in adult life have also 
been linked with abnormal fetal growth, both for underweight and overweight fetuses, 
in North American and European studies (Phillips, 1998). Further effects of 
undernutrition during early development include lowering of immunocompetence in 
adulthood through the early programming of thymic function (McDade et aI., 2001) 
and increase of obstructive airways disease in adulthood due to permanent effects of 
the structure and physiology of airways during periods of rapid growth (Lopuhaa et 
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al., 2000). The above have given rise to the "fetal origins" hypothesis which proposes 
that the nutrient and hormonal environment of the fetus can alter gene expression, 
resulting in developmental adaptations leading to permanent changes in physiology 
and metabolism (Godfrey, 1998). Evidence for the theory is provided by the 
seasonality of births observed in humans, as in other animals, and its effects on adult 
health. Seasonal patterns of nutrition and disease in rural African societies increase 
environmental stress which can lead to intra-uterine growth retardation and reduced 
birth weight (Moore et al., 1997). Mortality in young adults due to fatal infection in 
these groups shows a strong correlation with the season of birth, so that babies born 
up to two to three months after a hungry period have a carry-over effect even if 
maternal nutrition improves later in pregnancy (Moore et al., 1997; 1999). Similar 
effects can also be seen in Europe where those born in autumn have a higher life 
expectancy at age 50 than those born in spring (Doblhammer and Vaupel, 2001). 
Since these studies are based mainly on cohorts born in the early part or the first half 
of the 20th century we can see that the effect is decreasing significantly over time, in 
accordance with the lack of seasonal patterns in access to nutrients in contemporary 
Europe (Lummaa et ai., 1998; Doblhammer and Vaupel, 2001). 
Early developmental events not only affect the health and mortality of an 
organism, they can also have a profound effect on its ability to reproduce and may 
even affect subsequent generations. This would have been expected if adverse 
conditions early in life could affect organs producing or regulating reproductive 
hormones (Lummaa, 2003). Women with reduced early growth and low weight give 
birth to small babies with an increased risk of pregnancy complications and early 
mortality, while women born underweight have a higher chance of stillbirth or of 
losing their baby within the first days (Lummaa and Clutton-Brock, 2002). A study 
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from a British cohort showed that although birth weight was not associated with age 
at follicle depletion, women with lower weight at 2 years of age had earlier 
menopause, highlighting the influence of early post fetal development with 
reproductive ageing (Hardy and Kuh, 2002). Furthermore in 19th century Canada, 
Lummaa and Tremblay (2003) found that women born in the best months of the year 
(November-March, June and September) had a longer reproductive lifespan, larger 
number oflive births and more children raised to adulthood. Lumeyand Stein (1997), 
on the other hand, observed that women born in the five month famine in Denmark in 
1945, show no evidcnce for a fertility-reducing effect of early exposure to 
undernutrition, although these women seem to have an excess of perinatal deaths. 
Although the exact mcchanisms are not known, it is believed that early 
nutritional environments can be "memorized" by the organism over a narrow window 
during ontogeny. We will follow the reasoning ofWaterland and Garza (2002b) in 
dcscribing the process as "metabolic imprinting" rather than "programming". This 
way our held view that lifespan cannot be programmed or determined is satisfied and 
at the same time we can describe a mechanism where early experience may have a 
significant effect later in lifc (sce also Lucas, 2000; Waterland and Garza, 2002a). 
Thc two necessary characteristics for any such mechanism to be credible are that it 
must bc adaptive to early environmental conditions and that it must occur during a 
limited period of susceptibility (Waterland and Garza, 2002b). The precise stage of 
pregnancy during which undernutrition occurs will lead to different effects on the 
organism. So, early pregnancy undernutrition will probably result in symmetrically 
small low birth-weight babies, while undernutrition in mid-pregnancy can change the 
interaction bctwccn the fetus and thc placenta. Finally, low nutricnts in late 
prcgnancy could Icad to fctal wasting as energy is diverted from the fetus to the 
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placenta to maintain its function (Barker et aI., 1993). Detailed physiological 
mechanisms through which early undernutrition may affect adult lifespan could 
involve: 1) morphological variations in organ structure through different inductive 
interactions among different germ layers during organogenesis; 2) differences in cell 
numbers, where growth is achieved instead of the normal cellular proliferation, which 
is sensitive to nutrient availability, by increase of cell size (hypertrophy); 3) 
disproportional population growth of the most proliferating cells during clonal 
selection in conditions of some limiting nutrient factors; 4) metabolic differentiation, 
changing the capacity for adaptive and basal gene expression through DNA 
methylation, modulation of chromatin structure and changes in the autoregulation of 
DNA binding proteins; and 5) changes in signals determining time and extend of 
polyploidization of vital organs (for full description see the excellent work of 
Waterland and Garza, 2002b). 
At least in industrialized countries, we do not expect to find such extreme 
differences between social classes, where pregnant women and babies are exposed to 
famine and undernutrition, while our previous discussion seems more appropriate for 
countries of the third world or the previous experience of Europe. But recent 
experimental studies have shown that even subtle differences of early nutrition can 
have a significant effect later in life. What is more important is that these differences 
are usually linked with the social status of the parents. Smoking, for example, during 
pregnancy has been associated with restricted fetal growth, a habit that is more 
common in people of a low social class (Moore and Davies, 2002). In India, mothers 
with low weight during pregnancy had a higher chance of having a child who 
developed cardiovascular problems when adult (Stein et at, 1996). But the opposite 
is also true, maternal obesity, another current marker of low status, also has 
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detrimental effects for the health ofthe child later in life (Godfrey, 1998). The 
father's social class is strongly correlated with the social class of the child in 
adulthood, and independently it was also linked to non-fatal myocardial infarction and 
ischaemic heart disease, probably through the persisting effect of class early in life 
(Wannamethee et aI., 1996). Probably the most important effect of social status and 
later health is the quality of food received by the mother. A Scottish study has shown 
that a high-animal protein, low-carbohydrate diet is linked with raised blood pressure 
in the adult offspring, while other studies found that a low ratio of protein to 
carbohydrate and fat is also linked to lifelong elevated blood pressure (Godfrey, 1998; 
Shiell et aI., 200 I). In general, imbalance of maternal body composition during 
pregnancy is associated with unfavourable outcomes in the child's later life (Godfrey, 
1998). Keeping in mind the specific dietary habits and lack of proper health advice, 
either through lack of education or access to the relevant information, commonly 
found in lower social classes, it is easy to understand how an adverse early 
environment can affect the health of the population. This is not to say that the 
differences described up to now are solely due to maternal effects. On the contrary, 
we chose the term of imprinting to describe a process that very early in life will shape 
the way the organism responds to its environment, so that the early experience will 
make the individual more or less susceptible to later challenges. Metabolic imprinting 
and maternal effects in general will provide only the background where our future 
decisions and lifestyle are going to interact with our genetic make-up to increase or 
decrease the chances of events. 
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5.7 Social status and access to health services 
We have considered the differences between health and mortality of social 
classes, but until now we have avoided discussion of equity in access to the health 
services and ultimately treatment. In today's industrialized countries social 
development is closely linked to provision of health care to all members of the society 
with no class distinction. The two prevailing model strategies for social sector 
development are aimed directly at overcoming health service inequalities in an 
advanced market economy (Bloom, 2001). But the truth is that inequality seems to 
exist even in the most developed health care models. In Kentucky, USA, patients 
with either colorectal, lung, breast or prostate cancer on private insurance had the best 
survival, in contrast with those whose insurance was unknown who fared worse 
(McDavid et at., 2003). Considering that private insurance is a marker of income and 
occupation, the results are in accordance with the majority of studies in USA, Europe 
and Canada where patients from deprived areas had lower survival compared with 
those living in more affluent areas (McDavid et at., 2003). In the case of Spain, 
where the National Health Service (NHS) provides universal and free coverage, 
inequalities can be found in services that are only partially covered by the public 
health care system. Additionally, those that paid for a private service had to wait on 
average 18.8 minutes less for treatment than NHS patients, and even among the latter 
group, those of a low social class waited longer than the more privileged individuals 
(Borrell et at., 2001). In Finland during the increase in the supply of services from 
general hospitals in the 1990s, the lowest income groups gained access to fewer newer 
services than those belonging to higher classes (Keskimaki, 2003). A study involving 
NBS Direct, a health advice and information service in Britain, in an area of southeast 
London, including areas of extreme deprivation and relative affluence, found that call 
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rates increased with deprivation up to a point, then extreme deprivation reversed the 
pattern (Burt et aI., 2003). It seems that, in developed countries, the worse-off groups 
receive more hospital care and see general practitioners more often, whereas specialist 
visits and surgical care, in almost most cases, are more accessible to higher 
socioeconomic groups (van Doorslaer et aI., 2000; Keskimaki, 2003). Although a 
clear picture of inequality in access and utilization is emerging from the above, it may 
actually be quite misleading in terms of spread of the variation and significance of the 
results. The truth is that we know very little about the causes of these differences and 
their underlying patterns. As we saw earlier the needs for health care between social 
groups are very different, both in terms of incidence of poor health and frequency of 
diseases. Access and utilization may sound quite solid as measures of use, but in fact 
they do not give much information on the outcome or the quality of treatment which 
ultimately can increase the inequity (for a more detailed discussion of the problems 
see Goddard and Smith, 2001). 
5.8 Socioeconomic inequalities and evolution 
The rest of our discussion will focus on the question of whether and how 
social structure might affect the evolution of human populations. Evolution is 
commonly defined as the change of allele frequencies within a given population, 
although other definitions are also available. In order to have evolved differences 
within a single population, reproductive isolation is essential to split the original 
group into smaller compartments. In time, genetic drift and difference in the 
environment experienced by each smaller group will lead to a divergence between 
their genotypes. If the isolation is long enough it can lead to speciation. 
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H. G. Wells, in his book The Time Machine, inspired by the social inequality 
in the late 19th century Britain described a terrifying future, in which the delicate Eloi 
and the sub-terranean Morlocks are the products of thousands of years of evolution of 
the aristocrats and the working classes respectively. But is that science fiction or 
scientific probability? Can social class differences lead to gene changes through 
evolution or even speciation between classes in humans? In our species the degree of 
variability both between and within groups is so high that it is extremely unlikely, or 
just impossible, for something like that to occur. The entire Homo sapiens sapiens 
species is a single breeding population, especially now when modem ways of 
travelling contribute to the mixing of the previously localized populations 
(Chakraborty, 2003). On the other hand, caste systems in traditional societies, and 
segregation between social classes in more recent cases, that put barriers against the 
free flow of genes within the population, can lead to a low degree of genetic 
differentiation. This kind of isolation is usually linked with groups of a different 
religious or ethnic background relative to the wider population, the best examples 
being the Ashkenazi Jews and the Amish groups (Mitchell et aI., 2001; Behar et at, 
2004). Nevertheless, isolation due to social criteria has also been found. The 
traditional caste system in India and the European royal families are two good 
examples (Papiha, 1996; Stevens, 1999). Even in these cases the group is not 
completely isolated, and as is the case in other human populations (Bereczkei and 
Dunbar, 1997) women are allowed to marry up the scale, thus maintaining the gene 
flow with the background population. Differences in the cases of isolation mentioned, 
though, are the product of random genetic drift and inbreeding, and we are still far 
from finding any adaptive changes of allele frequencies between social groups. In 
truth very little work has been done towards finding any such case, but the frequent -
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in evolutionary terms - changes in the economic situation and the structure of our 
societies, are probably a contributing factor in the homogeneity of gene frequencies 
between different socioeconomic groups. 
Moreover we discussed the effects that early development and maternal effects 
can have in the health and lifespan of the individual, and we related those with 
socioeconomic status. The association between the genome and the environment is 
very complex, with a single genotype able to produce more than one phenotype. 
Since natural selection is applied at the phenotypic level but its effect are inherited at 
the genotypic level, it is difficult to predict how selection will operate in relation to 
social class (Mousseau and Fox, 1998). Two opposite possibilities can be envisaged 
in this case: 1) maternal effects wrongly predict the future environment, for example 
presenting a poor nutrient environment that changes in energy abundance later in life, 
causing insulin resistance due to early undernutrition, and development of diabetes in 
adulthood (Phillips, 1998), and 2) maternal effects accurately predict future conditions 
of nutrient availability. In the first case, the effect of a disadvantageous allele will be 
amplified by the outcome of development carrying a severe selective penalty, while in 
the second case the organism is already phenotypically adapted to handle the excess 
energy, with its genes being less severely selected against, even if they are not 
optimal. 
5.9 Models of human longevity and social status 
We have earlier presented two different models for the evolution oflongevity 
and its association with the genes and the environment experienced by the population. 
The first model was based on the disposable soma theory of ageing (Kirkwood and 
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Rose, 1991) and involved an immunogenetic trade-off between the mother's ability to 
complete a pregnancy and her ability to withstand infection. In terms of 
socioeconomic status in industrialized countries, the trade-off seems to be not 
applicable since deaths from infections are rare. Despite that, since evolution 
progresses much slower than human history, it will be interesting to test whether 
social classes that originated from the working classes of the previous century have 
different frequencies of the genes involved in the trade-off compared with the old 
aristocracy. The case should be very different in developing countries, where 
deprivation significantly increases the incidence of life-threatening infection and the 
presence of the trade-off should be clear and associated with socioeconomic status. 
The same should be the case for the disposable soma theory in general. Better 
survival and health, together with a much more favourable early development should 
be able to dampen the effects of the trade-off since the selection for the genes 
responsible decreases with decreasing selection for survival, while environmental 
parameters during early life and adulthood become more important. If this is the case, 
then the result obtained by Lycett et al (2000), where the longevity-reproduction 
trade-off was increasingly strong with increasing poverty, can be explained, as well as 
the fact that pre-I 700 women were mainly responsible for the relationship found in 
the paper from Westendorp and Kirkwood (1998). 
With our second model we examined the effect of the apo E gene on 
cardiovascular disease, the major non-communicable disease in the western world and 
a rapidly increasing problem in developing countries. In this case the gene-
environment interactions were the central factor linking the gene with morbidity or 
mortality. All the risk factors used for cardiovascular disease are also linked with 
social status, income and education. It is easy to see how social class will affect the 
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progression of the population and if the conditions remain stable, the segregation is 
long enough and the gene flow small, it will ultimately produce two groups with quite 
different allele frequencies. Unfortunately our model cannot account for the presence 
of maternal effects and early development that may disturb our predictions. 
5.10 Longevity and global data 
One of the most straightforward tests to see how longevity can be affected by 
social markers is to analyse the available global data. In this case we used 
information extracted from the liThe World Factbook 2004", a publicly available 
document profiling all countries in the world based on a number of different 
parameters ranging from political situation to the age-structure of the popUlation 
(http://www.cia.gov/cialpublications/factbooklindex.html). In our current analysis we 
used 10 different measures of reflecting social stratification in the population, 
including population, birth and death rate, infant mortality rate, total fertility rate, 
country GDP, GDP per capita, unemployment, internet users per 10,000 population, 
and %GDP spent in military expenditure. The Minitab statistical program gives us 
the ability to select the "best subset" of variables with the higher coefficient of 
regression and the minimum number of variables using a number of regression 
analyses. During the procedure the program examines all the one-predictor models 
and returns the two with the highest value of the coefficient of determination R2, then 
all the two predictor-models are examined and the two with the largest R2 are 
displayed, the process is repeated until the model contains all predictors. Using life 
expectancy as the response and running a regression test for the best subset of 
variables able to describe the changes of longevity we identified that two of the five-
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variable models can explain 94.5% of the total variation of life expectancy in the 
population (Figure 5.1). Increasing the number of the variables used, had no effect on 
the adjusted R-square value of94.5%. Thus one of the two five-variable model 
including birth, death, infant mortality, and total fertility rates plus one of GOP per 
capita or Internet users is adequate, while the rest of the parameters do not provide 
additional information. To distinguish between the two alternatives we ran a 
regression analysis for each model comparing their F-values, and a regression analysis 
for the model fitting all six of them. From those we can conclude that the subset 
containing GOP-per capita gives a better description oflife expectancy both due to a 
higher F-value in comparison with the alternative subset regression and retaining its 
significance in the six-variable model, in contrast to Internet users per 10,000 of 
population. A correlation analysis between life expectancy at birth and GOP-per 
capita revealed that there is significant correlation between them with a Pearson 
coefficient of 0.606, thus an increasing GDP per capita is associated with a longer 
lifespan. The population, birth and death, infant mortality, and total fertility rates 
included in the best subset model describe the demographic state of the population 
and given that the effects of social status on longevity are dependent on demographic 
transitions, as discussed earlier for the changes of disease risk and income between 
developing and developed countries, the close association was expected. The 
variables Internet users and GOP per capita, on the other hand, describe access to 
information and goods in general respectively. In the case of the per capita GOP, 
which gave the best fit, what is measured is the purchasing power ofthe individual in 
its country of living, thus its ability to consume and get access to goods and services. 
The correlation between Internet users and GDP per capita (the latter explaining more 
than 65% of former), can partially explain why both of them can give models of 
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Best Subsets Regression: Life expecta versus Population, Birth rate, ••• 
Response 1s Life exp 
136 cases used 89 cases contain missing values. 
P B D I T GUIM 
o 1 e no Dnni 
p r aft Pet 1 
u t t a a 1\ e 1 
1 h h n 1 
- p r t 
a t G 1 n a 
t r r fDpoer 
Vars R-Sq J!.-sq(adj) C-p S 1 a a m e P e y t y 
1 76.S 76.3 440.6 5.7566 X 
1 63.4 63.1 759.3 7.1822 X 
2 90.7 90.5 97.0 3.6386 XX 
2 89.9 89.7 116.9 3.7940 XX 
3 93.4 93.2 33.2 3.0774 XX X 
3 93.3 93.1 35.3 3.0978 XX X 
4 94.2 94.0 14.8 2.8871 XX X X 
4 94.2 94.0 15.3 2.8922 XX X X 
5 94.7 94.5 5.5 2.7790 XXXX X 
5 94.7 94.5 5.7 2.7814 XXXX X 
6 94.8 94.5 5.2 2.7653 XXXX X X 
6 94.7 94.5 6.0 2.7741 XXXX X X 
7 94.8 94.5 6.0 2.7627 XXXX X XX 
7 94.8 94.5 6.9 2.7732 XXXXX X X 
8 94.8 94.5 7.5 2.7685 XXXX XXXX 
8 94.8 94.5 7.7 2.7702 XXXXX X XX 
9 94.9 94.5 9.3 2.7766 XXXXX XXXX 
9 94.8 94.5 9.4 2.7781 XXXXXXX XX 
10 94.9 94.5 11.0 2.7848 XXXXXXXXXX 
Figure 5.1. Best subset analysis describing changes of variables with population 
parameters. The first column contains the number of the predictors used, while the X 
mark in the last column identifies which ones they were. R-Sq is the R2 coefficient of 
detennination while R-Sq (adj) is the R2 adjusted for degrees of freedom. C-p is a 
measure of error for the fit of residuals while s is the standard deviation about the 
regression line. 
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good fit for lifespan, although the possibility that infonnation itself can be a 
contributing factor can not be discounted. 
An interesting aspect of our analysis was the reverse association of lifespan 
expectancy at birth and fertility measurements, both as birth rate and as total fertility 
rate. The birth rate describes the average annual number of births per 1,000 
population and is dependant on the level of fertility and the age structure of the 
population, while the total fertility rate is a more direct measure of fertility and it is 
defined as "the average number of children that would be born per woman if all 
women lived to the end of their childbearing years and bore children according to a 
given fertility rate at each age" (http://www.cia.gov/cia/publications/factbookldocs/ 
notesanddefs.html). As expected both measures are very closely linked with one 
another (adjusted R-sp 96.7%) but birth rate seems to be more closely correlated with 
lifespan than total fertility (Figure 5.2), with birth and total fertility rates explaining 
62.8% and 58.9% oflife expectancy variance respectively. Due to the complicated 
nature of the trade-off between reproduction and longevity, especially in humans, it is 
not clear if the reverse association observed is due to physiological factors or 
behavioural patterns, or a combination of the two. A similar procedure used for 
expected lifespan (removing life expectancy and total fertility from the variables) in 
order to identify the best subset of parameters describing birth rate, showed that death 
rate, infant mortality and unemployment accounted for 74.5% percent of the variance 
of the birth rates with infant mortality being the most important predictor. 
The analysis of the global data has provided us with a number of interesting 
observations mainly concerning the effect of demographic parameters on longevity 
and the importance of the individual's purchase power. Moreover, we were able to 
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Figure 5.2. Graph representing the regression line between Life expectancy at birth 
and birth rate based on global data. Also seen are the 95% confidence intervals (eI) 
as red and the 95% prediction band (PI) as blue lines. 
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identify core components of the disposable soma theory concerning the link between 
life expectancy and measures of fertility. Unfortunately, differences in culture, 
policies and resources between each country limit the applicability of our results. 
That does not mean though, that strong associations are not identifiable rather that 
their quantitative values can be miscalculated and that weaker association can be lost. 
5.11 Epilogue 
From our everyday experience we see that there are marked differences 
between people belonging to different social groups no matter which criteria we use 
to distinguish those groups. We saw that education, occupation and income are 
predictors of lifespan and health in old age. A number of different factors responsible 
for these associations were presented. People with lower education or income are less 
worried about the future health implications of their diet and lifestyle, having a higher 
incidence of obesity, cardiovascular problems and diabetes. Psychological stress can 
also be considered as an important determinant of longevity and mortality. Inability 
to control one's life and incomplete social participation are two factors that elevate 
psychological stress in members of many social classes. Even mild environmental 
stresses, and especially temperature related stress, can have a profound effect on 
mortality. When the ability to avoid exposure is linked with income, social 
inequalities in excess deaths are observed. Early development and maternal effects 
can result in predispositions for a number of diseases when adult. A balanced diet and 
a healthy lifestyle of the mother have significant effects on her offspring. Access to 
health services also has a social gradient. Disadvantaged groups lose out on many 
services provided, despite being more often in contact with non-specialist health care 
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professionals. We concluded that frequent changes in social structure, the high 
variability in human populations, the ability of females to move through social classes 
and the plasticity of the phenotype, make evolutionary changes on a social basis 
unlikely to occur. Finally, we discussed the impact that social structure will have in 
the models we developed and their abilities to predict changes between 
socioeconomic groups and showed evidence for the association of life expectancy and 
GOP per capita on a global scale. 
Utopias always describe the perfect society where all live happilly, in harmony 
and equity. Unfortunately reality is much different, inequality in life and health are 
easy to find in developed and developing countries alike. We may have improved the 
conditions for all classes in the last 100 years, today's lower socioeconomic groups 
living much better and longer than the richest in the beginning of the 20th century. 
But the improvement is not the same for everyone. Since 1976 the highest social 
class show a S.7 years extension in lifespan, compared with just 1.7 for the more 
disadvantaged (Marmot, 2003). We started by making clear that we will restrict the 
discussion to biology, but while biology can observe and find associations between 
parameters, the solutions should be looked for in sociology, philosophy and most 
importantly policy planning. Maybe there is no perfect health system that will 
alleviate inequality, since its roots go much further than mere treatment. Maybe the 
only way to abolish inequality is to abolish disease (Jessop, 2000). Maybe we should 
try to change society instead of changing the individual (Marmot, 2003). No utopias 
exist or will ever do. Harmony and equity are goals that we all feel obliged to achieve 
but we constantly fail. No two people are equal in terms of abilities and needs and 
there is no equity where inequality is the building block. That is not to say that we 
should feel complacent about the inequalities we see around us. On the contrary, we 
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should strive to eliminate them and to provide everyone with the chance to fulfil their 
needs. We should all have the same chances in our lives and the ability to pursue our 
dreams. 
172 
6 Conclusions 
This project aimed to elucidate the gene-gene and gene-environment 
interactions relevant to human ageing, by using epidemiological studies to construct a 
framework model that could both account for existing data and also be used to help 
identify the critical genes involved. It also aimed to provide a theoretical account for 
the intrinsic variability of the ageing process, especially between different 
socioeconomic groups within a single population. To address these aims we used the 
published literature and the established evolutionary theories of ageing to develop 
mathematical and computerized statistical models. The use of theoretical tools 
provided us with the ability to infer more general principles for the genetics of ageing 
than is possible when dealing experimentally with the effect of single (or a small 
number of) genes. Furthermore, recent advances in computing power made possible 
the construction of models containing complex relationships between a large number 
of environmental and genetic parameters, thus permitting programs with detailed and 
realistic interactions between the relevant factors. 
We started by discussing the prevailing views for the evolution of ageing and 
the experimental evidence supporting them. We have seen that evolutionary theory 
considers ageing as a non-adaptive characteristic of life history which has evolved 
either through a mutation accumulation process based on a mutation-selection balance 
or through the action of trade offs and pleiotropic genes, or most likely through a 
combination of both. Furthermore we reviewed what is currently known for the 
genetic mechanisms underlying the ageing process in a variety of model organisms 
and in humans. The importance of maintenance and repair of DNA, and generally the 
ability to withstand physiological stress constantly emerge as central mechanisms 
during ageing both in model organism and human progeria mutations. A promising 
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genetic pathway extending lifespan is the IGF pathway which seems to be 
evolutionary conserved from yeast to mammals. Its action signifies the ability of 
lifespan to respond rapidly to changing environmental conditions through genes 
which are central during early development and gene-environment interactions during 
adulthood. 
The modelling aspect of the work started with simple computer programs, e.g. 
with the aim of representing the disposable soma theory of ageing in the advanced 
Mathematica programming language. Analysis of the model parameters elucidated 
the detailed predictions ofthe model as well as some weaknesses of its simple 
mathematical representation in the case of humans. The next step was to use the 
disposable soma theory to construct a new model of trade-offs. The disposable soma 
theory, as we saw, considers the organism as a 'good economist' that seeks both to 
maintain its body (soma) and produce offspring with its limited resources in a way 
that will maximise its evolutionary fitness (Kirkwood and Rose, 1991). The expected 
survival ofthe organism in the wild will be the factor that determines the optimal 
energy allocation between maintenance and reproduction. Too high an investment in 
survival would be wasted when the organism dies, while too Iowan investment would 
result in premature death. Although the theory was first proposed in the context of 
physiological ecology, it can also account for the existence of genetic trade-offs 
between longevity and reproduction. In our model we changed the original equations 
used for the disposable soma theory model so that we could include further trade-offs, 
specifically the immunogenetic trade-off suggested by Westendorp et al (2001). In 
their paper Westendorp et al (2001) provided evidence that women with an innate T-
hclper type-l (Th 1) phcnotype have a greater probability of spontaneous abortion than 
women with an innate T-helpcr type-2 (Th2) phenotype, while individuals with the 
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Thl phenotype show lower susceptibility to fatal infection, indicative of a greater 
likelihood of survival in an environment where infectious diseases exert a significant 
mortality pressure. In the model we included parameters that could account for the 
reaction of the immune system towards the foetus and towards infections. Using 
population data from the World Health Organisation we were able to calculate the 
optimal level of the trade-off in two populations, Denmark and The Gambia, with 
very different infectious loads. Moreover, the model could be used to predict the rate 
of evolutionary change in the frequencies of genes specifying the immunogenetic 
trade-off in a way that could address whether or not the relatively recent reductions in 
exposure to infectious disease in developed countries could be responsible for 
significant, and perhaps ongoing, genetic change. 
In our model we established for the first time the evolutionary plausibility of 
such a trade-off in humans. Furthermore, the model shows how within the context of 
the disposable soma theory, and given the ecological factors affecting mankind, this 
immunogenetic trade-off may have been critical for determining human longevity 
until relatively recently in the now-developed populations, and may still be crucial in 
developing countries. Finally, we illustrated in clear, quantitative terms how the 
advantage of increased resistance to fatal infectious disease could be offset by the 
increased risk of spontaneous abortion to produce an optimal range of gene 
frequencies where these effects are balanced according to the prevailing 
environmental parameters. 
Our predictions for the immunogenetic trade-off are in accordance with 
recently acquired results by Westendorp (unpublished data) collected from an African 
(Ghanaian) population with high infection load. Moreover our assumptions about the 
genetic structure responsible for the trade-off and our predicted speed of frequency 
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change for the relevant genes seem to correspond very well with what is seen in 
epidemiological studies (Westendorp, personal communication). 
Considering the estimates that only 30% of all human pregnancies reach 
successful completion while 50% of those lost are missed before the recognition of 
late menses (Choudhury and Knapp, 2001) we can easily understand the importance 
of work associated with a possible immunogenetic trade-off between reproduction and 
survival. Moreover, since the great majority of reproductive failure is due to 
unknown factors in a system where the immune status is of paramount importance, it 
is necessary to focus our attention to the action of the immune system of the mother 
towards the fetus. Our model provides theoretical support for an under-recognised 
potential source of reproductive problems and may explain their prevalence in a 
Western population, based on our recent history and evolution. 
The second model followed a different path and led to a different theoretical 
framework. Our objective was to examine the evolutionary pressures on the apo E 
gene and to identify whether or not it is still the subject of selection. Apolipoprotein 
E (APO E) is a member of a diverse family of proteins collectively known as 
apolipoproteins, carrier proteins specializing in lipoprotein particle formation, 
secretion, transport, binding and metabolism (van Bockxmeer, 1994). Carriers of 
different apo E alleles show a difference in the incidence of cardiovascular disease, 
peripheral atherosclerosis and Alzheimer disease, possibly stroke and even in the 
ability to recover from trauma (Smith, 2002). One of the fundamental ideas in the 
evolutionary theories of ageing is that the force of natural selection decreases with 
increasing age. Under the mutation accumulation theory of ageing it is expected that 
deleterious mutations expressed after the end of reproduction will be almost 
selectively neutral, presenting an interesting puzzle for the evolution of genes with 
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late action, such as apo E in humans. Recently, the "grandmother hypothesis" has 
sought to provide support to the notion that late-acting genes are not selectively 
neutral by proposing an idea based on the food sharing between close kin in social 
species (Hawkes et aI., 1998). A possible insight into apo E evolution has also been 
provided by its association with Alzheimer disease and oestrogen (Finch and 
Sapolsky, 1999; Sapolsky and Finch, 2000). We investigated these ideas using 
computer simulated populations with a number of lifestyle parameters corresponding 
to a contemporary European population. We treated the problem as a gene-
environment interaction, where the gene by itself does not produce any differences in 
mortality but in association with the environment it can produce different hazards for 
the individual. The lifestyle parameters used were well known risk factors for 
cardiovascular disease, such as diet, alcohol consumption, smoking and physical 
activity. Using a number of randomly generated probability functions we were able to 
follow the changes of the apo E alleles' frequencies under different situations as well 
as to compute the expected mean life span under each parameter set. 
Our results showed that apo E is still subject to some selection in a typical 
Western European population even when only a fraction of the population 
experiences apo E related mortality. We were able to examine quantitatively how this 
selection varied with different lifestyles. We were also able to elucidate some new 
aspects of the mutation accumulation theory and how it might act upon the 
distributions of gene effects within populations during the process of selection for 
longevity. At a more technical level, we provided an example of how an extreme-
value distribution can describe an altered form of the Gompertz model to account for 
the mortality patterns seen within the population. Finally, we sought to answer how 
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the apo E gene might have evolved and we proposed a two-stage process related to 
meat-eating and the spread of agriculture. 
Cardiovascular diseases are the main causes of mortality, at least in the 
Western world. Our work provides a framework through which epidemiological 
studies can address this complex problem in a more methodological way. More 
precisely our simulation is an example of the use of epidemiological data to account 
for the gene-environment interaction and its change with each generation. 
Furthermore we can use the model to predict how lifestyle changes are likely to affect 
longevity, and how selection might work to extend the lifespan of organisms. In our 
work we also show the important questions that we should ask when dealing with 
complex diseases and the factors that need to be quantified in order to obtain reliable 
results. 
Finally, we addressed the problem of social stratification in relation to 
heterogeneity of morbidity and mortality during ageing. Education, occupational 
status and income were considered in relation to lifespan and health. The effects of 
low and high temperature on seasonal mortality were also discussed. Psychological 
stress due to status and social participation was linked with longevity and social 
position. The importance of early development and maternal effects for the incidence 
of common diseases in adulthood was highlighted considering a number of different 
studies. We discussed the idea of unequal health service access and utilization 
between different social groups and their effects in different parts of the world. 
Moreover we considered how our two models can account for the heterogeneity and 
variability of the ageing process in individuals from different social groups within the 
same population based on the differences in environmental challenges faced, and 
whether these differences are enough to unevenly shape evolution and gene 
178 
frequencies between social groups found within a single population. We concluded 
that the plasticity of early life and the adaptive nature of maternal effects, plus the 
common changes in human history and the ability of women to cross social 
boundaries in marriage, will make such differences between classes improbable. Our 
discussion made evident the importance of a balanced health service and the necessity 
for everyone to expect a healthy and long life irrespective of social class. 
With this work we have shown how theoretical modeling of genetic and non-
genetic factors in human ageing can contribute a strong predictive framework for 
further studies on this important topic. We will be able to use insights from the work 
in a major population-based study of the factors influencing maintenance of health 
among the oldest age groups (the Newcastle 85+ study). We will also contribute 
insights into a new European Union Framework 6 integrated project on 'Genetics of 
healthy ageing' that will commence later this year. 
OCJ~ 'tou 7tA£OVO<; JlEPOl><; XPri~El 'tou" JlE'tptOU 7tUPEi<; ~roE1V, 
CJ1(UlOaUVUV CPUMlCJCJO)v &v EJlOl. 1(u'tao1')A.o~ ECJ'tU1. 
(Sophocles, The Oedipus at Colonus, 1211) 
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Appendix 1. Mathematica notebook for the implementation of 
the disposable soma theory of ageing. 
The disposable soma theory is based on the framework of physiological ecology and its main target is to describe the 
optimal balance between reproduction and maintenance in a given organism under specific conditions. 
To do that, ecological models can be used. Fitness can be defined in terms of the Malthusian parameter r, of the Euler-
Lotka equation: 
J e-r" I[x; s1 m[x; s1 dx = 1, 
where survivall[x;s] and fecundity m[x;s] are written as functions depending on age x and investment in maintenance s. 
From the above, the effect of different values of maintenance on survivorship and fecundity can be seen, and most 
importantly curves relating r to s can be obtained. 
The equations forl[x; s] and m[x; s] derived from the Gompertzmodel are 
I[x; s] = (1 - V) Exp[-a (e1h - ePa)! 13- y(x - a)] 
where 
V = total juvenile mortality 
a = basal vulnerability 
f3 = rate of ageing 
y = extrinsic age independent adult mortality as described in the Gompertz - Makeham equation 
JI. = a r P" + y Gompertz - Makeham equation 
a = age of maturity and 
h = peak rate of reproduction at age a 
The dependence on I is introduced in 13, a, and h as follows 
13 = po (S; - I) for s < so and 
p=Ofors~so 
so is the level of investment in maintenance required for no senescence to occur 
ao 
a=--1-8 
ao = the age of maturity when all energy is invested in reproduction 
h=ho(l-s) 
ho = reproductive rate when all the energy is invested in reproduction 
The original model was specific for the life history of the mouse where menopause does not occur. In the present 
context, where humans are considered, menopause shortens the reproductive life span much earlier than the actual 
longevity of the organism and so menopause must be included in the model. Here we have set the age of menopause at 
Printed by Mathematica for Students 
Appendix l.nb 242 
50, independent of investment. In a nonnal human population we might expect that to be able to change with increasing 
s. Due to the parameters chosen in this case, the individuals of this population are especially short-lived, mirroring 
primitive conditions of human evolution, so that the time of menopause is of little importance as we shall see later. 
The following parameters can be given values according to our current knowledge about the life history of primitive 
human populations. 
Age of first reproduction in years. 
a= 16; 
Reproductive rate in birth per woman per year 
h=0.5; 
a and p rates of ageing are 
a := 0.001 
p= 0.1305 
% juvenile mortality in a moderately protected environment can be 
V:= 0.4 
And adult age independent mortality 
'Y:= 0.01 
Considering that the level of investment required to succesfully maintain the organism free of damage and that minimum 
possible age of reproduction are 
.0:= 8 
10:= 0.8 
the values of ho and po can be calculated as 
po := 0.217S 
ho:= I 
Then the equations below can be solved 
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« Graphics'MultipleListPlot' 
« Graphics'Arrow' 
P[sJ /; (s < so):= po(so/I-I) 
P[sJ /; (s ~ 10) := 0 
a[sJ := 10/(1-.) 
h[sJ := ho (I - .) 
I[I_, IJ /; I ~ I[S] := (I - V) EIp[(-a (eMil s - eM'I-f'I) / P[s» - (y (I - a[s]))] 
I[I_, IJ /; I < 1[5] := 1 - V 
Clear[m] 
menopause = SO; 
m[I_, IJ /; menopause ~ J. ~ a[s] := h[s] EIp[-a (eMil I - eM'I-f'I) / P[s)) 
m[I_, IJ /; J. < 1[5] := 0 
mh_, IJ /; J. ~ menopause:= 0 
The dependance of survivorship and fecundity on the investment in maintenance can be graphically represented. 
Survival 
Plot[{l[J., 0.4], I[I, 0.5], I[I, 0,6)), {I, 0, l2S}, PlotRange -> {{O, 90}, {O, O.7}}, 
AlesLlbel ~ {"Age, I weeks", "I(l)"}, Epilog ... {Arrow[{O, OJ, (80, 0.6}), Text["s", {74, .6}]}] 
l(x) 
O. 6 I---'r'<~ 
0.5 
0.4 
0.3 
0.2 
0.1 
Age, x weeks 
20 40 60 80 
• Graphics· 
The three lines have an S of 0.4, 0.5 and 0.6 from left to right. So, higher investment in maintenance increases the 
survival of the organism. 
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Fecundity 
Plot[(m[x, 0.4], m[x, 0.5], m[x, 0.6]}, (x, 0, 125), PlotRange -> ((0, 55), (0, 0.62)}, 
AxesLabel ~ ("Age, I weeks", "m(x)"), Epilog ~ (Arrow[(4, OJ, (52, 0.3)], Text["s", (52, .34})}) 
m(x) 
0.6 
0.5 
0.4 
0.3 
0.2 
0.1 
10 
- Graphics-
Age, x weeks 
20 30 40 so 
The three lines with 5 - 0.4, 0.5, and 0.6 from left to right show that higher investment in maintenance results in longer 
reproduction with a lower starting point and a less steep decline later in life. 
To find the optimal strategy for the organism the above equations must be combined to give the dependence ofr on I 
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Timing[ 
r100 ListPlot[Join[Table[{s, r /. FindRoot[Jo e-rx I[x, s1 m[x, s1 dx = 1, {r, -1, I}]}, 
{s, 0.01, 0.41, .01}], 
r100 Table[{5, r /. FindRoot[Jo e-rx I[x, 51 m[x, s1 dx = 1, {r, -1, I}]}, 
{5, 0.42, 0.62, 0.04}], 
tOO 
Table[{ 5, r /. FindRoot[ Jo e-rx I[x, 51 m[x, s1 d X = 1, {r, -1, I}]}, 
(5,0.62,0.79, .01}]], PlotJoined ..... True, 
AxesLabel ..... (liS", "r"), PlotRange -> ((0, I), (-0.1, 0.1)}]] 
r 
0.1 
0.075 
0.05 
0.025 
s 
0.6 0.8 1 
-0.025 
-0.05 
-0.075 
-0.1 
The highest point of the curve describes the optimal strategy for humans under the specific conditions considered. The 
optimum investment in maintenance is close to. - 0.5, which gives a 5% annual increase of the population. 
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Effects of changing the parameters of the population 
The following commands tum ofT a number of messages that the program prints to let us know that some of the calcula-
tions exceed the precision depth of the application. Despite this loss of precision our results have been verified as 
accurate. 
Off[General::unfll 
Off[Nlntegrate::ploss] 
Off[FindRoot: :frsec] 
Off[Nlntegrate::ncvb] 
Off[NI ntegrate: :slwcon] 
Off[Graphics::gprim] 
Effect of chan2ing total juvenile mortality 
Clear[V); 
Timing{ MultlpleListPlo~ 
L
IOO 
Table[Joln[Table[{s. r /. FlndRoo4, r-rs I[x, s] m[x, s]dx = I, (r, -I, I)]}, (s, 0.01, 0.41, O.OS)], 
Tabl~{s, rIo FlndRoo4LIOOr-rsl[X, I] m[x, sldx = I, (r, -I, I>]), (s, 0.42, 0.62, 0.02)], 
Table{(s, r /. FlndRoo~J.IOO r-rs I[x, I] m[x, sl dx = I, (r, -1, I)]}, {s, 0.62, 0.79, O.OS}]], 
(V, 0.2, 0.6, 0.2)], PlotJolned ... True, SymbolShape ... (None), PlotStyle -> (Line), 
AlesLabel ... ("I", "r"), PlotRange -> ((0, I), {-O.I, O.OS}}, 
Epilog ... (Arrow[(0.42, O.OS), (0.55, 0.02}), Text["V", (0.55, .Ol)]})) 
r 
0.075 
0.05 
0.025 
• 1 
-0.025 
-0.05 
-0.075 
-0.1 
The increase of juvenile mortality exerts its effects both in the maximum value of r reached 
by the population and also on the optimal investment in maintenance required. As very 
early mortality is increased, the survival of the adult organism also has to increase to 
achieve its optimal strategy. 
Values for V-+ 0.2,0.4,0.6 
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Effect of changing rate of ageing a 
Clear[a1; 
Timing( M ultipleListPlo~ 
Table[Join[Table[(s, r /. FindRoo~ f.IM r-UI[x, 51 m[x, 51 dx = 1, {r, -1, 1}]}, (s, 0.01, 0.41, O.OS}J, 
Table{{s, r /. FlndRoo~f.I" r-UI[x, 5) m[x, s) dx = 1, {r, -1, l}J}, (SO 0.42,0.62,0.02)], 
Table{{s, r/.FlndRoo~f.I"~-UI[X' s)m[x, s)dx= 1, {r, -1, I)]}, (s, 0.62, 0.79, O.OSJ)), 
(a, 0.001, 0.01, 0.004S)]. PlotJoined .... True. SymbolShape .... (None), 
PlotStyle -> (Line), AxesLabel .... ("I", "r"), PlotRange -> ({O, I), (-0.1, 0.08)}, 
Epilog .... (Arrow[(O.48, 0.063), (O.67S, 0.01}), Text["a", (0.6, .01)))]] 
r 
0.075 
0.05 
0.025 
s 
1 
-0.025 
-0.05 
-0.075 
-0.1 
(29.344 Second, - Graphics-) 
Since a is the basal vulnerabi lity of the organism it is expected that it would have an impact on the balance between r 
and s required to reach the point of maximum population increase. This case is similar to what we saw when V 
changed. Again a frail population will have to invest more in maintenance to be able to reach its optimum reproduc-
tive potential. 
Values of a .... 0.001, 0.0055, O.oJ 
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Effect of changing rate of ageing {3 
Clear(J:!oI; 
Timing[ MultipleListPlo~ 
Table[Join[Table[{s, r /. FindRoo~.fOO e-rs I[x, 51 m[x. sI dx = 1, (r, -1, I)]), (s, 0.01, 0.41, 0.05)], 
Table[{s, r /. FindRoo( J.IOO e-rs I[x, 51 m[l, 51 dl = I, (r, -I, I)]), (I, 0.42, 0.62, 0.02)], 
Table[{s, r /. FindRoo(J.1OOe-rII[I, sI m[l, sIdl = 1, (r, -1, I)]), (I, 0.62, 0.79, 0.05»)), 
(/Jo, 0.15, 0.25, 0.05»). PlotJoined -+ True, SymbolShape-+ (None), 
PlotStyle -> (Line), Axe5Label-+ ("s", "r"), PlotRange -> ({O, 1), (-0.1, 0.1)), 
Epilog -+ (Arrow[{O.28, 0.099), (0.6,0.02)], Text["/Jo", (0.65, .01)]))) 
r 
0.1 
0.075 
0.05 
0.025 
-0.025 
-0.05 
-0.075 
-0.1 
{30. 547 Second, • Graphics.} 
s 
1 
248 
When the individuals of a population are ageing faster (higher po) those with a higher investment in maintenance will be 
able to do better since they will able to live for longer and at the same time be more fecund. 
Values of po -+ 0.15, 0.20, 0.25 
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Effects of changing extrinsic age independent adult mortality J' 
Oear[y]; 
Timing( M ultipleLl5tPlo~ 
Table[Joln[Table[{s. r /. FlndRoo~f.I" ~-"1[1I[, 5] m[lI[, I] dll[ = I, {r, -I, 1}]}, Is. 0.01, 0.41, o.oS}], 
Table[{s. r /. FindRoo~f.I" ~-"I[x, 5] m[lI[, 5] dll[ = I, {r, -I, I}]}, Is. 0.42,0.62, 0.02}]. 
Table[{s. r /. FindRoo~f.I" ~-"I[lI[, I] m[x, 5J dx = I, {r, -I, I}]}, Is, 0.62, 0.79, O.OSl)), 
{y, 0.02, 0.06. 0.02}]. PlotJolned ... True, SymbolShape ... (None). 
PlotStyle -> {Line}, AxesLabel ... {"I", "r"}, PlotRange -> {{O, I}, {-O.I, 0.08}}, 
Epilog ... {Arrow[{0.48, 0.06S}, {0.4S, 0.02S}], Tut["y", {0.4S, .olm]] 
r 
0.075 
0.05 
0.025 
s 
1 
-0.025 
-0.05 
-0.075 
-0.1 
(74.953 Second, • Graphics.) 
As y increases the amount in investment needed for the optimal strategy decreases. The optimum strategy is thus to 
invest more and more in reproduction than maintenance since the expected life span of the organism is reduced due to a 
higher probability of death by external random causes. This is one of the central aspects of the disposable soma theory 
under which the differences in lifespan between organisms is attributed to expected longevity in the wild. 
Values for y ... 0.0025, 0.2125, 0.04 
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Effects of changing minimum age at maturity ao 
Clearfao); 
Timing(MultipleListPlo( 
Table[Joln[Table[{s, r /. FlndRoo(J.
tOO 
e-n I[x, s) m[x, I) dx = 1, {r, -1, 1}]}, {s, 0.01, 0.41, O.OS}], 
Table({s, r /. FlndRoo(J.
tH 
e-n I[x, I) m[x, s) dx = 1, {r, -1, 1}n, {s, 0.42,0.62, 0.02}], 
Table({s, r /. FlndRoo(J.
tH 
e-n I[x, I) m[x, IJ dl = I, (r, -1, I}]), {50 0.62, 0.79, O.OS}]], {ao, 6, 10, 2}], 
PlotJoined ... True., SymbolShape ... (None), PlotStyle -> {Line}, AxesLabel-+ {"s", "r"}, 
PlotRange -> ({O, I), {-O.I, 0.09}}, Epilog ... (Arrow[{0.36, 0.09), {0.6, 0.02}], Text["ao", {O.SS, .Ol}]}]] 
r 
0.075 
0.05 
0.025 
s 
1 
-0.025 
-0.05 
-0.075 
-0.1 
(69.843 Second, - Graphics-) 
As the age of maturity increases investment in maintenance also increases, ensuring that the organism is in good condi-
tion to start reproducing later in life than previously. 
Values of ao ... 6, 8, 10 
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Effects of change of maximum rate of reproduction ho 
Clear[ho] 
Timing[MultipleListPlo~ 
LIOO Table[Join[Table[{s, r /. FindRooq 0 e-nl[x, s] m[x, s] dx = 1, {r, -1, I>]}, Is, 0.01, 0.41, O.OS}], 
Table[{s, r /. FindRoo~Lloo e-nl[x, 5] m[x, 5] elx = 1, {r, -1, I}]}, {s, 0.42, 0.62, 0.02}], 
Table[{s, r /. FindRoo~LIOO e-fll[x, s] m[x, s] dx = I, {r, -t, 1}]}, (s, 0.62, 0.79, O.OSJ)), 
tho, O.S, I.S, O.S}], PlotJoined -+ True, SymbolShape -+ {None}, 
PlotStyle -> {Line}, AxesLabel-+ {"s", "r"l, PlotRange -> {{O, t}, {-O.t, 0.09}}, 
Epilog -+ {Arrow[(0.6, O.O1}, {0.42S, 0.09S}], Text["ho", {O.S, .OSS}]}]] 
r 
0.075 
0.05 
0.025 
s 
1 
-0.025 
-0.05 
-0.075 
-0.1 
{30. 625 Second, • Graphics.} 
As the maximum rate of reproduction increases, less and less investment in maintenance is required to keep the popula-
tion at its maximum rate of increase. 
Values for ho -+ 0.5, 1.0, 1.5 
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Appendix 2. Mathematica notebook for the implementation of 
the immunogenetic model for the trade-offs between human 
fertility and lifespan. 
To illustrate our model we are going to use a very simple example. We will first consider the 
optimum strategies required in two very different populations, one from The Gambia where the 
infection load is large and one from Denmark where death due to infections is almost non-existent. 
Let us then imagine a woman from The Gambia, where she has to face the challenges of infections, 
moving to Denmark. We will follow her progeny and the change of the allele frequencies under the 
new conditions. 
To do that we will use the Denmark life tables to calculate the Gompertz equation parameters and 
then we will consider that the difference between the Danish and Gambian mortality curves are 
mainly due to infections and can affect the fitness ofT]. 
The first step is to consider that there is no external mortality in Denmark, thus the Gompertz param-
eters can be calculated directly by the Danish life tables with the use of a non linear fitting algo-
rithm. The ages used are between 9 and 94 since they are the range over which the Gompertz curve 
gives the best fit. 
Loading Packages 
« Statistics'NonlinearFit' 
Printed by Mathematica for Students 
Appendix 2.nh 
Denmark 
Data (WHO) 
DNK = {{9, O.000452}, (14, O.000736), (19, O.000922), 
(24, O.001293), (29, O.001596), (34, O.00265), (39, O.004688), (44, O.008466), 
{49, O.012113}, {54, O.019533}, {59, O.0333}, {64, O.057348}, {69, O.094244}, 
{74, O.139863}, (79, O.205224}, {84, O.312648}, {89, 0.456124}, (94, O.595709)}; 
Fitting an equation 
theorDNK= 
NonlinearFit[DNK, alpha Exp[beta x], {x}, {{alpha, O.0002}, {beta, O.08}}] 
0.000625216 eO. 0733576 x 
NonlinearRegress[DNK, alpha Exp[beta x], {x}, {{alpha, O.0002}, {beta, O.Ol}}] 
{BestFitParameters ~ {alpha ~ 0.000625251, beta ~ 0.073357}, ParameterCITable ~ 
Estimate Asymptotic SE CI 
alpha 
beta 
0.000625251 0.000117851 {0.000375419, 0.000875084}, 
0.073357 0.00210295 {0.0688989,0.077815} 
EstimatedVariance ~ 0.000144161, 
DF SumOjSq 
Model 2 0.733953 
ANOVATable ~ Error 16 0.00230657 
Uncorrected Total 18 0.73626 
Corrected Total 17 0.525679 
( 
1. -0.997232) 
AsymptoticCorrelationMatrix ~ -0.997232 1. ' 
Max Intrinsic 
FitCurvatureTable ~ II P E~n; 
max arameter- :fJects 
95. % Confidence Region 
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Plots 
Show[ListPlot[DNK], Plot[theorDNK, (x, 9, 94}]] 
0.6 
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O.S 
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- Graphics-
We will consider that 13 is a characteristic of the species so we can use the same value for both 
populations. We define po as the value of f3 when the optimum investment in maintenance is half 
the one required to have no age dependent mortality. 
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Gambia 
Data (WHO) 
GMB = {{9, O.00935198}, (14, O.00704255}, (19, O.01312712}, 
{24, O.02180081}, {29, O.02999855}, {34, O.03581704}, {39, O.03885223}, 
{44, O.04203231}, {49, O.04908543}, {54, O.06282653}, {59, O.08236681}, 
{64, O.1l697598}, (69, O.1701l485}, {74, O.25559405}, {79, O.36989701}, 
{84, O.51931764}, (89, O.68798683}, {94, O.79402981}}; 
Fitting an equation 
theorGMB = NonlinearFit[GMB, 
alpha Exp[O.0733576 x] + gamma, {x}, {(alpha, O.0006}, {gamma, O.l}}] 
0.0269311 + 0.000878084 eO. 0733576 x 
NonlinearRegress[GMB, alpha Exp[O.0733576 x] + gamma, 
(x), ({alpha, .0002), (gamma, O.l)}] 
{BestFitParameters ~ {alpha ~ 0.000878084, gamma ~ 0.026931 I}, ParamelerCITable ~ 
Estimate Asymptotic SE CI 
alpha 0.000878084 0.0000345661 {O.000804807, 0.00095136J}, 
gamma 0.0269311 0.011164 {O.00326461,O.0505977} 
EstimatedVariance ~ 0.00155808, 
DF SumOjSq 
Model 2 1.61273 
ANOVATable ~ Error 16 0.0249292 
Uncorrected Total 18 1.63766 
Corrected Total 17 1.03038 
( 
1. -0.55271) 
AsymptoticCorrelationMatrix ~ -0.55271 1. . 
Curvature 
Max Intrinsic 
FitCurvatureTable ~ II D E~n; 
max rarameter- '.fleets 
95. % Confidence Region 
o 
o 
0.524595 
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Plots 
Show[ListPlot[GMB], Plot[theorGMB, {x, 9, 94}]] 
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-Graphics-
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Now we can compare the WHO data values (points) and their fitted models (lines), for Denmark 
(dashed line and grey points) and the Gambia (solid line and black points) for the increase of the 
force of mortality with age 
x 
how[plot[theorDNK, {x, 9, 94}, PJotStyle -+ Dashing[{0.05, 0.05}]], 
PJot[theorGMB, {x, 9, 94}], 
ListPJot[D K, PlotStyJe -+ {AbsoJutePointSize[4], GrayLeveJ[0.5]}], 
ListPJot[GMB Plot tyle -+ AbsolutePointSize[4]], Frame -+ True, 
FrameLabel-+ {"age x years", "p(x)"}, ImageSize -+ 350] 
0.8 
0.6 
::s. 0.4 
• 
o 20 4 0 60 80 
age x years 
- raphic-
Having found the value [ the ompertz parameters we can find the contour plots for each set of 
conditions. From the data we can calculate the weighted mean of r for each order of 7J assuming that 
negative value f r d not exi t in the population. The indeterminate points are just those for 
which r is negative. 
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For Denmark 
• Turning off messages 
Off[ General: :spell] 
Off[Gencral::unD] 
Off[NIntegratc::ploss] 
Off[FindRoot::frsec] 
Off[NIntegrate::ncvb] 
Off[NIntegratc: :slwcon] 
Off[Grapbics::gprim] 
Off[Syntax::com] 
• Equations and contour plot 
Clear[K]; K := 0 
Clear[yo]; yo:= 0 
Clcar[ao]; ao := 8 
Clear[po]; po := 0.122167 
Clcar[ao]; ao := 0.000625216 
Clear[..\]; ..\ := 0 
Clcar[Vo]; V := 0.05 
Clcar[bo]; ho := 0.24 
Clcar[so]; so := 0.8 
Clear[p]; 
Clear[m]; 
Clcar[mo]; 
Clear[l]; 
P[SJ /; (s < so) := po (so/s-1) 
P[sJ /; (s ~ so) := 0 
a[sJ := ao/(1- s) 
h[sj := ho (1 - 5) 
1['1-, 11-, sJ /; x ~ a[s] := (1 - V) Exp[-(ao +..\ TJ) (eMs)" - eP's) _'s) / firs] - (x - a[s» (K 11 + yo)] 
V 
I[x-, TJ-, sJ /; x < a[s] := 1- V - (x - a[s» --
a[s] 
mo[x-, s-' TJj I; 50 ~ x ~ a[s] := h[s] Exp[-(ao + ATJ) (e4P1s)l_ e4PIs)-rs)/4 P[s)) 
mo[x-, s-' "j I; x < 8[S]:= 0 
mo[x-, 5-, 11~ /; X > 50 := 0 
m[x-, TJ-, sj:= mo[x, s, "1(1- _1_) 
,,+1 
Printed by Mathematica for Students 
258 
Appendix 2.nh 
Plot[l[x, 10,0.55], {x, 0, 1l0}, ImageSize -+ 350, 
PlotLabel-+ StyleForm["Denmark", FontSize -+ 12]] 
Plot[m[x, 10,0.55], {x, 10, 60}, ImageSize -+ 350, 
PlotLabel-+ StyleForm["Denmark", FontSize -+ 12]] 
Denmark 
1 
0.8 
0.6 
0.4 
0.2 
20 40 60 80 100 
-Graphics-
Denmark 
0.1 
0.08 
0.06 
0.04 
0.02 
20 30 40 50 60 
- Graphics-
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r[1]_, s~ := r /. FindRoot[J:94e-rx I[x, 1], s] m[x 1] ] dx = 1 {r -0.0 0.0 l] 
tickpos = JOin[Table[Log[10, 1]], {ll, 0.1, 1, 0.1}] Table[Log[10 1]] {II 2 10 I}]]' 
ticklabels = Map[If[Chop[Mod[#, 1]] = 0, 10" #, II "] & tickpo ]. 
cpl = ContourPlot[r[10'1, s], {1], -1, I}, 
{s, 0.01, 0.79}, Contours .... 30, ContourLine .... Fal e, 
FrameTicks .... (Transpose[{tickpos, ticklabels)], Automatic} 
PlotRange .... {Automatic, Automatic, CO, Automatic}}, Image ize .... 350] 
1. 1 0 
0 . 2 
O ~ ____ ~~~~~~~ __ ~ __ ~~~~~ 
0.1 
• ContourGraphics • 
r[10, 0.542] 
0.0313587 
1. 10 
Mean[Cases[Flatten[Table[r[i, z], {i, 0.2, 0.5, 0.1}, (z, 0.35, 0.75, 0.05)]] _? Positive]] 
Mean[Cases[Flatten[Join[Table[r[i, z], {i, 0.8, 1, 0.1}, {z, 0.35, 0.75, 0.05}] , 
Table[r[i, z], {i, 2, 3, I}, {z, 0.35, 0.75, 0.05}]]], _ ?Positive]] 
Mean[Cases[Flatten[Table[r[i, z], {i, 5, 10, I}, {z, 0.35, 0.75, 0.05}]], _? Positive]] 
Mean[{}] 
0.00951127 
0.0205863 
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For Gambia 
• Turning off messages 
Off[General::spell] 
Off[General::unn] 
Off[General::ovfl] 
Off[NIntegrate::ploss] 
Off[FindRoot::frsec] 
Off[FindRoot::frnum] 
Off[NIntegrate::ncvb] 
Off[NIntegrate::slwcon] 
Off[NIntegrate::inum] 
Off[NIntegrate::inovf] 
Off[Graphlcs::gprlm] 
Off[ReplaceAII: :reps] 
• Equations and contour plot 
Clear[K]; K:= 0.0269311 
Clear[yo]; yo:= 0 
Clear[ao]; 10 := 8 
Clear[fto]; po := 0.122167 
Clear[ao}; ao:= 0.000625216 
Clear[A]; A := 0.000252868 
Clear[Vo]; V:= 0.25 
Clear[ho]; ho := 0.75 
Clear[so}; 10 := 0.8 
Clear[p]; 
Clear[m}; 
Clelr[mo]; 
Clelr[I]; 
P[I.J /; (I < 10) := po (so/I-I) 
P[s.J /; (s ~ 10) := 0 
I[I.J := 10/(1 - I) 
h[s.J := ho (1 - I) 
1[1_. 'L. I.J /; 1 ~ a[s] := (1- V) Exp[-(/lO + A 'I)(elll.) x - elll.)a,")/ pes] - (1- a[s» (K 'I + yo» 
V 
1[1_, '1_, I.J /; 1 < a[s] := I - V - (x - a[s» --
a[s] 
mo{l_. 1_, 'I.J /; SO ~ I ~ ah]:= h[s] Exp[-(ao + A 'I)(e4 /l[') x - e 41l1') a'.) /4 pes]] 
mo{l_. 1_. 'I.J /; I < a[s] := 0 
mo[l_. 1_. 'I.J /; 1 > 50 := 0 
m[x_. 'L, IJ := mo[x ... 'I] (1- 'I: 1 ) 
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Plot[l[x, 1,0.55], (x, 0, HO), ImageSize -+ 350, 
PlotLabel-+ StyleForm["Gambia", FontSize -+ 12]] 
Plot[m[x, 1, 0.55], (x, 0, 60), ImageSize -+ 350, 
PlotLabel-+ StyleForm["Gambia", FontSize -+ 12]] 
Gambia 
1 
0.8 
0.6 
0.4 
0.2 
20 40 60 80 100 
-Graphics-
Gambia 
0.15 
0.125 
0.1 
0.075 
0.05 
0.025 
10 20 30 40 50 60 
- Graphics-
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0.4 
0.2 
( 94 
r[17-, -.J:= r / . FindRoot[ 19 e-rx I[x, 17, s] m[x, 17, s] dx = 1, {r, -0.05, 0.05}] 
tickpo = Join[Table[Log[lO, 17], {17, 0.1, 1, 0.1}], Table[Log[10, 17], {17, 2, 10, I}]]; 
tickJabel = Map[If[Chop[Mod[#, 1]] = 0, 10/\#, 1111] &, tickpos]; 
cp2 = ContourPlot[r[10TJ , ], {17, -1, I}, 
0.1 
{s,O.OI 0.79} Contours -+ 30, ContourLines -+ False, 
FrarneTick -+ {Transpose[{tickpos, tickiabels}], Automatic}, 
PlotRange -+ { utomatic, Automatic, CO, Automatic}}, ImageSize -+ 350] 
1. 10 
O ~ ______ ~~~~~~ __ ~~~~~~~~ 
o 1 
r phic • 
r[2 O. 26 ] 
. 314 54 
1. 10 
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Mean[Cases[Flatten[Table[r[i, z], (i, 0.2, 0.5, 0.1}, (z, 0.35, 0.75, 0.05}]], _? Positive]] 
Mean[Cases[Flatten[Join[Table[r[i, z], (i, 0.8, 1, 0.1}, (z, 0.35, 0.75, 0.05)], 
Table[r[i, z], (i, 2, 3, 1}, (z, 0.35, 0.75, 0.05}]]], _?Positive]] 
Mean[Cases[Flatten[Table[r[i, z], (i, 5,10, 1}, (z, 0.35, 0.75, 0.05}]], ?Positive]] 
0.0102003 
0.0193559 
0.00763002 
The last step is to find out the gene frequencies of 1] in The Gambia and then move them to Den-
mark to examine the predicted change. To do that we use the relative fitness of each genotype, 
where we divide the values of r by their highest value so that the best genotype has relative fitness 
1. And we make the simplifying assumption that only one gene is responsible for the balance 
between Thl and Th2. 
For The Gambia 
Ifwe call the two alleles of the immune reaction G and g then we can say that G homozygotes have 
an 1] of the order of 10 while g homozygotes have 1] of the order 0.1 and the heterozygotes I. Then 
in The Gambia the value of r will be: 
GG Gg 
0.0102003 0.0193559 
0.5269866 
l-s1 
SI =0.473013 
gg 
0.00763002 r 
0.39419608 relative frequency 
l-s2 
S2 = 0.605804 coefficient of 
selection 
We have an overdominance case when it comes to selection i.e the fitness of the heterozygotes is 
higher than either of the homozygotcs and thus we expect that a point of balance will exist between 
the two allclcs. 
The point of balance bctwccn the two allele frequencies can be calculated easily with the use of a 
standard formula 
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Clear[51); sl = 0.473013; 
Clear[52); 52 = 0.605804; 
Clear[pG); 
Clear[pg); 
52 
Print["Pa = It, pG = J 
51 + 52 
Print["pg = ", pg = 1 - pG) 
Pa = 0.561545 
pg = 0.438455 
265 
So using the allele frequencies in The Gambia as a starting point, we can investigate the change of 
these frequencies when a female population is moved to Denmark (or where the infectious load of a 
population is decreased significantly during a single generation). 
The first generation in Denmark will be: 
GG Gg 
0.315333 0.492424 
o 0.009511 
o 0.462013 
I-s 
s=1 
I-h s 
h = 0.462013 
gg 
0.192243 
0.020586 
I 
1 st generation 
r 
relative frequency 
coefficient of 
selection 
In this case we expect that in the end the g allele will become extinct from the population. To find 
the number of generations necessary for this and the rate of change of the g allele's frequency in 
each passing generation we can usc again a standard equation for selection under partial dominance. 
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Clear[PartialDominance] ; 
PartialDominance[GO-, gO-, h_, sj := Module[{x, g, G, i = 1, dQ}, 
] 
g = Table[O, Ii, 1, 1000}]; 
G = Table[O, {i, 1, 1000}]; 
g[[l]] = gO; 
GUl]] = GO; 
[ 
s g[[i]] GUi]) (G[[i]] + h (g[[i]] - G[[i]]) 6 
While - S -10- , 
1 - 2 h 5 g[[i]] G[[i]] - 5 G([i]fZ 
G[[i]] - h 5 g[[i]] G[[i]] - 5 G[[i])2 
G[[i + 1]] = ---------
1 - 2 h 5 g[[i]] G[[i]] - s G[[i]e 
g[[i + 1]) = (1 - G[[i + 1]]); 
Print[ i," "," Pa = ", G[[i]], " ", "Pg = ", g[[i]], " ", "dQ = ", 
_ 5 g[[i - 1]] G[[i - 1]) (G[[i - 1]] + h (g[[i -1]] - G[[i - 1]]) ]; 
1 - 2 h s g[[i - 1]] G[[i - 1]] - s G[[i - 1]]2 
Prlnt["GG", "", G[[i]]2, " If, "Gg", " ",2 G[[i]] g[[i]], " If, "gg", "", g[[i]]2]; 
1++] 
PartialDominancc[0.561545, 0.438455, 0.462013, 1] 
Lisr 
1 Pa = 0.561545 P, = 0.438455 dQ = - 1 _ 1.92403 List 
GG 0.315333 Gg 0.492424 gg 0.192243 
2 Pa = 0.289743 P, = 0.710257 dQ = -0.271802 
GG 0.0839508 Gg 0.411584 gg 0.504465 
3 Pa = 0.15252 P, = 0.84748 dQ = -0.137222 
GG 0.0232625 Gg 0.258516 gg 0.718222 
4 Pa = 0.0811141 P, = 0.918886 dQ = -0.0714063 
GG 0.00657949 Gg 0.149069 gg 0.844351 
5 Pa = 0.043371 P, = 0.956629 dQ = -0.037743 
GG 0.00188105 Gg 0.08298 gg 0.915139 
6 Pa = 0.0232564 P, = 0.976744 dQ = -0.0201146 
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GG 0.000540861 Gg 0.0454311 gg 0.954028 
7 PG = 0.0124896 Pg = 0.98751 dQ = -0.0107668 
GG 0.00015599 Gg 0.0246672 gg 0.975177 
8 PG = 0.00671286 Pg = 0.993287 dQ = -0.00577672 
GG 0.0000450625 Gg 0.0133356 gg 0.986619 
9 PG = 0.00360959 Pg = 0.99639 dQ = -0.00310327 
GG 0.0000130292 Gg 0.00719313 gg 0.992794 
10 PG = 0.00194138 Pg = 0.998059 dQ = -0.00166821 
GG 3. 76896 x 10-6 Gg 0.00387523 gg 0.996121 
11 Pa = 0.00104428 Pg = 0.998956 dQ = -0.000897098 
GG 1.09053 x 10-6 Gg 0.00208639 gg 0.997913 
12 Pa = 0.000561767 Pg = 0.999438 dQ = -0.000482517 
GG 3.15582 x /0-7 Gg 0.0011229 gg 0.998877 
13 Pa = 0.00030221 Pg = 0.999698 dQ = -0.000259556 
GG 9.1331 x 10-11 Gg 0.000604238 gg 0.999396 
14 Pa = 0.000162581 Pg = 0.999837 dQ = -0.000139629 
GG 2.64327 x 10-11 Gg 0.00032511 gg 0.999675 
15 Pa = 0.0000874656 Pg = 0.999913 dQ = -0.0000751158 
GG 7.65024 x 10-9 Gg 0.000174916 gg 0.999825 
16 Pa = 0.0000470551 Pg = 0.999953 dQ = -0.0000404106 
GG 2.21418 x 10-9 Gg 0.0000941057 gg 0.999906 
17 Pa = 0.0000253149 Pg = 0.999975 dQ = -0.0000217401 
GG 6.40845 x 10-10 Gg 0.0000506286 gg 0.999949 
18 Pa = 0.0000136191 Pg = 0.999986 dQ = -0.0000116958 
GG 1.85479 X 10-10 Gg 0.0000272378 gg 0.999973 
19 PG = 7.32688 X /0-6 Pg = 0.999993 dQ = -6.2922 X 10-6 
GG 5.36831 X 10-11 Gg 0.0000146536 gg 0.999985 
20 Pa = 3. 94176 X /0-6 Pg = 0.999996 dQ = -3.38511 X 10-6 
GG 1.55375 X 10-11 Gg 7.88349 X 10-6 gg 0.999992 
So we can see that initially the rate of change is very big but it tends to get smaller and smaller. We 
can say the allele is virtually absent from the population when its frequency falls below 1 in 
1000000. 
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Appendix ~ Mathematica notebook for the calculation J!f 
the allelic effect 
To calculate the allelic effect of 102 and 104 relative to the 103103 genotype we imagine a population of 
individuals all carrying the e3e3 genotype. The allele effect will be the difference in the mean 
lifespan if we change the genotype of the population from 103103 to E3EX where EX can be either 102 or 
£4. 
Plotting the Gompertz equation in a form representing the number of deaths at each age and applying 
the relative risk factors for the 102 and 103 carriers we can calculate the change of the mean lifespan in 
each case. 
1030, e20 and 1040 specify the number of carriers of each allele in a cohort of 100,000 
< < Statistics'ContinuousDistributions' 
« Statistics'NormaIDistribution' 
« Statistics'DcscriptiveStatistics' 
« Graphics'Arrow' 
« Graphics'Colors' 
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(20:= 13000 
(30:= 58000 
(40:= 29000 
a := 3.5136410-5 
p := 0.093832 
p3[xj := a ,.fl. 
p2[xj:= 0.9a,.fl. 
p4[xj := 1.13 a efl· 
121 
meanLifeSpanE3[xj = 2: x (e-fpJ/Y-lldy - ,.-fp3/Yldy); 
a=' 
121 
meanLifeSpanE2[xj = 2: x (e-fp2/y-lldy -,.-f p2(Yldy); 
a=' 
III 
meanLifeSpanE4[xj = 2: x (e-fp4(y-lldy _,.-f p4(Yldy); 
a=' 
Gompcrtu3[xj = e-fpJ(Y-lldy _ ,.-fp3(YldY; 
Gompertu2[xj = e-fp2(y-l)dy _ e-fp2(y)dy; 
Gompcrtu4[xj = ,,-rp4/Y-I)dy _ e-fp4/y/dY; 
Prlnt["Gompcrtz Curvc"] 
Plot[(Gompcrt7.f3[xJ, Gompcrtu2[xJ, Gompcrtu4[x]), (x, 0, 125), 
AXC5Labcl .. {"age", "Change In force\nof mortality"}, 
Plot Range -> ({O, 125), {O, 0.04}}, 
AXC50rlgln .. (O, 0), PlotStyle ... (Red, BlueVlolet, Blue), 
Epilog .. {Arrow[(48, 0.03}, (77, 0.03)], Text("E4 carriers", (35, .03)], 
Arrow[(48, 0.025), (74.5, 0.025)], Text["E3E3", (35, .025)), 
Arrow((48, 0.02), (72, 0.02)), Text["E2 carriers", (35, .02))}] 
Prlnt["Mean Life Span for d ->", meanLifeSpant"3[x]) 
Prlnt("Mean Life Span for (2 carrlcrs ->", meanLifeSpanE2(x)] 
Prlnt("Mean Life Span for E4 carrlcrs ->", meanLifeSpan(4[x)] 
Prlnt("Change In Mean Life Span between (3(3 and E2 carriers-> It, 
meanLifeSpaRE2[x] - meanUfeSpan(3[x)) 
Prlnt["Change In Mean Life Span between d(3 and (4 carriers-> ", 
meanUfeSpaRE4(x] - meanLifeSpanE3[xJ] 
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Gompertz Curve 
Change in force 
of mortality 
0.04 
0.035 
0.03 E4 carrier~------~~ljl 
0.025 E3E3 
0.02 E2 carrier8-------~ 
0.015 
0.01 
0.005 
20 40 60 80 
• Graphics. 
Mean Life Span for E3 ->78.4683 
Mean Life Span for E2 carriers ->79.5882 
Mean Life Span for E4 carriers ->77.1695 
100 120 
Change in Mean Life Span between E3E3 and E2 carriers-> 1.11992 
Change in Mean Life Span between E3E3 and E4 carriers-> -1.29875 
age 
Assuming that the alleles have an additive effect on lifespan we can calculate the difference caused 
by each genotype relative to E3d individuals. 
11.5 a2 21.5 a2 
tlE2 := a2 ,. Solve[79.S882 -78.4683 == + ,a2][[I]] 
13 13 
25a4 24a4 
aE4:= a4 ,. SOlve[77.l695 -78.4683 == -- + --, a4]£[I]] 
28 28 
Prlnt(ItThe d allele effect Is It, ad] 
Prlnt(ItThe E4 allele effect Is It, aE4] 
The t2 allele effect is 1.00405 
The t4 a/Meeffect is -1.10201 
So now based again on the assumption of the apo E additive effects we can easily calculate the 
relative change expected by each genotype relative to E3E3 and E2E4 genotypes: 
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Print["for E3E3 and dE4 ->",0] 
Print["for E2E3 ->", ad] 
Print["for E2E2 ->", 2 ad] 
Print["for E4E3 ->", aE4] 
Print["for E4E4 ->", 2 aE4] 
For £2£3 ->1.00405 
For £2E2 ->2.0081 
For E4£3 ->-1.10201 
For E4E4 ->-2.20402 
From this values we have to go back and calculate the relative risk factor associated with each 
genotype. 
RiskFactor[GT--1 := 
Modulc[(a = 3.51364 10-5, P = 0.093832, pR, p3, Rf}, 
pR[IJ := R a ,.,s; 
p3[IJ := a "'s; 
122 
Rf = R /. flndRoot[l: I (,.-r,,3[Y-IJdy -,.-.L",,3[YJ d Y) + GT == 
s,,1 
122 
l: I (,.-rpR[y-IJdy - ,.-.L"PR/YJdY), {R, 1l]] 
pi 
Prlnt["For dE3 and dE4 ->", 1] 
Prlnt["For 12E3 ->", Rlskfactor[aE2]] 
Prlnt["For dE2 ->", RlskFactor[2 ad]] 
Prlnt["For E4d ->", RlskFactor[aE4]] 
Prlnt["For E4E4 ->", RlskFactor[2 aE4]] 
For tJtJ and t2t4 ->1 
For t2t1 ->0.909864 
For t2t2 ->0.827868 
For t4tJ ->1.10927 
For t4t4 ->1.2)051 
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Appendix ~ Mathematica notebook for the calculation of 
the relative risk from the odds ratio 
Many health studies use logistic regression to analyse the data obtained. However the resulting odds 
ratio may overestimate the true effect of the risk factor of interest (Robbins et aI., 2002). The 
problem is that logistic regression and the odds ratio are accurate for rare events «10%) but are often 
used to study common outcomes (McNutt et aI., 2003). Since we are interested in the relative risk of 
each lifestyle parameter, we will the methodology of Zhang and Yu (1998) to approximate the 
relative risk from the adjusted odds ratio which is commonly used in CVD studies. 
For example, to calculate the relative risk associated with gender we are going to use the odds ratio 
provided by Stevens et al (2001) and the incidence described by Panagiotakos et al (2002). Using the 
formula: 
RR = OR 
(1- Po) + (Pox OR) 
where RR is the relative risk, Po is the incidence of the outcome in the non-exposed population and 
OR is the odds ratio. Substituting the incidence with 20% and the OR with 0.525 we can calculate 
the relative risk as 0.58. Using the Gompertz model for the number of deaths per year of age we can 
see that the difference produced between males and females is almost 6 years which is within the 
limits of the expected lag of cardiovascular disease between men and women. 
Weare going to use the same method to estimate the relative risk associated with each dietary pattern 
group of the Framingham study based on the odds ratio provided by Millen et al (2002). So the 
Heart Healthy group is used as the reference with risk ratio 1.0, the Light Eating risk is corrected to 
1.17, the Wine and Moderate is changed to 1.32 which is very close to the original odds ratio mainly 
due to the small representation of the group in the population, the relative risk for a High Fat diet is 
1.36 and finally the Empty Calorie diet risk factor was estimated to 2.07. 
To check the validity of the CVD risk factor associated with gender we are going to use the set of 
equations described previously to calculate the difference of age at peak mortality and compare it to 
the observed 5 - 15 years lag seen between men and women 
« Statistics'ContinuousDistributions' 
< < Statistics' NormalDistribution' 
< < Statistics'DescriptiveStatistics' 
« Graphics'Arrow' 
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a := 3.5136410-5 
p := 0.093832 
pmalc[x,J := a e/h 
pfcmalc[x,J:= 0.58 a eJJ:I 
122 
meanLlfcSpanmalt"{x,J = L I (e-J;"makfY-l)dY - e-r"makfY)dY); 
:1=8 
122 
mcanLlfcSpanfcmalt"{x,J = L I (e-J;""femalefy-I)dy - e-.r"femalefy)dy); 
:1=41 
Gompcrtzmalt"{x,J = e-J;"" .. ak{y-I)dy _e-r"makfY)dY; 
Gompcrtzfcmalt"{x,J = e-J;"femalefy-I)dy _ e-r"ftma'efY)dY; 
Prlnt["GomJ)('rtl Curve") 
Plot[(Gompertzmalt"{I), Gompertzfemalt"{x]}, {x, 0, 125}, 
AlcsLabel ... {"age", "Probability of death"}, PlotRange -> {{O, 125}, CO, 0.04}}, 
AlcsOrlgln ... CO, OJ, Epilog ... {Arrow[{45, O.03}, {77, 0.03}], Text["males", (35, .03}), 
Arrow[(45, O.025}, {80, O.025}], Text["females", (35, .025}]}) 
Prlnt["Mean Lire Span for males ->", meanLlfcSpanmalt"{x)) 
Prlnt["Mean Life Span for females ->", meanLifeSpanfemalt"{x)) 
Prlnt["Change In Mean Life Span between males and femalcs -> ", 
meanLifeSpanfemalt"{l) - meanLifeSpanmalt"{IJ) 
Gompertz Curve 
Probability of death 
0.04 
0.035 
0.03 
0.025 
0.02 
0.015 
0.01 
0.005 
20 40 60 80 100 120 
• Graphics. 
Mean L1fe Span for males ->18.4683 
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Mean Life Span for females ->84.261 
Cbange in Mean Life Span between males and females -> 5.79257 
Using the relative risk of 0.58 we observe a lag of 5.7 years at the peak mortality age. 
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Appendix~ Mathematica notebook for the calculation of the 
genotype environment interaction 
Due to lack of data on the quantitative link between apo E and the environmental risk parameters, we are going to 
calculate theoretically these associations based on current knowledge of their characteristics . 
• apo E X Diet 
In our discussion of the interaction between apo E and diet we assumed that a certain diet will exist such that no distinc-
tion between the different genotypes can be seen, and that the changes in diet will have a higher impact on £4 carriers 
relative to those having the E3 and £2 alleles, in line with published data. Furthermore we can fit a number oflinear and 
non-linear model curves through the 5 categories given by Millen et al (2002) to consider the distinct dietary patterns as 
a continuum. 
Based on the above we can find six curves that describe the relationship between diet and apo E genotype. We will 
assume that the E3£3 genotype curve corresponds to the risk factors measured in the population by Millen et al (2002). 
This is a good approximation and will simplify the problem significantly since apo £3£3 is the most numerous group 
(more than 60%), and in terms of risk factors, it lies approximately in the middle between £2 and £4 carriers' risk. 
The first step is to fit a curve through the data points for the dietary patterns. We will use a hybrid set of data between 
the age and multivariate adjusted odds ratio. The reason is that although we require the risk to be adjusted for other 
confounding factors, when this is applied at the level of IIDL cholesterol for a high fat diet a big part of the association 
with the apo E is lost. So we will use the multivariate-adjusted risk factors except in the case of the high fat diet where 
we will use the age-adjusted one. 
If we plot the five dietary patterns in a diet risk graph we can see that the data can easily be considered as being 
continuous 
cSatapoiDta. LiatPlot((l.0, 1.17, 1.32, 1.36, 2.07), PlotJoiDed .. True] 
2 
1.8 
1.6 
1.4 
1.2 
2 3 5 
• Graphics. 
We will use two different models to fit a curve through the points. A non-linear exponential with the equation 
y (x) = a ~fh and a linear quadratic described by y(x) - a + p x2• 
Printed by Mathematica for Students 
Appendix 5.nb 
« Stati.tic. 'NonlinearFit' 
Nonlinearllegre •• [{1.0, 1.17, 1.32, 1.36, 2.07}, 
alphaExp[betax), {x}, {{alpha, O.I}, (beta, O.OS}}) 
{BestFi tParameters ""* {alpha ""* 0.777504, beta ~ 0 .180799}, ParameterCITable ~ 
Estimate Asymptotic SE CI 
alpha 0.777504 0.126102 {O. 37619, 1.17882} 
beta 0.180799 0.0414913 {O. 0487549, O. 312843} 
EstimatedVariance""* 0.0297182, 
DF SumOfSq MeanSq 
2 10.1566 5.07832 Model 
ANOVATabl e ~ Error 3 0.0891546 0.0297182, 
Uncorrected Total 
Corrected Total 
5 10.2458 
4 0.66852 
( 
1. -0.942745) AsymptoticCorrelatiOnMatrix~ -0.942745 1. ' 
Max Intrinsic 
FitCurvatureTable ""* Max Parameter-Effects 
95. • Confidence Region 
fitcurve. Plot[O.7775 eO. uo,., (x, 0, 5)] 
1.4 
1.2 
0.8 
- Graphic.-
« Stati.tic.'LinearRegre •• ion' 
aegre .. (1.0, 1.17, 1.H, 1.36, :l.07}, (1, x"'2), x) 
{parameterTable ~ 1 
xJ 
Estimate 
0.944294 
0.0399733 
SE 
0.111248 
0.00795037 
RSquared ~ 0.893915, AdjulltedRSquared ~ 0.858554, 
EstJmatedvarJance ~ 0.0236399, ANOVATable ~ 
Curvature 
0.0698095} 
0.618342 
0.323557 
TStat 
8.48817 
5.02785 
PValue 
0.00343356, 
0.0151597 
DF SumOfSq MeanSq 
Model 1 0.5976 0.5976 
J 0.0709197 0.0236399 
FRatio 
25.2793 
pValue 
O.Ol51597} 
Error 
Total 4 0.66852 
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fitUnear - Plot(0.9442. 0.0. x 2 • {x. o. S}. PlotStyle .. {{Dashing({O.OS. O.OS} J}} J 
/ 
1.8 / 
1.6 / 
/ 
1.4 / 
/ 
1.2 ./ 
./ 
,." 
- 1 2 3 4 5 
- Graphics-
Show(datapoint •• fitcurva. fitlinaarJ 
data - {1.0. 1.17. 1.32. 1.36. 2.07} 
datanonUnaar _ Tabla(O. 7775 eo. lIo, •• (x. 1. 5) J 
dataUnaar_Tabla(0.9442+0.0.x2 • {x. 1. 5)J 
2 
1.8 
1.6 
1.4 
1.2 
4 5 
0.' 
- Graphics-
{1., 1.1', 1.32, 1.36, 2.0'} 
{O.931581, 1.1162, 1.3374, 1.60244, 1.92001} 
{0.9842, 1.1042, 1.3042, 1.5842, 1.9442} 
We can see that both models give lines of good tit with the data. Although the differences between the fitted lines are 
small we will use the linear model as having a marginally better tit and being as the simpler of the two. 
A point we have yet not explained is what x-o means in this model. As discussed earlier, the differences between the 
apo E genotypes are caused by the action of the environment. So the point of x=O is a diet that produces the exact same 
CVD risk factor for all six genotypes. 
To account for the differences between the genotypes we will consider that the relative risks between them are the 
relative difference between their curves. Thus having set the E3d curve equal to the population mean we could easily 
find the p parameter for all six genotypes. To do that we will divide the product of each curve with the one from the 
reference curve and make it equal to the relative risk between the corresponding genotype and the E3d one. 
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For the E2E2 genotype 
Clear[Jl22], 
[ n!.l (0.9442+Jl22x2) Solve .. 0.8279, Jl22] II!.1 (0.9442+0.04x2) 
/322. Select[Tab1e[Jl22/. '], Positive] 
{{.8n ~ -0. 943672}, {.822 ~ -0. 277625}, {.822 ~ -0.0976552 - 0.111175 i}, 
{.822 ~ -0.0976552 + 0.111175 i} I {.822 ~ O. 0346665}} 
{O. 034 6665} 
We require only the real and positive solutions so in this case the only acceptable solution is for P22 = 0.0345. 
Similar for the E2E3 genotype 
Clear [Jl2l] , 
[ n!.l (0.9442+Jl23x2) ] Solve - 0.9099, Jl2l 
n!.l (0. '442 + 0.04 x 2) 
Jl23 • Select [Tab1e[Jl23 /. '], Positive] 
{(.823 ~ -0.94362), (.823..., -0.280229), {.823 ~ -0.0976954 -0.114627i}, 
(.823 ~ -0.0976954 + 0.114627 i), {.823 ~ O. 0372985}} 
{0.0372985} 
The E2t4 genotypes and the E3f3 genotypes were considered equal so they also share the same slope 
For the E3f4 genotype 
Clear [Jl34 I, 
[ 
n:.l(0.'442+/3Hx2) ] 
Solve - 1.10U, Jl34 
n!ol (0.'442+0.04x2) 
/334 • Se1ect [Tab1e [/334 /. 'I, positive] 
«.834..., -0. 943492), (.834..., -0.286076) I (.834..., -0.0977118 - 0.122101 i), 
(.834..., -0.0977118 + 0.122101 i) I {.834..., O. 0430503}} 
(0.0430503) 
And finally for the f4t4 genotype 
Clear [Jl44 I , 
[ 
n:.l(0.'442+t!44x2) ] 
Solve - 1.2305, Jl44 
n!.l (0.'442+0.04x2) 
/344. Se1ect[Tab1e[/344 /. 'I, positive) 
«.844 ..., -0. 943415), (P44..., - O. 289348}, {PH..., -0.0976829 - 0.12614 i}, 
(P44 ..., -0.0976829 + 0.12614 i}, (P44 ~ O. 0461875}} 
{0.0461875} 
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allgenot • Plot ({ 0.9442 + /322 x2, 0.9442 + /323 x2, 
O.9442+/3x2, O.9442+/334x2, 0.9442+/344x2), {x, 0, 5}] 
TableForm(Table ( 0.9442 + /322 x2, 0.9442 + /323 X2, 0.9442 + /3 x2, 
0.9442+/334x2, 0.9442+/344x2), {x, 0, 5}], 
TableBeadings -> {None, (-152152-, -152153-, -153153/152154-, -153154-, -E4e4-)}] 
2 
1.8 
1.6 
1.4 
1.2 
1 
- Graphics· 
£2£2 
0.9442 
0.978866 
1. 08287 
1.2562 
1.49886 
1. 81086 
2 3 
£2£3 
0.9442 
0.981499 
1.09339 
1.27989 
1.54098 
1.87666 
5 
£3£3/£2£4 E3£4 E4E4 
0.9442 0.9442 0.9442 
0.9842 0.98725 0.990388 
1.1042 1.1164 1.12895 
1.3042 1.33165 1.35989 
1.5842 1.633 1.6832 
1.9442 2.02046 2.09889 
To see the impact of our initial assumption that the E3E3 curve was equal to the population mean we will calculate the 
overall weighted mean for the six curves and compare it to the one provided by the original data. 
freq22 ,.0.017, 
freq23 ,. 0.116, 
freq33 ,.0.558, 
freq2C .. 0.019, 
freq34 ,.0.251, 
freq44 I. O.Olt, 
.e.ocurve. 
279 
Platteo[Table[freq22 (0.'442+~22x2) +freq23 (0.'442+~23x2) +freq33 (O.9442+/3x2) + 
freq24 (0. 94U + ~ x 2) + freq3t (0.9442 + /334 x 2) + freq44 (0.9442 + /344 x 2), {x, 1, 5}]] 
{0.984803, 1.10661, 1.30963, 1.59385, 1.95927} 
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Show[fitliDear, Li.tPlot [lIleaocurve, PlotJoiDed ... True, PlotStyle ... Hue [. 8J J J 
1.8 
1.6 
1.4 
1.2 
- 1 4 5 
• Graphics. 
So we can see that the initial assumption has a very small impact on the values of the risk factors between the two curves. 
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• apo E X Alcohol 
As we mentioned earlier a number of studies have found a U- or J- shape association between alcohol consumption and 
the risk of CVD. In order to link the action of alcohol with the effect of the apo E genotype we will use a set of U 
shapes with parameters that correspond to the relative risk of each genotype. Again the first step will be to fit a curve 
through the data provided. Although Stampfer et al (2000) considered a J- curve we can extend that to describe a U-
curve based on the fact that at the point of high consumption the risk factor for CVD increases and on the assumption 
that this point is a point of symmetry for the curve. In this case it is easy to describe the alcohol risk factor as points of a 
quadratic curve of the form a(x-q;f+y . 
If we plot the points of the risk factors setting the final group as the point of symmetry then we can have an indication of 
the expected U-shaped curve. 
<satacurv •• Li.tPlot[(1.65. 1.41. 1.26. 1.0. 1.26. 1.41. 1.65}. PlotJoined-+ True] 
1.4 
1.3 
1.2 
1.1 
• Graphic •• 
To fit the quadratic curve then 
« Btathtie. 'Monlin •• rlit' 
Clear [alpha] , 
Cl •• r[g .... ] , 
MonUn.arR.gre .. [(l.6S. 1.41. 1.26. 1.0. 1.26. 1.41. 1.65}. 
alpha (x- 4)2 +1. (x). (alpha}] 
{sestFitParameter .... {alpha ... 0.0790816}, ParameterCITable .. 
Estimate Asymptotic SE CI 
alpha 0.0790816 0.00877897 {0.0576003, 0.100563}' 
EstimatedVariance ... 0.0151058, 
Model 
ANOVATabl. -+ Error 
Uncorrected Total 
Corrected Total 
AsymptoticCorrelationMatrix-+ (1.), 
DF 
1 
6 
7 
6 
Max Intrinsic 
FitCurvatureTable ... Max Parameter-Effects 
95. , Confidence Region 
SumOfSq 
13.5058 
0.0906347 
13.5964 
0.320743 
Curvature 
o 
o 
0.408678 
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fitcurv •• Plot[O.0791 (x- 4)2 + 1.0, {x, 1, 7}) 
Tab1e[O.0791 (x_4)2+1.0, {x, 0, 7}) 
1.7 
1.6 
1.5 
1.4 
1.3 
1.2 
1.1 
1 2 3 5 6 7 
• Graphics. 
{2.2656, 1.7119, 1.3164, 1.0791, 1., 1.0791, 1.3164, 1.7119} 
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To compare them we can just fit them in the same graph. We see that the fitted curve underestimates the risk of group 2 
and 3 but their values still remain within the confidence intervals predicted by Stampfer et al (2000). 
Show(datacurv., fiteurve] 
1.7 
1.6 
1.5 
1 .• 
1.3 
1.2 
1.1 
• Graphics. 
As in the case of diet we will consider that the fitted curve corresponds to the E3E3 (and E2E4) genotype and that all 
genotypes reach 1.0 8S the minimum risk factor. Using the E3f3 curve and knowing the relative risk between the apa E 
alleles we can calculate the a of the curves corresponding to the rest of the genotypes. 
Clear[Q22J, 
[ n!.l (Q22 (x-4)2+1.0) Solve - 0.8279, Q22] 
n!.l (0.0791 (x - 4)2 + 1.0) 
Q22 • 8e1eet (Tab1e (Q22 /. 'J, Poaitive) 
{{a22~-1.07695}, {a22~-0.868977}, {a22~-O.561207}, 
{a22~-0.142079-0.250355i}, {a22~-O.142079+0.250355i}, {a22~O.0690731}} 
{O.0690731} 
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Clear[a23], 
[ 
n!.1 (a23 (x - 4)2 + 1.0) 
Solve = 0.9099. a23] 
II!ol {O. 0791 (x - 4) 2 + 1. 0) 
a23. Select[Table[a23 I. ']. Positive] 
{{a23 -+ -1.0B01l}. {a2l -+ -0.858185}, {a2l -+ -0.576961}, 
{a23 -+ - 0 .140502 - 0 .2561B9 i}, {a23 -+ -0.140502 + 0.256189 i}, {a2l -+ O. 0740343}} 
{0.0740343} 
Clear [aH] , 
[ 
n!.1 (a34 (x - 4)2 + 1.0) 
Solve so 1.1093. a34] 
II!.1 (O.0791 (X_4)2+1.0) 
aH. Select [Table [aH I. '], Positive] 
{{crH-+-1.0870B}, {crH-+-0.828646}, {a34-+-0.617254}, 
{crH-+-O.137013-0.26875i}, {a34-+-0.137013+0.26875i}, {cr34-+0.0847887}} 
{0.0847887} 
Clear[a23], 
[ 
n!.1(crU(x-4)2+1.0) ] 
Solve -~~-------- - 1.2305, a44 
II!.1 {O.0791 (x - 4)2 + 1.0) 
aU. Se1ect [Tab1e [aU I. '], Poaitive] 
{{crU-+-1.09094}, {cr44-+-0.806151}, {cr44-+-0.645567}, 
{cr44 -+ - 0 .135086 - 0.275499 i}, {a44 -+ - 0 .135086 + 0.275499 i}, {a44 -+ O. 0906069}} 
{0.0906069} 
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aUgenota Plot[{a22 (X_4)2+1.0, a23 (X-4)2+ 1 .0, 
0.0791 (X_4)2+1.0, a34 (X_4)2+1.0, a44 (X_4)2+1.0), {x, 1, 7}] 
Tab1eForm[Table[{a22 (X_4)2+1.0, a23 (X_4)2+1.0, 0.0791 (X_4)2+1.0, 
a34 (x-4)2.1.0, a44 (x-4)2.1.0), (x, 1, 7)], 
TableRe.dings -> {None, (-E2E2-, -152153-, -153153/152154-, -153154-, -154154-»] 
1.8 
1.6 
1.4 
1.2 
• Graphics. 
152152 102103 e3e3/e2e4 e3e4 e4e4 
1. 62166 1. 66631 1.7119 1.7631 1. 81546 
1.27629 1.29614 1. 3164 1.33915 1. 36243 
1.06907 1.07403 1.0791 1.08479 1. 09061 
1. 1. 1. 1. 1. 
1. 06907 1.07403 1. 0791 1.08479 1.09061 
1. 27629 1.29614 1. 3164 1.33915 1. 36243 
1.62166 1. 66631 1.7119 1. 7631 1. 81546 
284 
The frequencies that will be used for each category are based on the UK National Statistics on alcohol consumption per 
week for both sexes. 
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• apo E )( Smoking 
In the case of smoking where the precise form of the interaction with apo E is still largely unknown we will follow the 
same methodology as in the case of diet. Moreover we will use the same model to fit the data provided by Stamp fer et 
al (2000). 
datacurve.Li.tPlot[{1.0, 1.55, 3.12, S.48}, PlotJoined .... True] 
5 
3 
2 
1.5 2 2.5 3 3.5 
• Graphics. 
« Stati.tic.· LinearRegre •• ion· 
Regr ••• [(1.0, 1.55,3.12, 5.48}, {1, x"'2}, x] 
{ParameterTable .... 1 
x2 
Estimate 
0.500581 
0.304922 
SE 
0.178176 
0.0189399 
RSquared .... 0.992343, AdjustedRSquared .... 0.988514, 
EstimatedVariance .... 0.0462746, ANOVATable .... 
Model 
Error 
Total 
DF 
1 
2 
3 
SumOfSq 
11.9941 
0.0925492 
12.0867 
MeanSq 
11.9941 
0.0462746 
TStat 
2.80948 
16.0995 
FRatio 
259.195 
PValue 
0.106781 
0.00383592 
PValue 
O.00383592} 
fitUne.raPlot[0.5006+0.30Ux2, {x, 1, 4}, PlotStyl ..... {(D .. hing[{O.OS, O.OS}]}}] 
5 / 
/ 
/' 
/' 
3 /' 
/' 
1 -
1.5 2 2.5 1 3.5 
• Graphics. 
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Show[datacurve, fitlinear] 
data- {1.0, 1.55, 3.12, 5.U} 
datalinear - Table [0.5006 + 0.3049 X2, (x, 1, 4}) 
5 
4 
3 
2 
1 
1.5 2 2.5 3 3.5 4 
• Graphics. 
{l., 1.55, 3.12, 5.48} 
{0.805S, 1.7202, 3.2447, S.379} 
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We can see again that the points of the fitted curve are within the 95% confidence interval provided by Stampfer et al 
(2000). 
Again we will use the same methodology used earlier in the association ofapo E with diet to calculate the interaction of 
genotype with smoking. 
For the £2£2 genotype 
Clear[tl22], 
[ n!'l (0.5006 + tl22 X2) ] Solve - 0.8279,1322 
n!'l (0.5006+0.3049x2) 
tl22. Select (Table (1322 I. \), poaitive] 
({t322 ~ - O. 666267}, (t322 .... -0.165764 - 0.393595 i}, 
{t322 ~ - 0 .165764 + 0.393595 i}, {t322 ~ O. 285135}} 
(0.285135} 
Similar for the f2f3 genotype 
Clear [tl23] , 
n!.l (0.5006+tl23x2) 
Solve [ - 0.9099, tl23] 
n!'l (0.5006 + 0.3049 x 2) 
1323 • Select (Table [tl23 I. \), Poaitive) 
{(t323~-0.674926}, (t323 .... -0.166313-0.404642i), 
(t323 ~ -0.166313 + 0.404642 i}, {t323 ~ 0.294892}} 
{O.294892} 
The f2f4 genotypes and the f3f3 genotypes were considered equal so they also share the same slope 
tI·0.3049, 
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For the £3E4 genotype 
C1ear[tlH] , 
[ IT!.1 (0.S006+tlHx2) Solve = 1.1093, tl H ] 
rr!d (0.5006 + 0.30U x 2) 
tlH • Se1ec::t [Table [tlH /. 'J, Positive] 
{{t334 ~ -0.694067}, {t334 ~ -0.167393 - 0.428609i}, 
{t334 ~ - 0 .167393 + 0.428609 i}, {t334 ~ O. 316193}} 
{0.316193} 
And finally for the E4E4 genotype 
Clear [tl44) , 
[ IT!.1 (0. S006 + tl44 x
2) 
Solve .. 1.2305, tl44] 
rr!.1 (0.5006+0.30Ux2) 
t!44. Se1eet[Table[t!44/. '), Positive] 
{{t344 ~ - O. 704621}, {t344 ~ -0.167921 - 0.441591 i} , 
(t344 ~ - 0 .167921 + 0.441591 i), (t344 ~ O. 327803)} 
{O.327803} 
aUg.not. Plot[(0.5006 + t!22 X2, 0.S006 + t!23 x2, 
0.S006+t!X2, 0.S006+t!34x2, 0.S006+t!44x2}, {x, 1, 4}] 
Tablel'orm[Table({0.S006 + t!22 X2, 0.5006 + tl23 X2, 0.5006 +tl X2, 
0.5006+t!Hx2, 0.5006+tl44x2}, {x, 1, 4}], 
TableRe.dinge -> {None, (-.2.2-, -.2.3-, -.3.3/.2e4-, -.3.4-, -e4e4-}}) 
1 
1.5 
• Graphics. 
E282 
0.785735 
1. 64114 
3.06682 
5.06277 
2 2.5 
82E3 
0.795492 
1.68017 
3.15463 
5.21888 
3 3.5 
E3E3/E2E4 
0.8055 
1. 7202 
3.2447 
5.379 
4 
e3E4 e4E4 
0.816793 0.828403 
1.76537 1. 81181 
3.34634 3.45083 
5.55969 5.74545 
We can see that by fitting the data we have lost the reference risk of 1.0. Since the fitting of the curve to the original 
data was good and the relative risk between the genotypes remains the same then this difference will not cause signifi-
cant changes to the selection of apo E, in which we are interested. 
Printed by Mathematica for Students 
287 
Appendix 5.nh 288 
• apo E X Exercise 
In the discussion on the way that exercise affects HDL and its association with Apo E, we concluded that the effect of 
exercise on blood lipoproteins was higher in individuals that exhibited initially high HDL associated relative risk. Thus 
that exercise will be more beneficial for the E4 carriers than for those with the E2. SO in a similar way to diet, we will 
expect that there is a level of exercise in which there will be no differences between the genotypes, while for less 
physical activity the relative risk will be higher. As in the previous cases we will use the data by Stampfer et al (2000) 
with the addition of a point for x=() that will stand for the point of common risk between the genotypes. 
datacurv •• LiatP1ot[{1.0, 1.05, 1.18, 1.23, 1.41}, P1otJoined .... True] 
1.4 
1.3 
1.2 
1.1 
2 3 4 5 
• Graphics. 
ccStatiatica'Lin.arR.gr.aaion' 
R.gr .. a[{1.0, 1.05, 1.18, 1.23, 1.U}, {l, x"2}, x] 
{parameterTable .... 1 
x2 
Estimate 
0.992235 
0.0165241 
SE 
0.0204706 
0.00146294 
RSquared .... 0.977026, AdjustedRSquared .... 0.969367, 
EstimatedVariance .... 0.000800428, ANOVATable .... 
Model 
Error 
Total 
OF 
1 
3 
4 
SumOfSq 
0.102119 
0.00240128 
0.10452 
MeanSq 
0.102119 
0.000800428 
TStat 
48.4711 
11.2951 
FRatio 
127.58 
PValue 
0.0000193356, 
0.00148825 
PValue 
0.00148825} 
fitlin.ar.P1ot[O.9922+0.016sx2 , {x, 1, 5}, P1otStyl ..... {{Dashing[{O.Os, O.Os})}}] 
1.4 / 
/ 
1.3 / 
/ 
/ 
1.2 /' 
/' 
1.1 
2 3 5 
• Graphics. 
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Show[ datacurve, fi tlinear] 
data. {1.0, 1.05, 1.18, 1.23, 1.41} 
datalinear.Table[0.9922+0.0165x2 , {x, 1, S}] 
1.4 
1.3 
1.1 
2 1 4 5 
• Graphics· 
{1., 1. OS, 1.18, 1.23, 1.41} 
{1.0087, 1.0582, 1.1407, 1.2562, 1.4047} 
We can see that the model fits the data very closely. Now we can make predictions for the risk factors for the rest of 
genotypes setting this curve as the one corresponding to the E3eJ genotype. 
For the E2E2 genotype 
Clear[tl22], 
[ n!.l (0.9922 + tl22 x2) ] Solve - 0.8279, tl22 II!.1 (0.9922+0.0165x2) 
tl22. Select (Table [tl22 I. \), Poaitive) 
{(t322 -t - O. 991987}, {t322 -t - O. 270305}, (1322 -t - 0 .101076 - 0.0840309 i), 
(t322-t-0.101076+0.0840309i), {t322-t0.0122493» 
(0.0122493) 
We require only the real and positive solutions so in this case the only acceptable solution is for P22 = 0.0123. 
Similarly for the E2f3 genotype 
Clear[tl23) , 
[ n!.l (0.9922+tl23x2) ] Solve - 0.9099, tl23 II!.1 (0.9922+0.0165x2) 
tl23 • Select [Table [tl23 I. \], poaitive) 
{{t323-t-0.991966}, (t323-t-0.271954), {t323-t-0.10131-0.0869627i}, 
{t323 -t -0.10131 + 0.0869627 i}, {t323 -t O.0143447}} 
{0.0143447} 
The E2E4 genotypes and the E3f3 genotypes were considered equal so they also share the same slope 
~.O.0165, 
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For the £3E4 genotype 
Clear [,s34] I 
r 
n!.1(O.9922+J334x2) 
Solve =1.l093,,s34] 
II!.1 (O.9922+0.0165x2 ) 
1334. Select[Tab1e[J334/. '], Positive] 
{{t334 ~ -0. 991915}, {t334 ~ -0.275724}, {t334 ~ -0.101747 - 0.093324 i}, 
{t334 ~ -0.101747+ 0.093324 i}, {t334 ~ 0.0189388}} 
{0.0189388} 
And finally for the E4E4 genotype 
Clear[J344] I 
n!.l (0.9922 + 1344 x2) 
Solver .. 1.2305, ,s44] 
II!'1 (0.9922 + 0.0165 x 2) 
1344. Select[Table[J344/. 'I, podtive) 
{{t344 ~ - O. 991884}, {t344 ~ -0. 277872}, {t344 -+ -0.101946 - 0.0967685 i}, 
{t344 ~ - 0 .101946 + 0.0967685 i}, {t344 -+ O. 0214526}} 
{0.0214526} 
aUgenot. Plot[(O.9922 + 1J22 X2, 0.9922 + 1J23 x2, 
0.9922+lJx2, 0.9922+Jl34x2, 0.9922+IJ44x2}, {x, 0,5») 
TablePona[Table [{ 0.9922 + Jl22 X2, 0.9922 + 1J23 X2, 0.9922 + JI x2, 
O.9922+IJ34x2, 0.9922+IJ44x2), {x, 0, 5}), 
TableRe.ding_ -> {None, {-a2a2-, -a2a3-, -.363/62.4-, -.364-, -64e4-}}) 
1.5 
1.4 
1.3 
1.2 
1.1 
1 :I 3 4 5 
• Graphics. 
e2&2 e2&3 &3&3/&2&4 e3&4 &4e4 
0.9922 0.9922 0.9922 0.9922 0.9922 
1.00445 1. 00654 1. 0087 1. 01114 1.01365 
1.0412 1.04958 1.0582 1.06796 1. 07801 
1.10244 1.1213 1.1407 1.16265 1.18527 
1.18819 1.22172 1.2562 1. 29522 1.33544 
1.29843 1.35082 1.4047 1.46567 1. 52851 
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Appendix~ Mathematica notebook for the comparison of statistical 
distributions and the Gompertz curve. 
« St2tistics'ContinuousDistributions' 
« St2tistics'NormalDistribution' 
« St2tistics'DescriptiveStatistics' 
« Graphics'Arrow' 
« Graphics'Colon' 
« Statistics'LinearRegression' 
First we construct a modified Gompertz curve describing the probability of death at each age for the population. 
a := 3.5136410-5 
p := 0.093832 
122 
meanLlreSpar(IJ = L II (r-rplY-tldy -,--"P(Yldy); 
• .0 
GomperotlJ = r-Cp(Y-tldy _,--"p(Yldy; 
Print["Gompertz Curve"] 
GompertzPDF = Plot[Gomperotl], (lI, 0, US), 
AlesLabel ... (Of age", "Probability or death"), PlotRange ... All, 
AlesOrigin'" (meanLifeSpan{I], O), Ticks ... None] 
Print["Mean Life Span ->", meanLlfeSpan{l)) 
Gompertz Curve 
Probability of death 
age 
• Graphics. 
Mean Lit. Span ->78.4683 
The y-axis meets the x-axis at the point of the mean age of the distribution. 
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Then we can construct a probability density function (PDF) of a normal distribution with the same mean and range, 
calculated from the expected values for the Gompertz model. 
SimpleDistr = NormalDistribution[ meanLifeSpan[x], 
[
122 ) 
" ~ (x - meanLifeSpan[x]i (e-.rp[Y-I] dy _ e-.J;;xP[y]dY) ]; 
FisberMeanLong = Mean[FisherDistr]; 
ormalPDF = Plot[pDF[ impleDistr, x], {x, 0, 125}, 
Axe Label-+ {"age" "Probability of death"}, PlotRange -+ All, 
e Origin -+ {meanLife pan[x], OJ, Ticks -+ None, PlotStyle -+ Red] 
Probability of death 
------~-------4--------~-- age 
- Graphics -
Another very popul r dj lribution in demographic analy i is the Logistic distribution. 
param t r og t= ;(,,( X~( -meaoLIt: pan[ ])2(e-r.PfY-tJdy_e-£P[)']dy))} 
LoW tiePD = Plotfl'D fLog! tieDI tribudon[meanLife pan[x), parameterLogis~, x), 
I ,0, 12 ), L b l-t ("a(: ", "ProbabUity of deatb"), PlotRange -+ AU, 
rlWD -t (m 0 It: pan{ J, OJ, Ticks -t one, Plot tyle -t BlueViolet) 
Probability of de t h 
a ge 
- Gr phics -
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Finally we construcl an Extreme Value distribution for the minimum using the parameters of the modified Gompertz 
curve. 
parameterE tr me= ~ [ 
10.5822 
PDF[ExtremevalueDistribution[a , b l , x l 
E trPDF = Plot[pDF[E treme alueDi tributior(-8S, parameterExtremti, - x), {x, - 8, 120}, 
PlotRange -+ 11. Origin -+ (-Mean[ExtremeValueDistributior(-8S, parameterExtremti), OJ, 
Ticks -+ l one, Plot lyle -+ Blue) 
- Gr phic8 -
Tfwe compare al1 of Ihem togetb r we can ee bow clo ely imilar are the Extreme Value distribution for the minimum 
and our model. 
Sbow(GompertzPDr, NormalPDP, LogisticPDP, ExtrPDPj 
Prob bility of de th 
age 
- Graphic. -
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Appendix 7. Mathematica notebook for the calculation of the Gomp-
ertz and Gumbel distribution parameters. 
« Statistics'LinearRegression' 
< < Statistics'DescriptiveStatistics' 
The data for the probability of death at each age and their graph can be seen below. 
data = {615.9, 46.5, 28.2, 18.4, 15.5, 11.2, 14.4, 12.6, 11.1, 10.4, 12.7, 12.2, 16.1, 16.9, 22.0, 23.5, 36.7, 
58.1, 76.7, 77.7, 77.0, 79.9, 79.5, 82.1, 88.9, 85.3, 84.0, 93.6, 89.8, 100.9, 95.9, 102.7, \05.3, \09.5, 
114.8, 116.9, 121.6, 128.3, 134.2, 148.1, 159.7, 170.9, 180.1, 190.1, 209.8, 233.6, 265.6, 291.4, 308.4, 
353.9, 384.2, 400.7, 433.4, 481.1, 524.6, 581.7, 660.7, 731.1, 785.6, 871.9, 963.3, 1053.9, 1139.3, 
1232.7, 1326.3, 1481.5, 1613.8, 1775.9, 1894.2, 2079.4, 2237.8, 2437.5, 2611.8, 2796.0, 2957.9, 3126.5, 
3239.7, 3384.2, 3491.2, 3535.9, 3508.7, 3533.9, 3605.7, 3690.5, 3592.7, 3473.1, 3236.9, 2999.0, 
2828.7, 2531.3, 2190.0, 1868.0, 1632.7, 1347.0, \098.9, 869.8, 655.2, 516.9, 359.3, 243.4, 166.5} ; 
LlstPlot[ data, 
AxesLabel .... ("age", "Number of deaths")] 
Number of deaths 
3500 
3000 
2500 
2000 
1500 
1000 
500 
20 
- Graphics-
40 
. 
. 
. 
. 
. 
. 
.. 
.. 
.... 
"" .. 
60 
Predicted by the given frequencies of deaths per age 
100 
total = ~ data[(l)); 
1=1 
data[[x)) 
PDF = Table[ , (x, I, 100}]; 
total 
100 
meanvalue= ~ PDF[[x]) x; 
s=1 
Prlnt["Mean Is ", meanvaluel 
Mean is 75.9604 
Predicted by a rounded frequency population 
. 
. . 
.¥ • 
• 
. 
. 
80 
. 
. 
• . 
. 
100 
DataLlst = Flatten[Table[Table[x, (I, 1, Round[data[[x))])], (x, 1, 100}]]; 
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meanSim = N[Mean[DataList)); 
Print["Mean is ", meanSim] 
varianceSim = N[Variance[DataList]]; 
Print["Variance is ", varianceSim] 
SD = .yN[Variance[DataList]] ; 
Print["Standard deviation is ", SD] 
Mean is 75.9591 
Variance is 214.711 
Standard deviation is 14.9907 
It can be easily seen that the shape of the data corresponds to the prediction of the Gompertz law as seen earlier 
295 
The data for the natural logarithm of the mortality in the population together with their graph can be seen below. To 
accurate calculate the slope of the line we have to avoid child mortality, which is not accounted by the Gompertz model. 
The most accurately part of the curve to calculate the Gompertz parameters is between 6-99 years. 
Indata = Drop[Drop[{-5.086760684, -7.667042262, -8.16653632, -8.595154733, -8.765654551, -9.088122739, 
-8.838776816, -8.971323472, -9.097011687, -9.171119659, -8.963480294, -9.003326203, 
-8.721760357, -8.679712121, -8.412833176, -8.347450417, -7.899308495, -7.440485738, 
-7.162647529, -7.148553766, -7.156216638, -7.119711641, -7.123426815, -7.090476916, 
-7.010896038, -7.050471581, -7.064409089, -6.955895654, -6.996586493, -6.879167822, 
-6.928978915, -6.858965115, -6.832647806, -6.793534135, -6.744786451, -6.725433722, 
-6.685412048, -6.630123542, -6.584223554, -6.483141352, -6.406374114, -6.336775732, 
-6.282886939, -6.227186881, -6.12613945, -6.016577248, -5.885304351, -5.789667214, 
-5.730023786, -5.588937083, -5.502884532, -5.456375671, -5.373687674, -5.264302488, 
-5.17238981, -5.063087154, -4.928824919, -4.820097583, -4.739730679, -4.626189553, 
-4.516061011, -4.414715129, -4.324210659, -4.231539801, -4.143072728, -4.015496414, 
-3.910973556, -3.793973339, -3.705984922, -3.586539496, -3.483948754, -3.365897808, 
-3.260427252, -3.151754704, -3.050441923, -2.945096195, -2.854493162, -2.750169912, 
-2.651915645, -2.565561545, -2.49362454, -2.399911304, -2.283684833, -2.151625213, 
-2.05657694, -1.956042306, -1.879574806, -1.796888601, -1.679683354, -1.59641804, 
-1.531778041, -1.467343909, -1.358616939, -1.283737773, -1.197662755, -1.116111511, 
-1.066958187, -0.927508415, -0.883022798, -0.846713365, -0.777888409}, 5], -1]; 
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IndataPlot = ListPlot[lndataJ 
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. 
• Graphics. 
Now we can fit a line to the data considering the equation: 
y(x)= Ln(a) + f3 x 
Regress[lndata., {t, xl, xJ 
{ParameterTable "'* 1 
x 
Estimate 
-9.25216 
0.0877779 
SE 
0.0584783 
0.00105784 
TStat 
-158.215 
82.9788 
PValue 
O. 
O. 
RSquared "'* 0.986673, AdjustedRSquared "'* 0.98653, EstimatedVariance "'* 0.0799424, 
Model 
ANOVATable",* E 
rror 
Total 
DF 
1 
93 
94 
Solve[Log[aJ = -9.252156, aJ 
([0' "'* 0.0000959047)} 
SumOjSq 
550.442 
7.43465 
557.877 
MeanSq 
550.442 
0.0799424 
FRatio 
6885.48 
So the Gompertz parameters for ages 6-99 will be a = 0.0000959047 andf3 = 0.0877779 
In regRession Plot = Plot[-9.252156 + 0.0877779 s, (x, I, 94}); 
20 40 60 80 
-2 
-4 
-6 
-8 
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Show[1ndataPlot, lnregRessionPlotl 
20 40 60 80 
-4 
-8 
• Graphics. 
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//Fotios I)renos 
iI26-08-2003 
//V'ersion 1.1 
liAr! alternative way to work the llpo-E 
Ilmodel for fast times using c++ 
/!Header files used 
'include ciostream> 
II'include <process.h> 
'include <time.h> 
.include <gsl/gal rng.h> 
'include <gsl/gsl-randist.h> 
'include <math.h>-
'include <sstream> 
'include <string> 
'include <fstream> 
#include <cstdlib> 
'include <ctime> 
'include <8ys/types.h> 
'include <uni8td.h> 
using namespace std; 
//Definitions of program variables 
gsl_rng *r; 
canst gsl_rn9_type *Ti 
long seed; 
int female genotype; 
int male_genotype; 
'define MIN (X, Y) «X) < (Y)? (X) (y)) 
IIInline function for the construction of the curve sum 
inline double temp_aum(int age, double total_risk) { 
double alpha _ 3.51364 * pow(10.0, -5.0); 
double beta - 0.093832; 
double temp; 
temp - (pow(M E, -(total risk * alpha * 
(-(1 I beta> + (pow (M_E, -beta + age *beta) I 
beta)))) - pow(M E, -(total risk * 
alpha * (-(1 I beta) + (pOW(M E, age * beta) / 
beta I) I) ) ; -
return (temp); 
/IFunction for random number generator of an Extreme value 
Iidistribution for the minimum. also known as log-Weibull and 
IIGumbel type I distribution. 
double gsl ran gumbelcustom (const gsl rng * r, canst double a, canst 
double b) - - -
{ 
double x _ gsl_rng_uniform-POs (r); 
double z _ a + b * log(log(l / (1 - x))); 
return Z; 
//Female risk factor 
double freq2, freq3, freq4; 
double frq22, frq23, frq33, frq24 , frq34, frq44; 
double female (double frq22,double frq23,double frq33, 
double frq24,double frq34,double frq44) 
int diet, alcohol, smoking, exercise; 
int sex. 1; 
//Random numbers definitions 
double random genotype _ g81 rng uniform(r); 
double random=diet - gsl_rng=uniform(r); 
double random alcohol - gsl rng uniform(r); 
double random smoking - gsl rng uniform(r); 
double random=exercise - gsl_rng_uniform(r); 
double random genotype temp - random genotype; 
double random-diet temp - random diet; 
double random alcohol temp - rando; alcohol; 
double random:smoking:temp - random=smokin9; 
double random_exercise_temp • random_exercise, 
//Parameters of the normal curve 
double sex risk, diet risk, alcohol risk, smoking risk, 
exer~ise_risk, total_risk; - -
int agel _ 0; 
int age2 • 0; 
double tempI - 0; 
double temp2 - 0; 
double temp3 _ 0; 
double temp4 - 0, 
double alpha _ 3.51364 * pow(lO.O, -5.0); 
double beta - 0.093832; 
double mean_of_distribution - 0; 
IIGenotype declaration 
if (random_genotype_temp <- frq22) { 
female genotype - 22; } -
else if (random_genotype_temp <- (frq22 + frq23)) { 
female genotype - 23; } -
elae if (random_genotype_temp <- (frq22 + frq23 + frq33)) { 
female_genotype. 33; 
} 
else if (random_genotype_temp <- (frq22 + frq23 + frq33 + frq24» 
female genotype - 24; } -
else if (random_genotype_temp <-
(frq22 + frq23 + frq33 + frq24 + frq34» ( 
female genotype - 34; ) -
else if (random_genotype_temp <-
(frq22 + frq23 + frq33 + frq24 + frq34 + frq44» ( 
female genotype - 44; ) -
elae 
cout « "error in genotype declaration- « "\n"; 
IIDiet group selected 
if (random_diet_temp <- 0.00) I 
diet _ 0; 
} 
else if (random_diet_temp <- 0.200) I 
diet - 1; 
} 
else if (random diet temp <- 0.679) 
diet - 2; - -
) 
else if (random diet temp <- 0.715) ( 
diet. 3; - -
) 
else if (random_diet_temp <- 0.918) I 
diet - 4, 
) 
else if (random_diet_temp <- 1.00) ( 
diet - S; 
) 
else { 
cout « "error in diet selection" « "\n"; 
//diet _ 5; 
I/Alcohol consumption group selected 
if (random_alcohol_temp <- 0.33) ( 
alcohol - 1; 
) 
else if (random alcohol temp <- 0.52) 
alcohol - 2~ -
) 
else if (random alcohol temp <- 0.66) 
alcohol - 3~ -
) 
else if (random alcohol temp <- 0.76) 
alcohol. 47 -
) 
else if (random_alcohol_temp <- 0.86) ( 
alcohol - 5; 
) 
elae if (random alcohol temp <- 0.90) 
alcohol - 6i - -
) 
elae if (random_alcohol_temp <_ 1.00) { 
alcohol - 7; 
else 
cout « "error in alcohol selection" « "\n"; 
) 
{{alcohol _ 1; 
IISmoking group selected 
if (random_smoking_temp <- 0.44) ( 
smoking - 1; 
) 
else if (random_smoking_temp <- 0.7S){ 
smoking _ 2; 
) 
else if (random_smoking_temp <_ O.SS){ 
smoking - 3; 
) 
else if (random_smoking_temp <- 1.0)1 
smoking. 4; 
) 
else 
cout « "error in smoking selection" « "\n"; 
Iismoking - 4; 
IIPhysical activity group selected 
if (random exercise temp <- 0.00) 
exercise-. 1; -
) 
else if (random_exercise_temp <- 0.19) ( 
exercise • 2; 
) 
else if (random_exercise_temp <- 0.40) ( 
exercise - 3; 
) 
else if (random_exercise_temp <- 0.60){ 
exercise • 4; 
) 
else if (random_exercise_temp <- 0.77) ( 
exercise _ 5; 
) 
else if (random_exercise_temp <- 1.00) ( 
exercise. 6; 
) 
else 
cout « ·error in exercise selection· « "\n"; 
//exercise • 6; 
//Sex assosiated risk 
if (sex -- 0) ( 
sex risk - 0.58; ) -
else if (sex __ 1) ( 
sex risk. 1.01 ) -
else { 
cout « "fail to allocate sex" « ·\n"; 
IIApO R x Diet risk factors 
if (female_genotype .- 33) 
if (diet •• 01 { 
diet risk. 0.9442; } -
else if (diet •• II { 
diet risk. 0.9842; } -
else if (diet •• 21 ( 
diet risk. 1.1042; ) -
else if (diet •• 31 ( 
diet risk. 1.3042, ) -
else if (diet •• 41 ( 
diet risk. 1.5842; ) -
else { 
diet risk. 1.9442, } -
} 
else if (female_genotype •• 341 ( 
if (diet •• 01 ( 
diet risk. 0.9442, ) -
else if (diet •• II ( 
diet risk. 0.98725, ) -
else if (diet •• 21 { 
diet risk. 1.1164; } -
else if (diet •• 3) { 
diet risk. 1.33165; } -
else if (diet •• 4) ( 
diet risk. 1.6331 ) -
else ( 
diet risk. 2.02046; ) -
} 
else it (female_genotype •• 23) ( 
if (diet •• 0) ( 
diet risk. 0.9442, ) -
else it (diet •• 1) ( 
diet risk. 0.981499, ) -
else if (diet •• 21 ( 
diet risk. 1.09339; ) -
else it (diet •• 31 { 
diet risk. 1.27989; } -
else it (diet •• 4) ( 
diet risk. 1.54098, ) -
else ( 
diet risk. 1.87666, ) -
else if (female_genotype •• 44) { 
if (diet •• 0) { 
diet_risk. 0.9442; } 
else if (diet •• II ( 
diet_risk. 0.990388, ) 
else if (diet •• 21 ( 
diet_risk. 1.12895; ) 
else if (diet •• 31 ( 
diet_risk. 1.35989, ) 
else if (diet •• 41 ( 
diet_risk. 1.6832; ) 
else ( 
diet_risk. 2.09889; ) 
else if (female genotype •• 24) ( 
if (diet •• -0) ( 
diet risk. 0.9442; ) -
else if (diet •• 1) ( 
diet risk. 0.9842, ) -
else if (diet •• 2) ( 
diet_risk. 1.1042; 
) 
else if (diet •• 3) ( 
diet_risk. 1.3042; 
) 
else if (diet •• 4) ( 
diet risk. 1.5842; ) -
else ( 
diet_risk. 1.9442, 
) 
} 
else if (female_genotype •• 22) ( 
if (diet •• 0) ( 
diet risk. 0.9442; ) -
else if (diet •• 1) { 
diet risk. 0.978866; } -
else if (diet •• 2) ( 
diet risk. 1.08287; ) -
else if (diet •• 31 { 
diet risk. 1.2562; } -
ehe if (diet •• 4) ( 
diet risk. 1.49886; ) -
elae { 
diet_risk. 1.81086, 
} 
else { 
cout « "error in genotype-diet selection" « "'n", } 
//Ape E x Alcohol risk factors 
if (female_genotype _. 33) { 
if (alcohol •• 1) { 
alcohol risk. 1.7119; } -
else if (alcohol ._ 2) { 
alcohol risk. 1.3164; } -
else if (alcohol ._ 3) { 
alcohol risk. 1.0791; } -
else if (alcohol ._ 4) { 
alcohol risk. 1.00; } -
else if (alcohol ._ 5) 
alcohol risk. 1.0791; } -
else if (alcohol ._ 6) 
alcohol risk. 1.3164; } -
else { 
alcohol risk. 1.7119; } -
} 
else if (female genotype •• 34) 
if (alcohol-•• 1) ( 
alcohol risk. 1.7631; } -
else if (alcohol ._ 2) { 
alcohol risk. 1.33915; } -
else if (alcohol ._ 3) { 
alcohol risk. 1.08479; } -
else if (alcohol _. 4) { 
alcohol risk. 1.00; } -
else if (alcohol ._ 5) { 
alcohol risk. 1.08479; } -
else if (alcohol ._ 6) { 
alcohol risk. 1.33915; } -
elae { 
alcohol risk. 1.7631; } -
} 
else if (female_genotype ._ 23) 
if (alcohol.. 1) { 
alcohol risk. 1.6631; } -
else if (alcohol ._ 2) { 
alcohol risk. 1.29614; } -
elae if (alcohol ._ 3) { 
alcohol riak • 1.07403; } -
elae if (alcohol __ 4) { 
alcohol_risk. 1.0; 
else if (alcohol _. 5) { 
alcohol risk - 1.07403; } -
elae if (alcohol •• 6) { 
alcohol risk _ 1.29614; } -
else ( 
alcohol risk - 1.66631; } -
else if (female genotype •• 44) 
if (alcohol-.- 1) { 
alcohol risk _ 1.81546; } -
else if (alcohol __ 2) { 
alcohol risk - 1.36243; } -
else if (alcohol __ 3) { 
alcohol risk - 1.09061; } -
else if (alcohol __ 4) { 
alcohol risk. 1.0; } -
else if (alcohol ._ 5) { 
alcohol risk - 1.09061; } -
else if (alcohol ._ 6) { 
alcohol risk - 1.36243; } -
else { 
alcohol risk. 1.81546; } -
} 
else if (female_genotype ._ 24) 
if (alcohol ._ 1) { 
alcohol risk. 1.7119; } -
elae if (alcohol •• 2) { 
alcohol risk. 1.3164; } -
else if (alcohol __ 3) { 
alcohol risk. 1.0791; } -
else if (alcohol __ 4) { 
alcohol risk. 1.00; } -
else if (alcohol ._ 5) 
alcohol risk - 1.0791; } -
else if (alcohol ._ 6) 
alcohol risk. 1.3164; } -
else ( 
alcohol risk. 1.7119; ) -
e188 if (female genotype ._ 22) 
if (alcohol-__ 1) { 
alcohol risk. 1.62166; } -
else if (alcohol -_ 2) { 
alcohol risk - 1.27629; } -
else if (alcohol __ 3) ( 
alcohol risk - 1.06907; ) -
else if (alcohol __ 4) ( 
alcohol risk - 1.00; ) -
else if (alcohol __ 5) 
alcohol risk - 1.06907; } -
else if (alcohol __ 6) { 
alcohol risk - 1.27629; } -
else { 
alcohol risk - 1.62166; } -
} 
else ( 
cout « -error in genotype-alcohol selection- « -\n"; ) 
I/ApO E x smoking risk factors 
if (female_genotype _. 33) { 
if (smoking •• 1) ( 
smoking_risk - 0.8055; ) 
else if (smoking -_ 2) ( 
smoking_risk - 1.7202; ) 
else if (smoking _. 3) ( 
smoking_risk. 3.2447; 
) 
else I 
smoking_risk _ 5.379; 
} 
} 
else if (female_genotype •• 34) { 
if (smoking •• 1) I 
smoking risk. 0.816793; } -
else if (smoking _. 2) { 
smoking risk _ 1.76537; } -
else if (smoking _. 3) ( 
smoking risk - 3.34634; ) -
elae { 
smoking risk _ 5.55969; } -
} 
else it (female_genotype •• 23) { 
if (smoking •• 1) { 
smoking risk - 0.795492; } -
elae if (smoking -_ 2) ( 
smoking risk _ 1.68017; ) -
elae it (smoking -. 3) { 
smoking risk _ 3.15463; ) -
else ( 
smoking risk _ 5.21888; ) -
) 
else if (female_genotype -- 44) I 
if (smoking -- 1) I 
smoking_risk - 0.828403; } 
else if (smoking -- 2) I 
smoking_risk - 1.81181; } 
else if (smoking __ 3) { 
smoking_risk _ 3.45083; 
} 
else ( 
smoking_risk _ 5.74545; 
) } 
else if (female_genotype __ 24) 
if (smoking _. 1) I 
smoking_risk. 0.8055; 
) 
else if (smoking __ 2) { 
smoking_risk _ 1.7202; 
} 
else if (smoking __ 3) { 
smoking_risk. 3.2447; 
} 
else { 
smoking_risk _ 5.379; 
} 
else if (female_genotype _. 22) { 
if (smoking -. 1) { 
smoking risk _ 0.785735; } -
else if (smoking _. 2) ( 
smoking_risk _ 1.64114; 
) 
else if (smoking _. 3) ( 
smoking_risk _ 3.06682; 
) 
else { 
smoking risk _ 5.06277; } -
} 
else ( 
cout « -error in genotype-smoking selection- « "\0"; ) 
//Apo E x Exercise risk factors 
if (female_genotype ._ 33) { 
if (exercise -. 0) { 
exercise risk _ 0.9922; } -
e18e if (exercise •• 1) { 
exercise risk. 1.0087; } -
else if (exercise •• 2) { 
exercise risk. 1.0582; } -
else if (exercise •• 3) { 
exercise risk. 1.1407; } -
else if (exercise •• 4) { 
exercise risk. 1.2562; } -
else { 
exercise_risk. 1.4047; 
else if (female_genotype •• 34) 
if (exercise •• 0) { 
exercise risk _ 0.9922; } -
else if (exercise •• 1) { 
exercise risk - 1.01114; } -
else if (exercise •• 2) { 
exercise risk. 1.06796; } -
else if (exercise •• 3) { 
exercise risk. 1.16265; } -
else if (exercise •• 4) { 
exercise risk _ 1.29522; } -
else { 
exercise_risk _ 1.46567; 
} 
else if (female genotype •• 23) 
if (exercise ._ 0) { 
exercise risk. 0.9922; } -
else if (exercise •• 1) { 
exercise risk. 1.00654: } -
else if (exercise •• 2) ( 
exercise risk - 1.04958; ) -
else if (exercise •• 3) { 
exercise risk. 1.1213; } -
else if (exercise •• 4) { 
exercise risk. 1.22172; } -
else { 
exercise_risk. 1.35082; 
} 
else if (female genotype •• 44) 
if (exercise •• 0) { 
exercise risk. 0.9922; } -
else it (exercise •• 1) { 
exercise risk. 1.01365; } -
else if (exercise •• 2) { 
exercise_risk. 1.07801; 
else if (exercise •• 3) { 
exercise risk - 1.18527; } -
else if (exercise •• 4) { 
exercise risk _ 1.33544; } -
else { 
exercise_risk. 1.52851; 
else if (female genotype •• 24) 
if (exercise •• 0) { 
exercise risk - 0.9922; } -
else if (exercise •• 1) { 
exercise risk _ 1.0087; } -
else if (exercise •• 2) { 
exercise risk. 1.0582; } -
else if (exercise •• 3) { 
exercise risk - 1.1407; } -
else if (exercise •• 4) { 
exercise risk. 1.2562; } -
else { 
exercise risk. 1.4047; } -
else it (female genotype •• 22) 
if (exercise •• 0) ( 
exercise risk - 0.9922; } -
else if (exercise •• 1) { 
exercise risk _ 1.00445; } -
else if (exercise •• 2) ( 
exercise risk. 1.0412; ) -
else if (exercise •• 3) { 
exercise risk. 1.10244; } -
else if (exercise •• 4) ( 
exercise risk. 1.18819; ) -
else { 
exercise_risk. 1.29843; 
} 
else ( 
cout c< "error in genotype-exercise selection" c< ",n"; ) 
//Total risk 
total risk • sex risk • diet risk • alcohol risk • 
- smoking_risk • e~ercise_risk; -
liGumbell PDF curve parameters calculation 
while (agel <- 122) { 
++agel; 
temp1 - agel· temp_sum(age1, total_risk); 
temp2 +_ templ; 
} 
mean_of_distribution - temp2; 
while (age2 <- 122) 
++age2; 
temp3 - (age2 - mean of distribution)· 
(age2 - mean of distribution)" 
temp sum (age2, total risk); 
temp4 +_ - temp3 ; -
} 
double sigma - sqrt(temp4); 
double betaGumble _ sigma" sqrt(6.0) I 3.14159; 
double alphaGumble - mean_of_distribution + beta" 0.5772; 
double temp_ran_gumbelcustom _ gsl_ran_gumbelcustom(r, 
alphaGumble, betaGumble); 
double random_death_age - temp_ran_gumbelcustom; 
/*cout « -\nthe female genot~~ is • « female_genotype « 
·\n-
c< -total risk factor • « total riSK « -\n-
« ·che mean of the disribution • « mean_of_distribution 
« "\nlt 
-sigma is • « sigma « -\n-
« -random death age is •• « random_death_age « 
"\n";*/ 
return (random_death_age); 
liMale risk factor 
double male (double frq22,double frq23,double frq33, 
double frq24,double frq34,double frq44) 
int diet, alcohol, smoking, exercise; 
int aex - 0, 
//Random numbers definitions 
double random_genotype - gsl_rng_uniform(r); 
double random_diet - gsl_rng_uniform(r); 
double random_alcohol _ gsl_rng_uniform(r), 
double random_smoking - gsl_rng_uniform(r), 
double random_exercise _ gsl_rng_uniform(r), 
double random genotype temp _ random genotype, 
double random-diet temp - random diet, 
double random_alcohol_temp - random_alcohol; 
double random smoking temp - random smoking; 
double random=exercise_temp • random_exercise; 
IIParameters of the normal curve 
double sex risk, diet risk, alcohol risk, smoking risk, 
exercise_risk, total_risk~ - -
int agel - 0; 
int age2 • 0; 
double templ - 0; 
double temp2 - 0; 
double temp3 - 0; 
double temp. - 0; 
double alpha - 3.51364 • pow(10.0, -5.0); 
double beta _ 0.093832; 
double mean_of_distribution - 0; 
liGenotype declaration 
if (random_genotype_temp <- frq22) { 
male_genotype - 22; 
} 
else if (random_genotype_temp <- (frq22 + frq23» { 
male genotype - 23; } -
else if (random_genotype_temp <- (frq22 + frq23 + frq33» { 
male_genotype. 33; 
} 
else if (random_genotype_temp <- (frq22 + frq23 + frq33 + frq24» 
male_genotype. 24; 
} 
else if (random genotype temp 
(frq22 + frq23 + frq33-+ frq24 + frq34» { 
male3enotype • 34; 
} 
else if (random_genotype_temp <-
(frq22 + frq23 + frq33 + frq24 + frq34 + frq44» { 
male-.genotype • 44; 
} 
else 
cout « -error in genotype declaration- « -\n" 
« "random_genotype_temp - « random_genotype_temp 
« -\n-
« -with frq22 • « frq22 
« "\n(frq22 + frq23) " « frq22 + frq23 
« "\n(frq22 + frq23 + frq33) " « frq22 + frq23 + 
frq33 
« "\n(frq22 + frq23 + frq33 + frq24) " « frq22 + 
frq23 + frq33 + frq24 
« "\n(frq22 + frq23 + frq33 + frq24 + frq34) " « 
frq22 + frq23 + frq33 + frq24 + frq34 
« "\n(frq22 + frq23 + frq33 + frq24 + frq34 + 
frq44) " « frq22 + frq23 + frq33 + frq24 + frq34 + frq44 
« -,nit; 
IIDiet group selected 
if (random_diet_temp <- 0.00) 
diet - 0, 
} 
else if {random diet temp <- 0.200) I 
diet - 1; - -
} 
else if {random_diet_temp <_ 0.679) 
diet _ 2; 
} 
else if {random_diet_temp 0.715) I 
diet _ 3; 
} 
else if {random_diet_temp <- 0.918) I 
diet _ 4; 
} 
else if {random_diet_temp <- 1.00) I 
diet - 5; 
} 
else I 
} cout « "error in diet selection" « .\n.; 
{/diet _ 5; 
//Alcohol consumption group selected 
if {random_alcohol_temp <_ 0.33) { 
alcohol _ 1; 
} 
else if {random alcohol temp <_ 0.52) 
alcohol _ 2; -
} 
else if {random alcohol temp <_ 0.66) 
alcohol _ 3; -
} 
else if (random alcohol temp <_ 0.76) 
alcohol _ 4; -
} 
else if (random_alcohol_temp <_ 0.86) { 
alcohol - 5; } 
else if (random_alcohol_temp <_ 0.90) 
alcohol - 6; } 
else if (random_alcohol_temp <_ 1.00) I 
alcohol _ 7; 
} 
else 
} cout « "error in alcohol selection" « .\nw; 
//alcohol _ I, 
{/smoking group selected 
if (random_smoking_temp <- 0.44) I 
smoking - 11 
} 
elBe if (random_smoking_temp <_ 0.78)1 
smoking - 2; ) 
else if (random_smoking_temp <_ 0.85)1 
.making • 3; 
) 
else if (random_smoking_temp <_ 1.0)1 
smoking - 4; 
I 
else I 
} 
cout « "error in smoking selection" « ",n"; 
{{smoking. 4; 
//Physical activity group selected 
if {random_exercise_temp <_ 0.00) 
exercise. 1; 
} 
else if (random exercise temp <_ 0.19) 
exercise. 2; -
} 
else if {random_exercise_temp <- 0.40) I 
exercise. 3; 
} 
else if {random_exercise_temp <_ 0.60){ 
exercise •• ; 
} 
else if {random exercise temp <_ 0.77) 
exercise - 5;- -
} 
else if {random_exercise_temp <_ 1.00) { 
exercise - 6; 
} 
else 
} cout « "error in exercise selection" « "\n"; 
I!exercise • 0; 
//Sex assosiated risk 
if (sex -- 0) { 
sex risk. 0.58; } -
else if (sex -- 1) I 
sex risk. 1.0; } -
else I 
cout « "fail to allocate sex· « "'0"; 
} 
{{Apo B x Diet risk factors 
if (male_genotype -- 33) I 
if (diet -- 0) I 
diet risk. 0.9442; } -
else if (diet __ 1) I 
diet_risk - 0.9842; 
I 
else if (diet -- 2) I diet_risk _ 1.1042, 
} 
else if (diet -_ 3) I 
diet_risk - 1.3042, 
} 
else if (diet __ 4) I 
diet_risk. 1.5842; 
} 
else I 
diet_risk _ 1.9442; 
} 
elBe if (male~enotype -- 34) I 
if (diet •• 0) I 
diet risk. 0.9442; } -
else if (diet •• 1) I 
diet risk. 0.98725; } -
else if (diet •• 2) I 
diet risk. 1.1164; } -
else if (diet •• 3) I 
diet risk. 1.33165; } -
else if (diet •• 4) I 
diet risk. 1.633; } -
else I 
diet risk. 2.02046; } -
} 
else if (male_genotype •• 23) 
if (diet •• 0) { 
diet risk. 0.9442; } -
else if (diet •• 1) { 
diet risk. 0.981499; } -
else if (diet •• 2) { 
diet risk. 1.09339; } -
else if (diet •• 3) { 
diet risk. 1.27989; } -
else if (diet •• 4) { 
diet risk. 1.54098; } -
else { 
diet risk. 1.87666; } -
else 1f (male genotype •• 44) 
if (diet :. 0) { 
diet risk. 0.9442; } -
else if (diet •• 1) { 
diet risk. 0.990388; } -
else if (diet •• 2) { 
diet risk. 1.12895; } -
else if (diet •• 3) { 
diet risk. 1.35989; } -
else if (diet •• 4) { 
diet risk. 1.6832; } -
else { 
diet risk. 2.09889; } -
elae if (male_genotype •• 24) { 
if (diet •• 0) { 
diet_risk. 0.9442; } 
else if (diet •• 1) { 
diet_risk. 0.9842; } 
else if (diet •• 2) I 
diet_risk. 1.1042; 
} 
else if (diet •• 3) { 
diet_risk. 1.3042; } 
else if (diet •• 4) I 
diet_risk. 1.5842; } 
else { 
diet_risk. 1.9442; } 
} 
else if (male genotype •• 22) 
if (diet :. 0) { 
diet risk. 0.9442; } -
else if (diet •• 1) { 
diet risk. 0.978866; } -
else if (diet •• 2) I 
diet risk. 1.08287; } -
else if (diet •• 3) { 
diet risk. 1.2562; } -
else if (diet •• 4) I 
diet risk. 1.49886; } -
else { 
diet_risk. 1.81086; 
} 
elae { 
cout « -error in genotype-diet selection- « -\n-; 
I 
liApO E x Alcohol risk factors 
if (male genotype •• 33) { 
if (alcohol •• 1) I 
alcohol risk. 1.7119; } -
else if (alcohol •• 2) { 
alcohol risk. 1.3164; } -
else if (alcohol •• 3) { 
alcohol risk. 1.0791; } -
elBe if (alcohol •• 4) { 
alcohol risk. 1.00; } -
else if (alcohol •• 5) 
alcohol risk. 1.0791; I -
else if (alcohol •• 6) 
alcohol risk. 1.3164; } -
else ( 
alcohol risk. 1.7119; ) -
else if (male_genotype •• 34) ( 
if (alcohol •• 1) ( 
alcohol risk. 1.7631; ) -
elae if (alcohol •• 2) ( 
alcohol risk. 1.33915; ) -
elae if (alcohol •• 3) { 
alcohol risk. 1.08479; } -
elae if (alcohol •• 4) ( 
alcohol riak • 1.00; ) -
else if (alcohol •• 5) ( 
alcohol risk. 1.08479; ) -
else if (alcohol •• 6) ( 
alcohol risk. 1.33915; ) -
else { 
alcohol risk. 1.7631; } -
else if (male_genotype •• 23) { 
if (alcohol •• 1) { 
alcohol risk. 1.6631; } -
elae if (alcohol •• 2) { 
alcohol risk. 1.29614; } -
else if (alcohol •• 3) ( 
alcohol risk. 1.07403; ) -
else if (alcohol •• 4) { 
alcohol risk. 1.0; } -
else if (alcohol •• 5) { 
alcohol risk. 1.07403; } -
else if (alcohol •• 6) { 
alcohol risk. 1.29614; } -
else { 
alcohol riak • 1.66631, } -
} 
else if (male_genotype •• 44) { 
if (alcohol •• 1) { 
alcohol risk. 1.81546; } -
elae if (alcohol •• 2) { 
alcohol risk. 1.36243, } -
elae if (alcohol •• 3) { 
alcohol_risk. 1.09061; 
) 
else if (alcohol •• 4) ( 
alcohol risk. 1.0; ) -
e18e if (alcohol •• 5) ( 
alcohol risk. 1.09061; ) -
e18e if (alcohol •• 6) ( 
alcohol risk. 1.36243; ) -
else ( 
alcohol risk. 1.81546; ) -
elae if (male_genotype •• 24) { 
if (alcohol •• 1) { 
alcohol risk. 1.7119; } -
else if (alcohol •• 2) { 
alcohol risk. 1.3164; } -
else if (alcohol •• 3) { 
alcohol risk. 1.0791; } -
else if (alcohol •• 4) { 
alcohol risk. 1.00; } -
else if (alcohol •• 5) 
alcohol risk. 1.0791, } -
else if (alcohol •• 6) 
alcohol risk. 1.3164; } -
else { 
alcohol risk. 1.7119; } -
else if (male_genotype •• 22) { 
if (alcohol •• 1) { 
alcohol risk. 1.62166; } -
elaa if (alcohol •• 2) { 
alcohol risk. 1.27629; } -
elae if (alcohol •• 3) { 
alcohol risk. 1.06907; } -
else if (alcohol •• 4) ( 
alcohol risk. 1.00, ) -
else if (alcohol •• 5) { 
alcohol risk. 1.06907; } -
else if (alcohol •• 6) { 
alcohol ri.k • 1.27629, } -
else { 
alcohol risk. 1.62166; } -
} 
else { 
cout « -error in genotype-alcohol selection- « -\n.l } 
/IApe E x smoking risk factors 
if (male_genotype __ 33) { 
if (smoking •• 1) { 
smoking_risk - 0.8055; 
} 
else if (smoking ._ 2) { 
smoking risk - 1.7202; } -
else if (smoking .- 3) { 
smoking risk. 3.2447; } -
else { 
smoking risk. 5.379; } -
else if (male_genotype __ 34) { 
if (smoking __ 1) { 
smoking_risk _ 0.816793; 
} 
e1ae it (smoking ._ 2) { 
smoking_risk. 1.76537; 
} 
else if (smoking ._ 3) { 
smoking_risk - 3.34634; } 
else { 
smoking_risk - 5.55969; } } 
el.e if (male_genotype __ 23) { 
if (smoking -. 1) { 
smoking_risk _ 0.795492; 
} 
else if (smoking ._ 2) { 
smoking_risk _ 1.68017; 
} 
else if (smoking._ 3) { 
smoking_risk. 3.15463; 
} 
elae { 
smoking_risk. 5.21888; } 
else if (male_genotype __ 44) { 
if (smoking _. 1) { 
smoking_risk. 0.828403; 
} 
e1ae if (smoking ._ 2) { 
smoking_risk _ 1.81181; 
} 
el.e if (smoking ._ 3) { 
smoking_risk - 3.45083; 
} 
ehe I 
smoking risk. 5.74545; } -
else if (male_genotype __ 24) { 
if (smoking ._ 1) { 
smoking_risk - 0.8055; } 
else if (smoking __ 2) { 
smoking_risk - 1.7202; } 
else if (smoking -_ 3) { 
smoking_risk - 3.2447; } 
else { 
smoking_risk - 5.379; } 
} 
else if (male_genotype __ 22) { 
if (smoking ._ 1) { 
smoking risk _ 0.785735; } -
else if (smoking __ 2) { 
smoking risk _ 1.64114; } -
else if (smoking -. 3) { 
smoking risk - 3.06682; } -
else { 
smoking risk - 5.06277; } -
} 
else { 
cout « -error in genotype-smoking selection- « -\n-; } 
IIApO E x Exercise risk factors 
if (male_genotype •• 33) I 
if (exercise -- 0) { 
exercise risk. 0.9922; } -
else if (exercise -- 1) I 
exercise risk. 1.0087; } -
else if (exercise __ 2) { 
exercise risk. 1.0582; } -
e1ae if (exercise __ 3) { 
exercise risk _ 1.1407; } -
else if (exercise -- 4) I 
exercise risk _ 1.2562; } -
else { 
exercise_risk. 1.4047; 
} 
else if (male_genotype -- 34) I 
if (exercise __ 0) { 
exercise risk _ 0.9922; } -
el.e if (exercise __ 1) { 
exercise risk. 1.01114; } -
else if (exercise •• 2) { 
exercise risk - 1.06796; } -
else if (exercise •• 3) { 
exercise risk. 1.16265, } -
else if (exercise •• 4) { 
exercise risk. 1.29522; } -
else { 
exercise_risk. 1.46567, 
else if (male_genotype •• 23) { 
if (exercise •• 0) { 
exercise risk - 0.9922; } -
else if (exercise •• 1) { 
exercise risk. 1.00654; } -
else if (exercise •• 2) { 
exercise risk. 1.04958; } -
else if (exercise •• 3) { 
exercise risk. 1.1213, } -
else if (exercise •• 4) { 
exercise risk. 1.22172; } -
else { 
exercise risk. 1.35082; } -
} 
else if (male_genotype •• 44) { 
if (exercise ._ 0) { 
exercise risk. 0.9922; } -
else if (exerciss _. 1) { 
exercise risk. 1.01365; } -
else if (exercise _. 2) { 
exercise risk - 1.07801, } -
else if (exercise __ 3) { 
exercise_risk. 1.18527, 
else if (exercise _. 4) { 
exercise risk. 1.33544, } -
elae { 
exercise_risk. 1.52851, 
else if (male_genotype •• 24) { 
if (exercis • • _ 0) { 
exercise risk. 0.9922; } -
elae if (exercise ._ 1) { 
exercise risk. 1.0087, } -
else if (exercise ._ 2) { 
exercise risk - 1.0582; } -
else if (exercise •• 3) { 
exercise risk - 1.1407; } -
else if (exercise •• 4) { 
exercise risk. 1.2562, } -
else { 
exercise_risk. 1.4047; 
e18e if (male_genotype •• 22) { 
if (exercise •• 0) { 
exercise risk _ 0.9922; } -
else if (exercise ._ 1) { 
exercise risk. 1.00445; } -
else if (exercise •• 2) { 
exercise risk _ 1.0412; } -
else if (exercise •• 3) { 
exercise risk _ 1.10244; } -
else if (exercise •• 4) { 
exercise risk. 1.18819, } -
else { 
exercise_risk. 1.29843; 
} 
else { 
cout « "error in genotype-exercise selection" « "\n"; } 
//Total risk 
total risk - sex risk * diet risk • alcohol risk • 
- smoking_risk • e~ercise_risk; -
//Normal curve parameters calculation 
while (agel <_ 122) ( 
++agel, 
templ • agel. temp sum(agel, total risk), 
temp2 +. tempI, - -
} 
mean_of_distribution _ temp2; 
while (age2 <_ 122) 
++age2; 
temp] • (age2 - mean of distribution). 
(age2 - mean of distribution). 
temp_8um(age2, total_risk), 
temp4 +- temp3, 
} 
double sigma _ aqrt(temp4), 
double betaGamble • sigma • aqrt(6.0) I 3.14159, 
double elphaGumble - mean_of_distribution + bete • 0.5772; 
double temp ran gumbelcustolll - gsl ran gumbelcustOll(r, 
alphaGumble, betaGumble), - -
double randOM_deeth_age _ temp_ran_gumbelcustom, 
,*cout « w\nthe male genotype is • « male_genotype « -\nw 
·cotal risk factor· « total risk « "\nB 
-the mean of the disribution ~ « mean_of_distribution 
« '"\n" 
« ·sigma is • « sigma « "\n" 
« -randOM death age is ... « random_death_Bge « 
'"\n'";*/ 
return (random_deeth_age); 
i/Function to add an array 
int sum int errey(int pt!],int n) { --
int temp _ 0; 
for (int i - 0, i c n; ++i) 
temp +_ pt!i]; 
return tempi 
I!Generat ing the number of offspring per couple 
int number_of_offspring (void) { 
0, 0, 
double fecundity!51] - {O, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 
0.007800, 0.007800, 0.007800, 0.007800, 0.007800, 0.051700, 
0.051700, 0.051700, 0.051700, 0.051700, 0.128300, 0.128300, 
0.128300, 0.128300, 0.128300, 0.116700, 0.116700, 0.116700, 
0.116700, 0.116700, 0.0~3000, 0.043000, 0.0~3000, 0.043000, 
0.043000, 0.006700, 0.006700, 0.006700, 0.006700, 0.006700, 
0.000200, 0.000200, 0.000200, 0.000200, 0.000200, oj; 
double Opt_fecundity • 0; 
pt_fecundity • fecundity; 
int offspring!51]; 
int *pt offspring; 
pt_offspring _ offspring; 
int female fin age - (int) female (frq22, frq23, frq33, frq24, 
frq3~, frq~4); - -
int male_fin_age - (int) male (frq22 , frq23, frq33, frq24 , frq34 , 
frq44); 
II int temp. min(50, min (female_fin_age, male_fin_age»; 
int tempi, 
int temp; 
IIAlternative to min function 
I*if (female fin age <~ male fin age) { - - - -
templ=female_fin_age; 
else 
{ 
templ~male_fin_age; 
J 
if (50 <_ tempI) 
{ 
temp= 50 i 
} 
else 
{ 
temp-templ; 
J*/ 
temp _ MIN(50, MIN(female_f in_age , male_fin_age»; 
for (int life - 0; life c- temp; 1ife++) 
Opt offspring++ • gsl ran bernoulli(r, Opt fecundity++); 
int total=no • sum_int_array(offspring, temp); -
/·cout « '"\nfemale death age" « female fin age « "'n" 
« "male death age· « male fin age «-·,n" 
« "number of offspring" «-tot;l_no « "\n";*/ 
return (total_no); 
std::string convertToString(int x) 
{ 
std::ostringstream 0; 
if (0 c< x) 
return a.strO I 
1/ some sort of error handling goes here ... 
return -conversion error-; 
int convertFromString(canst std::string_ s) 
( 
.td::istringstream i(.); 
int X; 
if (i u x) 
return XI 
II some sort of ~rror handling goes here ... 
return 0; 
I/Finding the genotype of the offspring 
int offspring_genotype (void) ( 
int temp female genotype. female genotype; 
int temp=male_genotype • male_genotype; 
std::string female_genotype_string • convertToString 
(temp_female_genotype); 
std::string male_genotype_string • convertToString 
(temp_male_genotype); 
char offspring_char [3) • {. " • ' •• \O'}; 
char ·pt_offspring_char • offspring_char; 
int random_offspring_temp • gsl_rng_uniform_int(r, 100); 
int random_offspring - random_off spring_temp; 
if (random offspring < 25) 
pt offspring charCO) • female genotype string[O); 
pt=offspring=char[l) • male_genotype_string[O]; 
else if (random offspring < 50) { 
pt_offsprlng_char[O] • female_genotype_string[O]; 
pt_offspr1ng_char[1] • male_genotype_string[l]; 
else if (random_offspring < 75) { 
pt offspring charCO] • female genotype string[l]; 
pt=offspring=char[l] • male_genotype_string[O]; 
else if (random_offspring < 100) ( 
pt_offspring_char[O] • female_genotype_string[l]; 
pt_offspring_char[1) • male_genotype_string[1) , 
else 
cout « "error in offspring char" « "\n"; 
int temp-part1 - offspring_charCO]; 
int temp-part2 - offspring_char[l); 
if (temp-part1 ~ temp-PArt2) 
char temp_string [3] , 
} 
char ·pt_temp_string - temp_Btring; 
pt_temp_Btring[O) - pt_offspring_char[O]; 
pt_offspring_char[O) _ pt_offspring_char[l); 
pt_offspring_char[l] - pt_temp_string[O]; 
11 .. 1se [ 
Ilcout « " ... « ·\n·l 
II} 
int fin_offspring-genotype _ atoi(offapring_char); 
I"cout « "\n\nthe genotype of the offspring is • « 
offspring_char « 
"\n";"/ 
return(fin_offspring_genotype); 
static int offspring_genotype_array[6); 
int offspring_array (int offspring_gen)! 
if (offspring_gen •• 22) ( 
offspring_genotype_array[O) +. I; 
else if (offspring_gen •• 23) ( 
offspring_genotype_array[l] +- 1; 
else 1f (offspring_gen •• 33) ( 
offspring_genotype_array[2) +. I; 
else if (offspring gen •• 24) ( 
offspring_genotype_array[3) +. 1; 
else if (offspring gen •• 34) { 
offspring_genotype_array[4] +- 1; 
else if (offspring_gen __ 44) ( 
offspring_genotype_array[5) +- 1; 
else 
cout « "error in offspring_genotype_array" « "\n"; 
I-for (int z _ 0; z < 6; Z++) ( 
cout « offspring_genotype_array[z] « " '; 
) 
cout « ·\nR~- _______ ~ ______________ ~ ____________________ _ 
\n"i-/ 
return(O); 
int temp_offspring_arraYI 
void entire-PQpulation (double population) 
int temp_number_of_offspring; 
for (int pop _ 1; pop <_ population; pop++) ( 
temp_number_of_offspring - number_of_offspring(); 
for (int f - 1; f <- temp number of offspring; f++) 
offspring_array-(offspring_genotype(»;} 
int main () 
{ 
gsl_rng_env_setup(); 
T • gsl_rng_default; 
r • 9s1_rn9_alloc(T); 
seed. time(NULL) * getpid(); 
gBl_rng_Bet(r. aeed); 
char *buffer; 
int decimal, sign; 
double file random. gsl rng uniform(r); 
buffer. fcVt (file rando.. S. kdecimal. ~sign ); 
char file name(39];-
atrcpy (file name, "fotios"), 
strcat (file-name. buffer); 
strcat (file=name.'.nb'); 
/IOpening the output file 
ofBtream my_file(file_name}; 
if (Imy_file) ( 
cerr « 'Failed to open my_file.\n'; 
exit(EXIT_FAILURE); 
/1 Ini ti al Population and frequencies 
int population. 200000; 
frq22 • 0.017; 
frq23 • 0.116; 
frq33 • 0.558; 
frq24 • 0.019; 
frq34 • 0.251; 
frq44 • 0.039; 
freq2 • frq22 + (frq23/2) + (frq24/2); 
freq3 • (frq23/2) + frq33 + (frq34/2); 
freq4 • (frq24/2) + (frq34/2) + frq44; 
11-74sec for population of 1000 for 10 generations 
clock_t start_time. clock(); 
IILoop and number of generations 
for (int gen. 1; gen <. 50; ++gen) 
/*cout « w _______________ GENERATION w« gen « • - ____ _ 
------·--------\n" 
« 'frequency 2 i8 • « freq2 "\n-
ec -frequency 3 is .. « freq3 "'n" 
« ~frequ~ncy 4 i8 .. freq4 « "\n" 
e< "frq22 is " frq22 « "\n" 
eC "frq23 is .. frq23 "\n" 
<e "frq31 18 " frq3l ·\n" 
« "frq24 is " « frq24 « -'n-
« ·frq34 i •• « frq34 « -\n-
« -frq44 is W « frq44 c< W\nw;./ 
entire-POpulation(population/(2 * 0.88}); 
//0.886 
my_file « 'generation(' « gen « .] • (. « 
freq2 <c • ,. « freq3 « .. 
II};" « "\n"; 
« freq4 « 
my_file « ·OffspringGenotypes(" « gen « "l_{" « 
offspring_genotype_array(O] « 
.. , .. « 
offspring_genotype_array(l] « 
", .. « 
offspring_genotype_array(2] « 
", • « 
offspring_genotype_array(3] « 
.. , .. « 
offspring_genotype_array(4] « 
.. , .. « 
offspring_genotype_array(5] « '};\n'; 
population. offBpring_genotype_array[O] + 
offspring_genotype_array(l] + 
offspring_genotype_array(2] + 
offspring_genotype_array(3] + 
offspring_genotype_array(4] + 
offspring_genotype_array(5]; 
if (population •• 0) ( 
} 
cout « ·population extinct" « "\n"; 
exit(EXIT_FAILURE); 
Ileise 
II cout«" b"c< "\n"; 
II} 
double tempbottom • 2 * population; 
double tempfreq2top • 2 * offspring_genotype_array(O] + 
offBpring_genotype_array(l] + 
offspring genotype array(3]; 
freq2 • tempfreq2top I tempbottom; 
double tempfreq3top • 2 * offspring_genotype_array[2] + 
offspring_genotype_array(l] + 
offspring_genotype_array[4]; 
freq3 • tempfreq3top I tempbottom; 
double tempfreq4top • 2 * offspring_genotype_array[5] + 
offspring genotype array[3] + 
offspring genotype array[4]; 
freq4 • tempfreq4top I tempbottom; 
double temp-POpulation • population; 
frq22 • offspring_genotype_array[O] I temp-population; 
frq23 • offspring genotype array(l] I temp-population/ 
frq33 • offspring=genotype=array(2] I temp_population/ 
frq24 • offspring_genotype_array(3] I temp-POpulation/ 
frq34 • offspring genotype array(4] I temp-POpulation; 
frq44 • offspring=genotype=array(s) I temp-POpulation; 
offspring genotype array[O] • 0; 
offspring=genotyp.=array(l] • 0; 
offspring_genotype_array(2) _ 0; 
offspring genotype array(3) _ 0; 
offspring-genotype-array(4) - 0; 
offspring=genotype=array(S) _ 0; 
my file.close(); 
clock_t stop_time - clock(); 
cout « -Time taken • • « 
static_cast<double>(stop_time - start_time) 
CLOCKS PER SEC « " secs.\n" 
-fr;quency 2 is • freq2 -\n-
<c -frequency 3 i8 • « freq3 « ·\nw 
<c -frequency 4 i8 • « freq4 « -\n-
« -frq22 is • « frq22 c< -\n-
"frq23 is " frq23 c< -\n-
<c ·frq33 is • <c £rq33 « -\nw 
« -frq24 is • « frq24 « -\n-
« -frq34 i8 • « frq34 « -\n-
« -frq44 is • « frq44 « -\0-; 
return (EXIT_SUCCESS); 
I 
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Appendix~ Mathematica notebook for the calculation of the random 
walk change per generation 
Loading Packages 
« Statistics'DescriptiveStatistics' 
« Graphics'MultipleListPlot' 
« Statistics'Confidencelntervals' 
« Statistics'DataManipulation' 
Setting Directory 
Directory[] 
C:lProgram FileslWoljram ResearchlMathematical4.0 
SetDirectory["C:\backed up\Mathematica\ApoE resuIts/lstJun"] 
C:lbacked uplMathematicalApoE resultsl]stJun 
Directory[] 
C:lbacked uplMathematicalApoE results\lstJun 
ListOfFiles = FileNames["(otios*.nb"]; 
NumberOfFiles = Length[ListOfFiles]; 
Number Of Generations 
gen = SO; 
Modules for Alleles Frequencies and Random Walk 
TotalSampleRu~generationNumber _? NumberQ, aIleleNumber _? NumberQ1 := 
Module[{ListOfFiles = FileNames["(otios*.nb"], NumberOfFiles = Length[ListOfFilesj}, 
ListTest = Table[Get[ListOfFiles[[i]]]; 
generation[generationNumbe!j[[alleleNumber- 1]], (i, 1, NumberOfFiles)] 
RandomWalk[alleleNumber_?NumberQ] := 
Module[{ListOfFiles = FlleNames["(otios*.nb"]}, 
RW = Flatten[Table[{Table[Get[ListOfFiles[[SetOfValues]]]; generation[i + l][[alleleNumber- 1]] -
generation[i][[alleleNumber-I]], {I, 1, 49}]}, {SetOfValues, I, 60}]] 
Printed by Mathematica for Students 
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F or Allele £2 
aUeleElMean = Table[Mean[TotaISampleRun[i, 2]], {i, 1, gen}]; 
alleleElSD = Table[StandardDeviation[TotaISampleRun[i, 2)), {i, 1, gen}]; 
aUeleElSDabove = Table[alleleElMean[[i)) + 2 x alleleElSD[[i)), {i, 1, gen}]; 
alleleElSDbelow = Table[alJeleElMean[[i)) - 2 x alleleElSD[[i)), {i, 1, gen}]; 
alleleElPlot = MultipleListPlot[alleleE2Mean, allelet:2SDabove, alleleElSDbelow, 
PlotJoined -+ {True, Automatic, Automatic}, SymbolShape -+ {None, PlotSymbol[Box, 1], PlotSymbol[Box, 1J}, 
SymbolStyle -+ {RGBColor[0.8, 0.8, 0], RGBColor[0.8, 0.8, OJ}, PlotStyle -+ RGBColor[O.8, 0.8, 0)) 
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Random Walk Analysis 
Confidence Intervals 
RWe2 = RandomWalk{2] 
RWe2Mcan = Mcan{RWc2] 
0.000335217 
RWe2SE = StandardDeviation[RWe2] 
0.00193138 
.. 
30 40 50 
...... . 
..... . 
" .. 
RWe2SE RWc2SE 
RWc2CI = {RWe2Mean - x 1.96, RWe2Mean + x I.96} 
V gen x NumberOfFiles V gcn x NumberOfFile 
{0.000266103, 0.00040433} 
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For Allele £3 
alleleE3Mean = Table[Mean[TotaISampleRun[i, 3]], {i, 1, gen}]; 
alleleE3SD = Table[StandardDeviation[TotaISampleRun[i, 3]], {i, 1, gen}]; 
alleleE3SDabove = Table[aUeleE3Mean[[i]] + 2 x aUeleE3SD[[i]], {i, 1, gen}]; 
alleleE3SDbelow = Table[alleleE3Mean[[ill - 2 x alleleE3SD[[i]], {i, 1, gen}]; 
alleleE3Plot = MultipleListPlot[alIeleE3Mean, alleleE3SDabove, alleleE3SDbelow, 
PlotJoined -+ {True, Automatic, Automatic}, SymbolShape -+ {None, PlotSymbol[Box, 1], PlotSymbol[Box, I]}, 
SymbolStyle -+ {RGBColor[0.9, 0, 0], RGBColor[0.9, 0, OJ}, PlotStyle -+ RGBColor[0.9, 0, 0]] 
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- Graphics -
Random Walk Analysis 
Confidence Intervals 
RWe3 = RandomWalk[3] 
RWe3Mcan = Mean[RWe3] 
0.000278457 
RWc3SE = StandardDeviation[RWe3] 
0.00272725 
RWe3SE RWe3SE 
RWe3CI = {RWe3Mean - x 1.96, RWe3Mean + x 1.96} 
V gen x NumberOfFiles V gen x NumberOfFiles 
{O.OOO J 80864, 0.000376051} 
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For Allele £1 
aIJeleE4Mean = Table[Mean[TotalSampleRun[i, 4]], {i, 1, gen}]; 
aUeleE4SD = Table[StandardDeviation[TotaISampleRun[i, 4]], Ii, 1, gen}]; 
aUeleE4SDabove = Table[alleleE4Mean[[i]] + 2 x a\leleE4SD[[i]], Ii, 1, gen}]; 
aUelCE4SDbelow = Table[a\lelu4Mean[[iJ] - 2 x a\leleE4SD[[i]], Ii, 1, gen}]; 
a\leleE4Plot = MultipleListPlot[aIleleE4Mean, a\leleE4SDabove, alIeleE4SDbelow, 
PlotJoined -+ {True, Automatic, Automatic}, SymbolShape -+ {None, PlotSymboI[Box, 1], PlotSymbol[Bo , In, 
SymbolStyle -+ {RGBColor[O, 0, 0.9], RGBColor[O, 0, 0.9]}, PlotStyle -+ RGBColor[O, 0, 0.9]] 
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Random Walk Analysis 
Confidence Intervals 
RWe4 = RandomWalk[4] 
RWe4Mean = Mean[RWe4] 
- 0.000613672 
RWe4 E = StandardDeviation[RWe4] 
0.00226254 
RWe4 E 
RWe4CI = {RWe4Mcan - -;::==========::::::= x 1.96, RWc4Mean + x 1.96} 
" gen x NumberOfFiles " gen x NumberOfFile 
{-0.000694636, -0.00053270B} 
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Graph representing the total allele frequencies change 
Show[alIeleuPlot, alIeleuPlot, alIelec:4Plot] 
Print["The change u per generation is -> It, RWe2Mean, "with 95% CI -> It, RWe2CI ] 
Print["The change u per generation is -> It, RWe3Mean, "with 95% CI -> It, RWe3CI ] 
Print["The change E4 per gen~ration is -> It, RWe4Mean, "with 95% CI -> It, RWe4CI ] 
0.8 
0 . 6 
0.4 
0.2 
....... 
••••••••••••••••••••••••••• I • 
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
•• I I I I II I I • I _ I •••••••••••••• " •••••••••••••••• , .' 
............................ 
........................ . 
• • • • • • • • • I I t I I I •••••••••••••••••••••••••••••••• 
10 20 30 40 50 
- Graphic s · 
The change e 2 per generation is -> RWe2Mean wi t h 95% CI -> RWe2CI 
The change e 3 per generation is -> RWe3 Mean wi t h 95% CI -> RWe3CI 
The change e 4 per generation is -> RWe4 Mean wi t h 95% CI -> RWe4CI 
Printed by Mathematica for Students 
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